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ABSTRACT
During development, a variety of cell types undertake a guided migration to their target 
location and, consequently, display motile, proliferative and invasive behaviours. Failure 
in guided migration can result in severe developmental errors, including the formation of 
metastatic cancers or, in the case of germ cells, congenital defects. Primordial germ cells 
(PGCs) are the germ line stem cell progenitors that produce the gametes and pass the 
genetic material from generation to generation. In Drosophila melanogaster, as in many 
other organisms, the PGCs are set-aside at the beginning of embryogenesis as a distinct 
sub-set of cells that are easily detectable by immunochemical means. As such, they 
provide a good system in which to study the control of cell migration during 
development. Furthermore, since they are subject to various cell death and cell survival 
signals during their journey, they provide an opportunity to study the regulation of stem 
cell survival in vivo.
wunen and wunen-2 encode lipid phosphate phosphatases (LPPs) and regulate 
Drosophila PGC survival and migration. LPP-like activity has been detected in all cell 
and tissue types so far studied, but remarkably little is known of their biological 
functions, and their physiological substrates remain elusive. The first aim of this work 
was to investigate differences in substrate recognition between Drosophila Wunen and 
the mammalian LPP isoforms, both in vitro, by means of biochemical assays and in vivo, 
by examining the ability of the mammalian isoforms to recognise the same physiological 
substrate as Wunen in Drosophila embryos. It also investigates hetero- and homo­
oligomerisation of the fly and mammalian LPPs as a possible mechanism of action.
In order to fully understand these proteins, it is necessary to identify and 
characterise their receptors. This work identifies a G protein-coupled receptor involved 
in Drosophila PGC migration and survival, and investigates its possible relationship to 
Wunen.
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INTRODUCTION
21.1) Migratory cell types in Drosophila
The ability of cells to initiate and undertake guided migrations, sometimes over long 
distances, is an essential prerequisite of both foetal and adult development, from 
gastrulation up to organogenesis, and from instigation of the inflammatory response, 
to wound healing. Since cell migration is instrumental to so many processes, failure 
in its regulation can result in a wide range of pathologies, such as defects in brain 
development, foetal malformations, or tumourigenesis. The range of cell types that 
are capable of displaying motile behaviour is diverse, yet it is becoming increasingly 
apparent that many of the signalling pathways involved in the regulation of cell 
motility/migration are highly conserved, both from cell type to type, and between 
organisms.
There are a number of cell types that display motility during the development 
of Drosophila melanogaster, and research has revealed some of the signalling 
pathways responsible for their directed movement.
1.1a) Border cells
The Drosophila egg chamber consists of 15 nurse cells, which supply RNA and 
protein to the single oocyte, all surrounded by a monolayer of somatic follicular 
epithelial cells. The border cells arise as a group of 6 to 10 cells from the anterior 
follicular epithelium. During oogenesis, the border cell cluster migrates between the 
nurse cells towards the oocyte, located at the posterior end of the chamber. Upon 
arrival at the oocyte, they reorient and migrate dorsally, coming to lie over the oocyte 
nucleus. Their primary function upon arrival is to create the pore in the micropyle for 
sperm entry during fertilisation (Montell, 2003; Rorth, 2002).
A number of genes have been characterised that regulate border cell 
migration. One of these, slow border cells (slbo ), is a transcription factor, and 
homologue of vertebrate C/EBP (CCAAT enhancer binding protein). Loss of slbo 
results in defects in border cell migration, and a number of downstream targets of 
slbo  have subsequently been identified and shown to be required for correct 
migration of the border cell cluster (Montell, 2003).
The JAK/STAT signalling cascade is instrumental in a number of different 
developmental processes, and has been conserved from flies to vertebrates. 
Activation of the JAK/STAT cascade can be from an array of different ligands, 
including cytokines and growth factors, and can result in growth, differentiation and
3migration. The ligands bind their specific membrane-bound receptor, which 
associates with a cytoplasmic tyrosine kinase of the Janus family (JAK). Upon 
receptor dimerisation, the JAK phosphorylates one of its tyrosine residues, resulting 
in the recruitment of cytoplasmic ST AT (signal transducer and activator of 
transcription). STAT, having also been phosphorylated by JAK, dimerises, 
translocates to the nucleus, and induces gene transcription (Hombria and Brown,
2002). In Drosophila, there is one known STAT (Stat92E) (Hou et al., 1996; Yan et 
al., 1996), one JAK (Hopscotch) (Binari and Perrimon, 1994) and one ligand 
(Unpaired) (Harrison et al., 1998). In 2001, Domeless was identified as the receptor 
for the JAK/STAT pathway (Brown et al., 2001). A gain-of-function screen for 
genes interacting with slbo identified Stat92E, and so revealed the importance of the 
JAK/STAT pathway in border cell migration. Whilst Unpaired is required in the 
polar cells to induce border cell migration, it was demonstrated that hopscotch and 
Stat92E are required within the border cells themselves (Beccari et al., 2002).
Whilst components of the JAK/STAT pathway induce border cell migration, 
PVR/EGFR and PVF1 regulate guidance to the oocyte. PVF1 (PDGF/VEGF factor 
1) is a Drosophila homologue of mammalian platelet-derived/vascular-endothelial 
growth factors, identified in a gain-of-function screen, alongside its receptor, PVR 
(Duchek et al., 2001). Both PVR and EGFR (epidermal growth factor receptor) are 
expressed in border cells, where they perceive the guidance signals, PVF1 and 
Gurken, produced by the oocyte. EGFR appears to be largely redundant for this 
purpose, with border cells able to utilise either receptor to successfully locate the 
oocyte. EGFR is, however, specifically required for the second, dorsal phase of 
border cell migration, in response to Gurken (Duchek and Rorth, 2001; Duchek et 
al., 2001). In vertebrates, PDGF and its receptors are essential for a number of 
critical developmental processes, and loss of either PDGFR results in embryonic 
lethality. In mice, a wide range of cell types, including oligodendrocytes and lung 
a l v e o l a r  s m o o t h  m u s c l e  c e l l s ,  a r e  d e p e n d e n t  on 
PDGFa signals for correct development (for review see (Tallquist and Kazlauskas, 
2004)).
41.1b) Hemocytes
As with vertebrate blood cells, hemocytes in Drosophila undergo a characteristic 
migration beginning at stage 8. Hemocytes first arise 2 hours post-gastrulation, and 
are detected as a discrete population of cells in the procephalic mesoderm. As 
gastrulation proceeds they divide into two clusters, migrating anteriorly and 
posteriorly. From stages 13 to 14 they migrate towards the centre of the embryo, 
whereupon they spread out and disperse evenly as single cells, although dense 
clusters remain in the head, fore- and hind-guts (Tepass et al., 1994). VEGFR is 
expressed in the precursors of the vertebrate vascular system, and both VEGFR and 
its ligands play critical roles in vasculogenesis and hematopoiesis. As with border 
cells, PVR and its ligands also appear to regulate hemocyte migration in Drosophila. 
It has been reported that hemocytes express PVR from stage 8 onwards, whilst cells 
lining the migratory route express the PVF ligands. Loss of PVR results in initiation 
of migration but a failure to disperse correctly at later stages, whilst ectopic 
expression of the ligand is sufficient to mis-direct hemocytes to inappropriate tissues 
(Cho et al., 2002).
1.1c) Tracheal cells
A receptor tyrosine kinase (RTK) and its growth factor ligand are also involved in 
the migration of tracheal tip cells during Drosophila embryogenesis. The branching 
respiratory network originates from 10 clusters of approximately 80 cells, known as 
the tracheal placodes, located on either side of the developing embryo. These 
placodes invaginate, and then branch 5 to 6 times, before fusion of the individual 
metameres. Branchless (Bnl) is an FGF-like (fibroblast growth factor-like) 
chemoattractant expressed in cells surrounding the placodes, and towards which the 
extending primary branches migrate. This signal is received by the FGF receptor, 
expressed by the tip cells, and encoded by breathless (btl) (Affolter and Shilo, 2000; 
Ribeiro et al., 2003; Uv et al., 2003). Alongside this system, it has also been shown 
that, as with border cells, JAK/STAT signalling is required for specification of a 
migratory cell fate in the tracheal cells (Ribeiro et al., 2003).
l.ld ) Primordial germ cells
Although this is a far simplified overview of the main types of migratory cells in 
Drosophila, it serves to illustrate the overlap in signalling systems that are employed
5to regulate, induce, or guide cells to their final destinations. But what of primordial 
germ cells (PGCs)? PGCs are the stem cell progenitors of the adult germ-line. In 
D rosophila , as in many organisms, the PGCs are set aside at the beginning of 
embryogenesis as a distinct sub-set of cells, both temporally and spatially removed 
from their target tissue the somatic gonad. In order to locate and coalesce with the 
gonad, it is necessary for this specialised group of cells to undertake an active and 
invasive migration through the developing embryo, a process that begins early on in 
embryogenesis.
1.2) Drosophila embryogenesis and PGC migration
Drosophila embryogenesis is divided into seventeen discreet stages determined by 
easily distinguishable morphological characteristics (Campus-Ortega, 1985). By the 
completion of oogenesis, the anterior-posterior and dorsal-ventral axes of the 
D rosophila  egg have been established by the maternal signalling systems. 
Post-fertilisation the egg contains zygotic nuclei that undergo a rapid succession of 
divisions before migrating out to the periphery, coming to rest in a thin layer of 
cytoplasm surrounding the central yolk. At this stage, prior to cellularisation, the egg 
consists of a highly ordered cytoplasm with three levels of cytoskeletal organisation 
and the posteriorly located pole plasm (Foe and Alberts, 1983). Pole plasm is a 
specialised form of cytoplasm consisting of electron dense polar granules containing 
both RNA and protein. The pole plasm components are produced by the nurse cells 
during oogenesis, under the control of the maternal-effect genes. Any nuclei entering 
the pole plasm automatically follow a germline fate (Illmensee and Mahowald, 
1974).
During stage 3, polar buds form around the nuclei at the posterior pole of the 
embryo, which divide once. The nuclei divide once more whilst the embryo remains 
as a syncytial blastoderm during stage 4, before pinching off to form 12 to 14 PGCs. 
Thus the PGCs are the first cells to form in the developing embryo, and are easily 
identified by immunostaining as a distinct cluster at the posterior pole (Fig.l, stage
4).
The embryo now undergoes cellularisation, just prior to the onset of 
gastrulation in stage 6. Towards the end of stage 5, the group of PGCs, now
6numbering between 30 to 40, are carried dorsally by the movement of the underlying 
posterior midgut anlage (Fig.l, stage 8). As the posterior midgut invaginates, the 
PGCs are carried into the gut lumen, where they pack down towards its blind end 
before actively migrating out of the lumen across the single-celled gut epithelium 
(Fig.l, stage 9-10). Having exited at stage 10, the PGCs spread out over the basal 
side of the posterior midgut and re-orient themselves towards the overlying 
mesoderm. Having entered the lateral visceral mesoderm, the PGCs divide into two 
bilateral groups and continue their migration until they contact their target tissue, the 
somatic gonadal precursors in parasegments 10-12 (Martinez-Arias and Lawrence, 
1985) (Fig.l, stage 12). These two cell types continue to remain associated with each 
other during germ band retraction. At around stage 13 they coalesce to form the two 
gonads (Fig.l, stage 13). Only 10 to 15 PGCs are found in each gonad by the end of 
embryogenesis, a significant reduction in overall number. A proportion, therefore, 
are ‘lost’ along the way, although as yet, the exact method of loss is not well 
understood (Bate, 1993; Campus-Ortega, 1985).
Key
Hindgut 
PMG m  Mesoderm 
S* PGCs
Stg 12Stg9
Stg 10 Stg 11
Fig.l. Germ cell migration in Drosophila.
Embryos on the left o f the figure are viewed laterally, whilst those on the right are 
viewed dorso-ventrally (except for the cartoon corresponding to stage 10, which is 
also oriented laterally). All are shown with their posterior to the right, with 
primordial germ cells (PGCs) stained for the germ cell-specific protein Vasa in 
brown. Cartoons to the right o f photos are representative o f the stage and indicate
7mesoderm, posterior midgut (PMG), hindgut and PGCs according to the colour key. 
At stage 4, the graded area in the cartoon indicates the pole plasm, whilst the PGCs 
are located at the far posterior pole. This is the syncytial blastoderm stage, prior to 
cellularisation. Arrows in the stage 12 embryo indicate ‘Lost’ PGCs.
1.3) Factors regulating PGC migration 
1.3a) Structural changes during embryogenesis
Work on the structural and morphological changes that occur during PGC migration 
led to a number of important insights in the mid 1990s. Using transplantation, 
microscopy and primary culture techniques, it was reported that the PGCs change 
shape from spherical to elongate at the beginning of gastrulation and extrude long 
pseudopodia into the surrounding environment. These shape changes are associated 
with rearrangements of their actin cytoskeleton. It was determined that the onset of 
migration through the polarised monolayer of the midgut epithelium is an active 
process that is PGC-specific and dependent on the developmental stage of the 
somatic tissue. It is associated with rearrangements of the adherens junctions 
between the posterior midgut cells, allowing the PGCs passage through the 
intercellular spaces. It was further reported that PGCs are capable of autonomous 
movement in vitro, and that they are able to orient correctly on the basal surface of 
the posterior midgut post exit in snail twist mutants, which as embryos lack the 
overlying mesoderm (Callaini et al., 1995; Jaglarz and Howard, 1994; Jaglarz and 
Howard, 1995; Leptin, 1991; Warrior, 1994).
Genetic studies demonstrated that PGC migration is independent of germ 
band retraction, and that initiation of migration can occur in the complete absence of 
endodermal tissue (Warrior, 1994). These analyses, however, did not unearth any of 
the signalling molecules involved in guiding the PGCs to their target tissue.
1.3b) Drosophila genetics: screens and the power of the UASIGAL4 system 
Over the years, numerous Drosophila genes have been identified and characterised, 
the majority through the use of large-scale genetic screens. These can employ a 
number of approaches and can uncover either zygotic or matemal-effect mutations. 
The original screens investigated loss-of-function phenotypes and typically
8employed ethyl methane sulphonate (EMS) as a mutagen. EMS-mutagenesis was the 
basis of the Nobel prize winning screen by Christiane Nusslein-Volhard and Eric 
Wieschaus, which identified key genes involved in patterning the Drosophila 
embryo (Nusslein-Volhard and Wieschaus, 1980). X-ray irradiation, an alternative 
mutagen, has the advantage that it does not produce the mosaicism associated with 
mutagenesis of a single spermatid followed by segregation, that is often observed 
with EMS.
One method for uncovering genetic components of a pathway is to employ a 
screen for dominant enhancers or suppressors. This type of screen was utilised to 
elucidate the Sevenless RTK signalling pathway involved in the recruitment and 
specification of the R7 photoreceptor cell in fly ommatidia (for review see (Simon, 
1994)).
For a proportion of genes, loss-of-function is lethal, making phenotypic 
analyses challenging. The use of clonal screens side steps this by specifically 
introducing targeted homozygous mutations to particular clones of cells, within a 
background of wild-type cells within a tissue. These clones can be induced via 
X-rays, or by employing the Flp-FRT technique developed by Golic and Lindquist 
(Golic and Lindquist, 1989; Xu and Rubin, 1993).
It is important when analysing the results of a zygotic screen to consider the 
possible role of maternal-effect genes. The maternal component of these genes is laid 
down during oogenesis, and this early contribution to the developing embryo may 
well mask the effects of a zygotic mutation. A saturation screen of the second 
chromosome identified a number of loci encoding maternal-effect genes. This screen 
isolated homozygous viable females that were phenotypically normal themselves, but 
which produced abnormal eggs. Out-crossing these females to wild-type males failed 
to rescue the observed phenotypes, confirming the role of maternal-effect genes. 
Phenotypic categories included complete failure of eggs to begin development, 
failure in syncytial blastoderm formation, failure in cellularisation, and failure to 
complete gastrulation (Schupbach and Wieschaus, 1989).
An alternative method is to screen for gain-of-function phenotypes, and this 
can be achieved by use of the multi-functional UAS/GAL4 system designed by 
Brand and Perrimon (Brand and Perrimon, 1993). GAL4 is a transcriptional 
activator, first identified in Saccharomyces cerevisiae, that regulates the transcription 
of the GAL1 and GAL10 genes by binding to a 17 base-pair stretch termed the
9Upstream Activating Sequence (UAS). In 1993, Brand and Perrimon reported the 
development of the GAL4/UAS system in D rosophila , allowing for accurate 
temporal and spatial control of gene expression in a tissue-specific manner. The 
system works by cloning a gene of interest into a specially designed P-element 
vector that can be readily introduced into the Drosophila  genome by standard 
microinjection/transformation techniques (Rubin and Spradling, 1982). The vector, 
termed pUAST, contains five tandemly arrayed and optimized UAS sequences 
upstream of the multiple cloning site, automatically placing control of the gene of 
interest cloned into this site under GAL4 regulation. There are many fly lines that 
express G A M  in a variety of different tissues at varying times during development, 
and these are termed ‘drivers’, whilst flies containing an integrated UAS-geneX are 
termed ‘responders’. One of the most valuable features of this system is that the 
driver and responder are maintained in separate lines. Only by crossing the two 
together is effective transcription of the gene initiated in the resulting FI progeny. 
This means that genes that are otherwise toxic, lethal, or oncogenic can be kept quite 
happily in a dormant state as homozygous viable stocks until introduction of the 
GAM  driver (Fig.2).
Various modifications and refinements of this system have since been 
developed (for a comprehensive review see (Duffy, 2002)). Addition of UAS target 
sequences to P-elements (transposable stretches of DNA that randomly insert in the 
5 ’ end of genes throughout the Drosophila genome) resulted in EP elements, 
whereby introduction of a G A M  source results in the expression of endogenous 
genes and can be used alongside a reporter such as LacZ in genetic screens (Rorth, 
1996).
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TwistGAL4 pUAST-GFP
Fig.2. Schematic o f the UASIGAL4 system.
Flies containing a tissue-specific GALA driver are crossed to flies containing a 
UAS-geneX construct. In this example the driver is the mesoderm-specific 
twist-GALA and the responder is a GFP reporter. The result is FI embryos with GFP 
expressed specifically in the mesoderm, shown here diagrammatically in a stage 10 
embryo.
1.3c) Genetic pathways
Over the years a number of genes have been identified that regulate different stages 
of Drosophila PGC migration. These begin with genes expressed during oogenesis, 
the products of which regulate the expression of zygotic genes involved in PGC 
specification. Mutations in these maternal-effect genes can affect pole plasm 
formation (e.g. oskar, vasa or tudor) or, alternatively, anterior-posterior patterning 
(e.g. gurken) (Wylie, 1999). Disruption of these processes necessarily results in a 
failure to form PGCs. At around stage 9, serpent and huckebein are required for
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correct midgut differentiation, and mutations in either results in a failure of PGCs to 
migrate through the posterior midgut surface (Jaglarz and Howard, 1994; Moore et 
al., 1998).
Two maternal-effect genes that specifically affect PGC migration are nanos 
(nos) and pumilio (pum). Maternal nos mRNA is localised to the pole plasm and 
incorporated into the PGCs as they form, whereupon the resultant Nos protein works 
alongside Pum to repress the translation of maternal hunchback (hb). Repression of 
hb creates a posterior gradient that results in abdominal specification. Transplanted 
PGCs that lack maternal nos do not migrate correctly, fail to become incorporated 
into the embryonic gonad, and demonstrate premature gene activation (Kobayashi et 
al., 1996). PGCs form normally in embryos lacking maternal Nos, and migrate 
through the posterior mid-gut wall as in wild-type. Having exited at stage 10, 
however, PGCs fail to disperse over the surface, and instead cluster together, 
subsequently failing to enter the mesoderm or connect with the somatic gonadal 
precursors (Forbes and Lehmann, 1998). As well as acting in concert to suppress hb, 
it appears that pum  acts as a cofactor in the regulation of PGC migration, pum- PGCs 
transplanted into host embryos exit the posterior mid-gut normally, but also fail to 
associate with the embryonic gonad, and again, gene expression is initiated 
prematurely. It is postulated that this premature gene activation may ‘trick’ the PGCs 
into ‘believing’ that they have already completed their migration, so arresting them 
at too early a stage (Asaoka-Taguchi et al., 1999).
Interestingly, embryos from nos homozygous mothers showed a reduction in 
PGC number starting at stages 9-10 (Asaoka-Taguchi et al., 1999). This PGC loss 
was suppressed in combination with Df(3L)H99, a deletion that removes reaper, 
head involution defective and grim, all essential components for apoptosis. When 
transplanted into host embryos, these PGCs were incorporated into a range of 
somatic tissues. Here, they assumed the morphology of these tissues, expressed 
somatic tissue-specific markers and lost expression of the PGC-specific marker Vasa 
(Hayashi et al., 2004). Thus prevention of apoptosis in these PGCs allows them to 
differentiate into somatic cells. Furthermore, a proportion of these nos- PGCs 
resumed the ability to migrate correctly to the gonads, leaving the authors to 
conclude that whilst Nos is not essential for PGC migration, it is required to suppress 
apoptosis. This suppression subsequently allows correct migration to the embryonic
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gonads. It also appears to suppress the pathway leading to a somatic cell fate, a novel 
and interesting role.
Researchers recently investigated interactions between the receptor tyrosine kinase 
Torso, STAT92E, and Ras during embryogenesis. They noted that mutations in each 
of these resulted in fewer PGCs at cellularisation, whereas double mutants in 
STAT92E and Ras had a much more dramatic reduction in number. They concluded 
that co-activation of STAT92E and Ras by Torso is required for PGC proliferation. 
Furthermore, embryos deficient in maternal STAT92E demonstrated PGC migration 
defects -  rather than associating with the overlying dorsal mesoderm post-exit from 
the midgut at stage 11, PGCs were found still associated with the midgut itself. 
Paternal rescue resulted in the formation of a single, over-populated gonad, 
indicating a possible failure of the PGCs to separate correctly into two bilateral 
groups. Loss of both maternal and zygotic STAT92E resulted in a failure to form any 
gonads, with PGCs scattering randomly throughout the embryo. Conversely, 
increased activation of STAT92E by over-expression of Hopscotch resulted in 
increased motility, with PGCs showing early invasiveness into the interior of the 
embryo at stages 4-5, and premature exit through the midgut. Increased levels of 
STAT92E gave supernumerary PGCs, with any that failed to migrate correctly to the 
gonads also failing to be eliminated, the usual course for ‘lost’ PGCs in wild-type 
embryos (Li et al., 2003). Embryos deficient in Ras displayed similar defects in PGC 
migration to those observed in STAT92E null embryos. Loss of Torso resulted in 
PGCs that were completely immotile. Interestingly ectopic expression of Unpaired 
was sufficient to perturb migration, with PGCs ending up in ectopic locations. The 
authors conclude that somatic tissues secrete ligands that activate the STAT92E 
and/or Ras signalling pathways, providing migratory cues for the PGCs (Li et al.,
2003).
An exhaustive screen of the third chromosome by EMS mutagenesis 
identified yet more genes, including zinc finger homeodomain-1 {zfh-1), heartless 
(htl) and fear o f intimacy (foi). In zfh-1 or htl mutants, PGCs exit the posterior 
midgut but fail to migrate into the overlying mesoderm, instead remaining on the 
midgut basal surface. Mutations in fo i result in an aberration in PGC and gonadal 
mesoderm coalescence, with the somatic gonadal precursors failing to associate 
tightly with one another (Moore et al., 1998). All three of these mutations, however, 
alongside many others found in this screen, affect the development of the gonadal
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mesoderm, which consequently results in perturbed PGC migration, rather than 
disrupting the intrinsic migratory properties of PGCs themselves.
One gene also identified by this screen (although first cloned in 1988 (Gertler et al., 
1988)), that does affect PGC migration and not mesodermal development, was 
co lum bus. co lum bus  encodes a D rosoph ila  homologue of 3-hydroxy-3- 
methylglutaryl coenzyme A reductase (hmgcr). In hmgcr mutants, a proportion of 
PGCs remain associated with the endoderm and fail to enter the mesoderm. Those 
that do successfully make it to the mesoderm then scatter, failing to associate with 
their target tissue the gonadal mesoderm. In fact, HMGCoAr is expressed in the 
gonadal mesoderm, and by using a number of gonadal mesoderm-specific markers, it 
was determined that the development of this tissue is unaffected in these mutants. 
Use of the UAS/GAL4 system (Brand and Perrimon, 1993) demonstrated that 
ectopic expression of HMGCoAr in alternative tissues was sufficient to attract PGCs 
to those tissues (Van Doren et al., 1998). Thus it is postulated that HMGCoAr 
influences PGC migration by mediating a somatic signal that behaves as an attractive 
guidance cue.
A second gene identified by the EMS mutagenesis screen was hedgehog {hh). 
hh encodes a secreted signalling protein and is required for patterning during early 
embryogenesis in animals. In flies, Hh has a number of both short and long range 
signalling roles, including regulation of patterning and formation of the somatic 
gonadal mesoderm (Ingham and McMahon, 2001). Consequently, mutations in hh 
also result in perturbed PGC migration as one would expect from disruption of these 
processes (Moore et al., 1998). In 2001, however, it was reported that mis-expression 
of Hh using a number of different GAL4 drivers attracted PGCs to ectopic locations, 
a phenotype strikingly similar to that observed for HMGCoAr. Using a lacZ reporter 
construct, alongside antibodies to the mesoderm marker Clift, researchers were able 
to determine that Hh is expressed in the somatic gonadal precursor cells. 
Furthermore, generating germline clones in four genes in the Hh pathway 
{smoothened, patched, protein kinase A and fused) also resulted in aberrant PGC 
migration (Deshpande et al., 2001). Whilst these data may indicate that Hh is acting 
to modify a secondary signalling molecule that regulates PGC migration, it is also 
possible that Hh itself acts as an attractive somatic signal influencing PGC migration 
directly.
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In mammals, HMGCoAr catalyses the conversion of HMGCoA to mevalonate, a 
precursor of, among other things, isoprenoids and cholesterol. Hh is first synthesised 
as a precursor protein, before undergoing autoproteolysis by its C-terminal domain 
into two smaller peptides. Addition of cholesterol to the C-terminus of the 
N-terminal peptide results in an active signalling molecule (Nusse, 2003). This 
requirement for a cholesterol modification, alongside its PGC migration phenotype 
and expression data, raised the possibility that Hh could be acting downstream in the 
hmgcr pathway. This has since been ruled out by a computational analysis of the 
Drosophila genome, which revealed that flies lack the majority of enzymes involved 
in the synthesis of cholesterol (Santos and Lehmann, 2004b). Further investigation of 
the Drosophila homologues discovered by this analysis revealed that three genes 
downstream of hmgcr, namely fp p s , encoding farnesyl-diphosphate synthase, 
quemao (qm ), encoding geranylgeranyl-diphosphate synthase, and geranylgeranyl 
transferase type 1 (GGTT1) are all necessary for successful PGC migration (Fig.3). 
The first two genes, and qm, are both required for the synthesis of isoprenoids: 
whilst a mutation in either gene results in a weak PGC migration defect, similar to 
that seen in hm gcr mutants, mutations in both genes results in a strong PGC 
migration defect. Furthermore, these mutations enhance the phenotype seen in the 
hmgcr mutant. This indicates that these genes cooperate to synthesise downstream 
GGTT1 and that it is GGTT1 itself, or, more specifically, the geranylgeranylation of 
proteins, that plays a significant role in guiding PGC migration. This is further 
substantiated by the fact that mutations in the p sub-unit of GGTT1 have the same 
phenotype in flies as does pharmacological blocking of GGTT1 or its precursors in 
zebrafish, indicating an evolutionarily conserved signalling pathway (Thorpe et al., 
2004).
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Fig.3. Biosynthesis o f cholesterol and isoprenoids. For simplification, only those 
enzymes and products implicated in Drosophila PGC migration are shown. Crosses 
indicate where Drosophila homologues are lacking in the cholesterol pathway. 
(Adapted from Thorpe et al., 2004 and Santos and Lehmann, 2004).
1.3d) Wunen and Wunen-2
To date, two distinct pathways have been discovered that control Drosophila PGC 
migration through somatic signals, and both appear to act via some level of lipid 
modification. The first, as touched upon above, involves HMGCoA reductase and the 
geranylgeranylation of target proteins. The second involves Wunen (Wun) and its 
closely related counterpart Wunen-2 (Wun-2).
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wunen was first identified as a novel genetic locus at 45D on the second chromosome 
of Drosophila in 1996 (Zhang et al., 19%). It was shown by deficiency analysis that 
in a wunen mutant, PGCs enter and pack down towards the distal end of the posterior 
midgut quite normally. Upon exiting the gut at stage 10, however, the PGCs fail to 
cluster dorsally and orient towards the overlying mesoderm - instead they spread out 
randomly, whilst still displaying the physical characteristics of motility. A number of 
PGCs consequently fail to contact the somatic gonad and are found outside the 
gonads at the end of embryogenesis (Fig. 4). This is a variable phenotype with 
varying degrees of severity. Examination of forkhead expression and expression of 
the retrotransposon 412 confirmed normal molecular and morphological 
development of both the embryonic gut primordium and the somatic gonad in these 
mutants. Mosaic flies containing wild-type germ cells in either a wunen or wild-type 
back-ground revealed that Wunen function is required in the somatic tissue and not 
within the germ cells themselves (Zhang et al., 19%).
Having mapped and subsequently cloned the transcript responsible for the 
wunen phenotype, in situ hybridisation (ISH) revealed a dynamic RNA expression 
pattern, with the highest detectable levels in the hindgut primordium, where PGCs 
are not found in wild-type embryos, having packed down into the distal end of the 
gut by this stage. As the PGCs move up towards the apical side of the posterior 
midgut epithelium just prior to exit, Wunen expression increases on the lower side, 
i.e. in the region of the gut that the PGCs are actively migrating aw ay  from. 
Moreover, ectopic expression of Wunen in the overlying mesoderm using a fly strain 
containing the UAS-Wunc18 construct crossed to flies carrying the twist-GAL4 driver 
(Greig and Akam, 1993) prevents PGCs from entering this normally attractive tissue 
and the majority are left outside the gonad (Zhang et al., 1997) (Fig. 4).
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Fig.4. Wunen expression and phenotypes.
Embryos in A and B are viewed dorso-ventrally with the posterior on the right and 
are stage 13. The embryo in C is viewed laterally at stage 10. Germ cells are stained 
with a monoclonal anti-Vasa antibody and are visualised in brown. A) In Wunen 
loss-of-function mutants, a number o f PGCs fail to contact the somatic gonad and 
are left ectopic to the gonads at the end o f embryo genesis. The arrowhead indicates 
these, whilst arrows indicate the gonads. B) Ectopic expression o f Wunen in the 
mesoderm (stained blue) results in perturbation o f PGC migration and PGC loss. 
Only one PGC has successfully located the gonad, as indicated by the arrow. Just 
four other PGCs remain but have failed to reach the gonad, as indicated by the 
arrowheads. C) Wunen expression pattern in a stage 10 embryo by 1SH. High levels 
o f expression are indicated in the hindgut and region o f the posterior midgut that the 
PGCs avoid as they exit. The PGCs are shown diagrammatically in red exiting the 
midgut.
Analysis of the wunen sequence revealed homology to the mammalian lipid 
phosphate phosphatases (LPPs). In 1998 a large-scale screen for genes expressed 
during Drosophila embryogenesis encoding secreted or transmembrane proteins
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identified another LPP-like protein, CK02248 (Kopczynski et al., 1998). CK02248 
was shown by computational analyses to encode a homologue of wunen, and was 
consequently named tunen (A.M.Hayden, 2000). This gene was further identified in 
an EP-element gain-of-function screen for genes involved in the development of the 
neuromuscular system in Drosophila larvae, again as a novel gene with homology to 
wunen (Kraut et al., 2001). A similar screen for genes involved in PGC migration in 
Drosophila again identified this gene (Starz-Gaiano et al., 2001). For this screen, 
males containing a randomly inserted EP element were crossed to females containing 
both the reporter gene fat facets-lacZ (faf-lacZ) and the germ-cell specific driver nos- 
GAL4-VP16. This drives expression of each random gene specifically in the PGCs 
as soon as they become transcriptionally active at stage 9. Having determined a 
migration phenotype with two EP elements, EP2217 and EP2650, and re-confirmed 
that phenotype by driving expression of each in the mesoderm, plasmid rescue, 
Southern blot analyses and sequencing revealed tunen as the gene responsible and it 
was subsequently renamed wunen-2 (Starz-Gaiano et al., 2001) (Fig.5).
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Fig.5. The w un and wun-2 genomic region, indicating introns and translated 
regions (Adapted from FlyBase (2003).)
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wunen-2 is transcribed 5Kb away from wunen, in the opposite direction and ISH 
confirmed that wunen-2 has the same mRNA expression profile as wunen, with 
dynamic expression in the epidermis, lateral neuroblasts and the anterior midgut, but 
with strongest expression in the hindgut and lower side of the posterior midgut. Just 
like Wunen, ectopic expression of Wunen-2 in the mesoderm repels PGCs and 
prevents them from entering this tissue. Interestingly, close analyses of these 
Wunen-2 embryos revealed a second, later phenotype. Starting at stage 11, embryos 
over-expressing Wunen-2 in the mesoderm showed a dramatic reduction in PGC 
number -  in many embryos between only two to four PGCs were left by the end of 
embryogenesis. The same result was further confirmed for Wunen, as seen in Fig.4B. 
Development of the mesoderm in these embryos was unaffected, but the same 
reduction in number was observed when Wunen-2 was ectopically expressed in 
either the nervous system or the trachea. Thus not only are Wunen and its 
counterpart Wunen-2 involved in regulating PGC migration, they also appear to play 
a pivotal role in PGC survival.
RNase protection and ISH data indicated that the original mutations in wunen 
were in fact double mutations removing both Wunen and Wunen-2 somatic function. 
It was further reported that insertions EP2607 and EP2527 removed both Wunen and 
Wunen-2 function respectively, with neither demonstrating a PGC migration defect. 
This led to the conclusion that Wunen and Wunen-2 function redundantly to control 
PGC migration and survival (Starz-Gaiano et al., 2001).
1.4) Lipid Phosphate Phosphatases (LPPs):
1.4a) History
Lipid phosphate phosphatases (LPPs) are integral membrane proteins of around 35 
kDa, which dephosphorylate a number of bioactive lipid phosphates involved in lipid 
signalling pathways. Originally, phosphatidic acid phosphatase (PAP) activity was 
identified as important for the production of the second messenger diacylglycerol 
(DAG) from phosphatidic acid (PA), a precursor of triacylglycerols, 
phosphatidylcholine and phosphatidylethanolamine. The PAP-1 enzyme is located in 
the cytosol where it provides a reservoir of activity and it is activated by
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translocation to the endoplasmic reticulum. A second distinct PAP-like enzyme was 
first identified and characterised from rat liver preparations by Brindley et al in 1991. 
By developing specific assays, they were able to demonstrate that this second PAP, 
which they named PAP-2, localised to the plasma membrane and showed a high 
affinity for PA as a substrate. Unlike PAP-1, PAP-2 proved to be insensitive to 
A-ethylmaleimide (NEM) inhibition and was Mg2+ independent (Jamal et al., 1991).
The PAP-2 enzymes were renamed lipid phosphate phosphatases (LPPs) 
following the discovery that they are capable of dephosphorylating a range of 
phospholipid substrates, alongside PA.
The first successfully cloned mouse LPP-1 cDNA (Kai et al., 1996) was 
quickly followed by identification of a second isoform, rat Dri42 (LPP-3), and then 
human LPP-1 and LPP-3 (Barila et al., 1996; Kai et al., 1996; Kai et al., 1997). The 
third isoform, LPP-2, was also identified in humans (Hooks et al., 1998; Roberts et 
al., 1998). Having established the existence of three isoforms, splice variants were 
reported for the human protein (hLPP-la) and identified in rat lung by RT-PCR 
(LPP-la, b and c) (Leung et al., 1998; Nanjundan and Possmayer, 2001a). More 
recently, Plasticity-related gene-1 (PRG-1), a novel member of the LPP family, has 
been identified in rat hippocampus (Brauer et al., 2003).
Besides the mammalian and Drosophila LPP isoforms, LPP homologues 
have been identified in Saccharomyces cerevisiae  and Arabidopsis thaliana 
(Pierrugues et al., 2001; Toke et al., 1998).
1.4b) LPP structure
By using the Escherichia coli gene pgpB in the National Center for Biotechnology 
Information (NCBI) BLAST search program, Stukey and Carman identified a novel 
sequence motif present in twenty-three established or predicted LPP proteins (Stukey 
and Carman, 1997). From this, they proposed a novel phosphatase superfamily based 
on amino-acid sequence homology, and including fungal haloperoxidases, 
mammalian G6Pase, rat Dri42 and Wunen. The reported phosphatase sequence motif 
consists of three highly conserved domains, all between 4 to 11 amino-acids in 
length, and each including 3 or 4 absolutely conserved residues. The order of the 
domains in each protein is invariant (Fig.6).
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Fig.6. The three conserved domains that characterize the phosphatase superfamily
(as proposed by Stukey and Carman, 1997). Amino-acids shown to be essential for  
catalytic activity are highlighted in orange.
Further analyses using a statistically based search and multiple sequence alignment 
program (PROBE) (Neuwald, 1997) indicated that these membrane-associated 
proteins share conserved structural elements and may share a similar catalytic 
mechanism to related soluble globular enzymes. The family includes vanadium 
chloroperoxidase (CPO) of Curvularia inaequalis. This is an important family 
member, as its structure is already known. Comparisons with CPO led to the 
development of models for structure, and mechanisms of hydrolysis, for other family 
members, specifically in this case, the LPPs.
Hydropathy analysis indicates that the LPPs are membrane-spanning 
proteins. Studies into the topology of Dri42 using truncated proteins fused to a 
reporter confirmed this, and demonstrated that not only are both the N- and C-termini 
cytosolic, but that the 6 hydrophobic segments are inserted into the membrane by 
alternating halt/transfer and insertion signals (Barila et al., 1996). In 1999, Jasinska 
et al. demonstrated that LPP activity is only detected in the membrane fraction of 
rat2 fibroblasts stably expressing mLPP-1. Using a C-terminal tagged GFP-fusion 
protein, confocal microscopy, and immunostaining, they were also able to show that 
the C-terminus of mLPP-1 is cytosolic (Jasinska et al., 1999). As a follow up to this 
work they used site-directed mutagenesis to demonstrate that seven of the amino- 
acids within the three conserved domains are absolutely required for catalytic
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activity and, therefore, that these domains constitute the active site. Taken together, 
these results confirm that the active site, composed of the three domains, is located 
on the outer surface of the plasma membrane. The mammalian LPPs contain a 
conserved N-glycosylation site. It was further established that this site resides 
between domains 1 and 2 and is not required for catalysis. This further supports the 
location of the active site as extracellular (Zhang et al., 2000b) (Fig.7).
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1.4c) LPP localisation
Purification of the LPPs has proved challenging, leaving antibodies to these proteins 
hard to come by. Nevertheless, LPP-like activity has been detected in all cell and 
tissue types so far studied, in a range of different organisms, including yeasts and 
plants. Despite previous problems, Andrew Morris’ group did obtain an antibody to 
an N-terminal peptide sequence specific to LPP-3. They used this to examine the 
expression of LPP-3 in various mouse tissues, finding it to be differentially 
expressed in brain, kidney, liver, heart, spleen, lung and skeletal muscle (Sciorra and 
Morris, 1999). Whilst whole mount ISH indicates that LPP-1 and LPP-2 are 
expressed throughout mouse embryogenesis, LPP-3 displays a tissue-specific and 
dynamic expression pattern, coinciding with its role during embryonic development 
(Escalante-Alcalde et al., 2003).
To begin to elucidate the physiological function of the LPPs, it is necessary to 
characterise their cellular localisations. Work on LPP-1 and LPP-2 is a little less 
comprehensive than for LPP-3, but indicates that both proteins localise to the plasma 
membrane, as well as to ill-defined intracellular compartments (possibly the 
endoplasmic reticulum and Golgi apparatus) (Alderton et al., 2001; Jasinska et al., 
1999). Work on LPP-3 has proved more exhaustive and indicates that localisation is 
dependent on cell type. If stably expressed in human embryonic kidney cells 
(HEK293 cells), LPP-3 localises predominantly to the plasma membrane, as has 
been found by three separate groups (Alderton et al., 2001; Ishikawa et al., 2000; 
Sciorra and Morris, 1999). If expressed in COS7 cells, however, LPP-3 localises to 
the endoplasmic reticulum, as does rat Dri42 in both FRIC B cells (foetal rat 
intestinal cell line) and MDCK cells (Madin-Darby canine kidney) (Barila et al., 
1996; Sciorra and Morris, 1999). It has also been reported that 10-15% of LPP-3 
activity is present in caveolin-enriched, detergent-resistant membrane microdomains 
(DRMs) in Swiss 3T3 cells (Sciorra and Morris, 1999). This localisation is LPP-3 
specific, is not detected for LPP-1 and is further substantiated by findings that LPP-3 
activity is highly enriched in similar domains from rat lung tissue, isolated rat type II 
cells and mouse lung epithelial cell lines (MLE12 and MLE15) (Nanjundan and 
Possmayer, 2001b).
More recently, Jia et al. reported that LPP-1 and LPP-3 in MDCK cells localise
24
to distinct sub-domains of the plasma membrane. They determined that both contain 
sorting signals (a six residue N-terminal sequence in LPP-1 and a dityrosine motif in 
the second cytoplasmic loop of LPP-3) which result in LPP-1 localising to the apical 
side of the plasma membrane, and LPP-3 localising to the baso-lateral sub-domain 
(Jia et al., 2003).
1.4d) LPP substrates
The three LPP isoforms can de-phosphorylate a variety of phospholipids, namely 
phosphatidic acid (PA), lysophosphatidic acid (LPA), sphingosine-1-phosphate 
(SIP), ceramide-1 -phosphate (C1P) and diacylglycerol pyrophosphate (DGPP). The 
primary source of LPA and S1P production in vertebrates is activated blood platelets. 
Here, PA is converted to LPA through the action of Phospholipase A2 (PLA2) 
(Fig.8). SIP is generated by the action of sphingosine kinase (Fig.9). Both products 
are released into the extracellular environment where they become active signalling 
components of serum.
Phosphatidylcholine Lysophosphatidylcholine
PLA1, PLA2
Phospholipase D1. D2 Lysophospholipase D 
(Autotaxin)
C H j-O Q C R - 
RTOO-CH 0
CHa —O-P-OH
O' *H
PLA1. PLA2
Acyltransferases
LPP DAG kinase
CHj—OOCR'
LPA Z
C H j- O - P - O H  
O- H*
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Diacylglycerol (DAG) Monoacylglycerol
Fig.8. The action o f LPPs on PA and LPA (adapted from Brindley (Brindley, 
2004)).
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Fig.9. The action o f LPPs on S IP  and C1P (adapted from Waggoner et al 
(Waggoner et al., 1999)).
In fact both LPA and SIP are released from a number of different cell types, 
including adipocytes and fibroblasts, and can act in either a paracrine or autocrine 
fashion to elicit a wide variety of biological or pathological responses. LPA and SIP 
can induce platelet aggregation and angiogenesis (the formation of new blood 
vessels) and consequently, following their release from activated platelets, may be 
instrumental in wound repair. They are also known to stimulate cell proliferation, 
chemotaxis, cell-cell aggregation, growth-cone collapse and the activation of 
numerous other enzymes, including phospholipase D (Moolenaar, 1999; Pyne et al., 
2004; Waggoner et al., 1999). LPA can prevent apoptosis in certain cell types, but it 
can also support apoptosis in others; furthermore, LPA promotes tumour 
invasiveness. In fact, levels of LPA are specifically raised in the ascites of ovarian 
cancer patients (Fang et al., 2000; Mills et al., 2002).
LPA and SIP activate cell responses through their specific G protein-coupled 
receptors (GPCRs). There are at least seven members of these endothelial 
differentiation gene (Edg) receptors - Edg2, 4, and 7 are selective for LPA, whilst 
Edgl, 3 and 5 are selective for SIP. Multiple receptors can be expressed at any one 
time in any particular cell type, and can initiate a wide range of signalling pathways.
The conversion of sphingomyelin to the precursor ceramide by 
sphingomyelinases is the first step in the generation of a number of bioactive
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sphingolipids. Ceramide, produced by the action of LPPs on C1P, induces cell 
differentiation, inhibits cell division and induces apoptosis. Conversely C1P 
stimulates DNA synthesis and cell proliferation (Waggoner et al., 1999). SIP, 
produced from sphingosine by the actions of sphingosine kinase, can also prevent 
apoptosis. Importantly, it has been shown that treating mouse oocytes with SIP ex 
vivo prevents normal developmental apoptosis, and, furthermore, protects oocytes 
from apoptosis induced by anti-cancer therapies. An in vivo administration of SIP 
two hours prior to irradiation also prevents oocyte loss in mice (Morita et al., 2000).
Far less is known about DGPP, a novel lipid discovered in E.coli and 
S.cerevisiae. In these organisms, DGPP phosphatase (in E.coli the product of the 
pgpB gene (Dillon et al., 1996)) converts DGPP to PA, then dephosphorylates PA to 
produce DAG. LPP isolated from rat liver has been shown to catalyse the same 
reaction in vitro, as has mLPP-1, and rLPP-1 from membrane preparations of rat2 
fibroblasts presented with DGPP in triton micelle assays (Dillon et al., 1997; 
Jasinska et al., 1999).
The ability to modulate these bioactive substrates in vitro implies that the 
LPP family of enzymes may have important roles in regulating the levels of these 
potent signalling molecules in vivo. This regulation may involve the attenuation of 
their activities by dephosphorylation to a biologically inactive form, or 
transformation of their activities through conversion to an alternative bioactive form.
1.4e) Physiological functions o f LPPs
Despite the enormous amount of research that has been carried out on the LPPs, 
remarkably little is known of their actual functions in vivo, and their true 
physiological substrates remain frustratingly elusive. Data are certainly available on 
the differential expression patterns of the separate LPP isoforms, but this does not 
tell us what function they are actually performing. Knowledge of where the LPPs are 
expressed in vivo, however, in conjunction with in vitro data and the phenotypic 
results of ectopic expression and knockouts in different organisms, should eventually 
prove illuminating.
One of the first genes to be characterised, rat Dri42, may function in 
intestinal epithelial differentiation during development. Dri42, expressed in liver, 
kidney and lung epithelia, was first discovered during a search for genes 
up-regulated during development and differentiation. The mature villus epithelium
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consists of three distinct cell types -  absorptive enterocytes, goblet cells and 
enteroendocrine cells. Dri42 mRNA is expressed along the entire villus epithelium in 
both horizontal and vertical axes. Furthermore, Dri42 has been localised by ISH to 
developing and mature rat brain and spinal cord (Barila et al., 1994; Barila et al., 
1996; Suzuki et al., 1999).
Northern analyses have shown the human splice variant hL P P -la  to be 
down-regulated in tumour tissue, with the most dramatic changes seen in colon 
tumours. What specific role LPP-1 has in this case is still not known, but it has been 
proposed that it may present a gene therapy target in the future (Leung et al., 1998).
The AtLPP genes in A.thaliana encode homologues to the mammalian LPPs. 
Whilst AtLPP2 is expressed ubiquitously throughout the plant, AtLPPl is selectively 
expressed in the leaves and roots. Subjecting the plant to a number of external 
stimuli, including oxidative stress, ionising and gamma radiation and G-protein 
activation, resulted in a rapid and transient rise in the levels of AtLPPl expression, 
but no increase in AtLPP2, indicating either redundancy or distinct functions for 
each of these genes. Since PA and DGPP also accumulated in response to stress in 
these plants, it is speculated that in A.thaliana the function of at least one LPP gene 
may be to attenuate the potent signalling properties of these molecules (Pierrugues et 
al., 2001).
The use of gene targeting in embryonic stem cells allowed Zhang et al. to 
delete transmembrane domains 2 and 3, as well as domain 1, of mouse LPP-2. They 
interbred the resultant viable, fertile, heterozygous adults to produce homozygous 
null progeny. The lack of an LPP-2 transcript was confirmed by Northern analyses. 
Not only were the null offspring bom at the expected ratio, they were also perfectly 
viable and fertile adults, with no obvious phenotypic defects. Thorough 
histopathological analyses revealed no abnormalities in any of the major organ 
systems. The authors were left to conclude that in mice at least, LPP-2 is 
non-essential during embryonic development and possibly redundant to the LPP-1 
and LPP-3 isoforms (Zhang et al., 2000a).
In a striking contrast to these findings, mice null for LPP-3 displayed distinct 
and dramatic developmental defects. Using targeted mutagenesis, Escalante-Alcalde 
et al. deleted parts of the fourth, fifth and sixth transmembrane domains as well as 
the second internal and third external loop of LPP-3 in mice embryos. Analyses of
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embryoid bodies (cell structures derived from embryonic stem cells that have 
differentiated into the three germ layers - ectoderm, endoderm and mesoderm) 
confirmed the lack of intact protein, and the absence of phosphatase activity. 
Heterozygous mice were viable and fertile, but when interbred failed to produce any 
homozygous null offspring, indicating that LPP-3 is a vital gene for completion of 
embryogenesis in the mouse. PCR analysis of embryos seven to ten days post 
gestation indicated the expected ratio of wild-type to heterozygotes to homozygotes, 
demonstrating that the lethality of the null mutation occurs prior to embryonic day 
ten. Observation of homozygous null embryos prior to their death revealed a number 
of gross abnormalities. Besides a developmental retardation of twelve to twenty-four 
hours, endothelial cells failed to organise into a capillary network, resulting in 
limited formation of yolk-sac vasculature. This was coupled with incorrect 
development of the allantois (the precursor to the umbilical cord), resulting in a 
failure to form a chorio-allantoic placenta. The chorio-allantoic placenta separates 
the foetal and maternal circulatory systems and is essential for provision of nutrients 
to, and removal of waste from, the developing embryo (Escalante-Alcalde et al.,
2003).
Thirty percent of LPP-3 null embryos revealed further abnormalities, 
including anterior truncation and shortening of the anterior-posterior axes, as well as 
duplication of axial structures. In Xenopus laevis, correct establishment of the 
dorsoventral axis is dependent on the Wnt/p-catenin signalling pathway. When Wnt 
is absent from cells, p-catenin is phosphorylated by glycogen synthase kinase 3 
(GSK3) and targeted for ubiquitination and degradation in proteosomes. When Wnt 
is active, however, GSK3 is prevented from phosphorylating P-catenin through 
activation of Dishevelled, resulting in P-catenin stabilisation. P-catenin is then free to 
accumulate in the nucleus, where it interacts with members of the T-cell factor (TCF) 
and Lymphoid enhancer factor (LEF) transcription factors, to activate the expression 
of Wnt target genes. Stabilisation of p-catenin on the dorsal side of developing 
X.laevis embryos is critical for dorsoventral organisation (Weaver and Kimelman,
2004).
Increased expression of P-catenin in mouse embryos resulted in axis 
duplication. Evidence from Escalante-Alcalde et al. indicates a novel and previously 
unrealised role for LPP-3 in the regulation of P-catenin signalling during
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embryogenesis. They showed that not only does ectopic expression of LPP-3 in 
HEK293 cells inhibit TCF-activated transcription mediated by endogenous 
P-catenin, but that levels of endogenous P-catenin activity are raised in LPP-3 null 
embryonic stem cells, along with the expression of the Wnt target gene brachyury. 
Expression of mouse LPP-3 by introduction of mRNA into 2 dorsal blastomeres of a 
4-cell stage X.laevis embryo resulted in a ventralising affect similar to that seen from 
injection of Wnt agonists. Furthermore, they observed the same inhibition of 
TCF/p-catenin-dependent transcription in HEK293 cells when they over-expressed 
LPP-3 constructs in which a key catalytic site had been mutated or ablated, removing 
phosphatase activity (Escalante-Alcalde et al., 2003).
The conclusion from this work is that mouse LPP-3 is not only critical for 
early vascularisation and formation of the chorio-allantoic placenta, but may also act 
as an antagonist to the Wnt/p-catenin signalling pathway. Significantly, this latter 
role appears to be independent of its phosphatase activity.
A further role in angiogenesis has been suggested for hLPP-3 by findings that 
this protein contains an RGD domain in the second extracellular loop. RGD domains 
interact with integrins -  receptor proteins that mediate cell binding and response to 
the extracellular matrix. hLPP-3 was identified in a screen for genes influencing 
capillary morphogenesis, and was subsequently named VCIP (VEGF and type 1 
collagen inducible protein) (Humtsoe et al., 2003) before sequence analysis 
identified it as identical to the previously characterised hLPP-3 (Kai et al., 1997). 
Expression of VCIP in a cultured monolayer of endothelial cells was induced by 
addition of the cytokines VEGF, FGF and PMA. Expression of VCIP in HEK293 
cells promoted cell-cell interactions and the formation of aggregates, whereas 
expression of VCIP carrying a mutation in the RGD domain, or expression of the 
vector alone, had no effect. Interestingly, levels of apoptosis in the cells expressing 
the mutated RGD domain were increased, leading authors to speculate that this 
mutation may somehow alter the phosphatase activity of the enzyme, increasing its 
dephosphorylation of lipid phosphates to apoptosis-promoting factors such as 
sphingosine and ceramide (Humtsoe et al., 2003). It was shown through the use of a 
variety of techniques including solid-phase ligand binding assays, that VCIP 
specifically recognises the integrins a vP3 and a 5(3j, and that VCIP is preferentially 
expressed in inflamed and angiogenic tissues, co-localised to areas of a vp3 (Humtsoe
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et al., 2003). Significantly, hLPP-1 and hLPP-2 do not possess this RGD domain, 
indicating a specific and novel role of the LPP-3 isoform in humans. Interestingly, 
despite its role in vasculogenesis and capillary formation, mLPP-3 also lacks this 
domain, perhaps pointing towards a conserved function through a divergent 
mechanism. It is pertinent to note that both Wunen and Wunen-2 also lack this RGD 
domain.
Ubiquitous over-expression of LPP-1 in mice using an actin-promoter also 
resulted in multiple developmental defects, in a transgene copy-number (i.e. dose) 
dependent manner. Although no defects were observed in development of the major 
organs, pups were bom with decreased birth weight and a decrease in body hair due 
to an overall reduction in the density of hair bulbs. Litter sizes from these animals 
were smaller than average and although ovaries and uteruses from affected females 
showed no gross abnormalities, testes were atrophic with disrupted spermatogenesis. 
Interestingly, circulating LPA plasma levels were unaffected in these mice (Yue et 
al., 2004).
PRG-1, recently identified in lesioned rat hippocampus, putatively encodes 
another member of the LPP family. Biological findings with PRG-1 are also novel 
and exciting, and may prove particularly relevant in the ongoing search for the 
physiological substrates of the LPPs, especially Wunen. PRG-1 is primarily 
expressed in the central nervous system (with minor expression in the testis) and 
appears to be vertebrate-specific. ISH indicates that it is expressed in the developing 
hippocampus in neurones. During development, axonal outgrowth proceeds through 
a phospholipid-rich extra-cellular environment. In this environment LPA acts as a 
repellent, inducing neurite retraction and cell rounding. Whilst post-natal entorhinal 
axons expressing PRG-1 are resistant to LPA-induced collapse, those from 
embryonic day 16 with no PRG-1 expression show no such resistance (Brauer et al., 
2003).
Exposure to LPA also induced growth cone collapse in the neuronal cell line 
N1E-115. Introduction of PRG-1 expression into these cells made them resistant to 
LPA-induced growth cone collapse, and extra-cellular LPA degradation increased 
five-fold. Mutation of one conserved and essential residue required for phosphatase 
activity in LPPs (His252 to Lysine) did not protect against growth cone collapse in 
these cells and resulted in a loss of observed phosphatase activity, suggesting that the
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phosphatase activity is required for the protective effects of PRG-1 (Brauer et al., 
2003).
Doubts have been raised, however, as to the validity of these findings within 
the context of the LPP ‘field’, since three key residues, absolutely conserved between 
other members of the family and essential for phosphatase activity, show 
non-conserved substitutions in the PRG-1 protein (Fig. 6). Discrepancies appear to 
exist between data generated in the original study (Brauer et al., 2003) and 
subsequent data generated using radiolabelled phospholipid substrates in both N1E- 
115 and HEK293 cells, leaving others to conclude that PRG-1 activity is not in fact 
directly attributable to an LPP activity (McDermott et al., 2004). As noted by the 
original researchers and cited in their response to this criticism, however, data 
published from the work presented here clearly demonstrates that the different LPP 
isoforms present very different bioactivities when assayed within an actual in vivo 
system (Brauer et al., 2004; Burnett and Howard, 2003). Whilst still contested at the 
present time, it remains to be determined as to whether PRG-1 is truly a novel 
member of the LPP family. If it proves to be so, then it would appear that LPP 
proteins might regulate axonal outgrowth in mammalian systems.
Similar to the role of LPP in mouse axis specification, Drosophila Wunen has 
been implicated in the development of left/right asymmetry during embryogenesis 
(Ligoxygakis et al., 2001). Combined with its function in germ cell migration and 
survival, therefore, Wunen appears to be important for a number of developmental 
processes and provides a good opportunity to study these enzymes in greater detail.
1.5) Alms of the investigation
As interest in the physiological significance of the LPPs increases, it becomes 
increasingly important to identify their endogenous substrates and to characterise 
their exact roles in vivo. Given the remarkable bioactivity of the known lipid 
substrates for these enzymes and the specificity of some of their receptors, it seems 
curious that the separate isoforms should present such broad range activity in 
biochemical assays. Much of the work on substrate specificity to date, however, has 
used triton micelle assays or cell culture techniques, rather than directly testing for 
substrate preference in vivo using model organisms.
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The aim of the present work was to explore potential specificities in substrate 
recognition between the different LPP isoforms both biochemically in vitro, and 
biologically in vivo, by examining their ability to recognise an endogenous substrate 
within a physiological environment. A further aim was to investigate the ability of 
the LPPs to form and function as oligomeric complexes, and the requirement or 
otherwise of these complexes for both biological and biochemical activity either in 
vitro or in vivo.
As Wunen influences PGC migration and survival, there must be receptors 
present on the surface of PGCs that can recognise and interpret this signal. This work 
also set out to identify and characterise such a receptor(s), and investigate any role it 
may itself play in PGC guidance and survival during Drosophila embryogenesis.
2) CHAPTER ONE 
Substrate Specificities of the LPP Isoforms
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2.1) Introduction
The structure of the LPPs has yet to be solved and consequently much of the 
information regarding mechanisms of catalysis and interactions within the active site 
has been gleaned from structural knowledge of chloroperoxidase (CPO). CPO is a 
member of the phosphatase superfamily proposed by Stukey and Carman (Stukey 
and Carman, 1997) and found in the fungus Curvularia inaequalis. In the presence of 
hydrogen peroxide, CPO converts chloride to hypochlorous acid. It is believed to use 
this to oxidize plant walls, enabling its subsequent entry into the plant. The crystal 
structure of CPO was solved in 1996 and has facilitated models projecting the 
catalytic mechanism of the LPPs (Hemrika et al., 1997; Messerschmidt and Wever, 
1996; Neuwald, 1997). CPO contains a vanadate ion bound to its active site through 
interactions with a number of residues that are highly conserved throughout the 
superfamily. It is believed that this ion is bound in a similar manner to the phosphate 
group in the LPPs. Indeed, vanadium displays phosphatase activity, but also acts as 
an inhibitor to a range of phosphate-metabolizing enzymes. Likewise, the peroxidase 
activity of CPO is inhibited by the presence of phosphate (Stankiewicz et al., 1995).
The seven residues highlighted in orange in Fig.6 are predicted to 
interact directly with the vanadate ion in CPO via Hydrogen-bonds. The 
corresponding residues in mouse LPP-1 and Wunen are shown in Table 1. By 
individually mutating each of these residues, immnopurifying GFP-tagged versions 
of each protein and investigating their subsequent ability to dephosphorylate 
32P-LPA, Zhang et al were able to demonstrate that, true to the proposed model, each 
of these residues is essential for catalytic activity in mouse LPP-1 (Zhang et al., 
2000b), and together compose a three dimensional extra-cellular catalytic site. 
Mutation of H274 and H326 in Wunen-2 also eliminated its biological activity on 
PGCs when over-expressed in the mesoderm (Starz-Gaiano et al., 2001).
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CPO Mouse LPP-1 Wunen Wunen-2
K353 K120 K132 K214
R360 R127 R139 R221
P361 P128 P141 P222
S402 S169 S190 S272
H404 H171 H192 H274
R490 R217 R238 R320
H496 H223 H244 H326
Table 1. Conserved amino-acids. The seven amino-acids believed to constitute the 
active site within the three conserved LPP phosphatase domains. All seven were 
shown to be essential for catalytic activity in the mouse (Zhang et al., 2000b).
Past work has demonstrated that all three of the LPP isoforms are capable of 
dephosphorylating five known phospholipid substrates, namely PA, LPA, SIP, C lP 
and DGPP, with varying degrees of specificity (Dillon et al., 1997; Furneisen and 
Carman, 2000; Jasinska et al., 1999; Kai et al., 1997; Roberts et al., 1998; Waggoner 
et al., 1996). Interestingly, considerable discrepancies exist between published 
results on relative substrate preference. For example, Kai et al reported that whilst 
LPA was hydrolyzed more efficiently than C1P, LPP-1 showed no activity 
whatsoever on SIP. Conversely, Roberts et al reported that four substrates were 
hydrolyzed in order of preference: LPA>PA>S1P>C1P, whereas Jasinska et al. 
observed similar levels of efficiency for all four. Conflicting data also exists for LPP- 
3, with Kai et al. recording activity on SIP at eight times the rate of activity on LPA 
and C1P, whilst Roberts et al., seemingly in complete contradiction, reported that 
LPA and PA were hydrolyzed more efficiently than C1P, which in turn was 
hydrolyzed more efficiently than SIP. Variation in substrate specificity between 
groups investigating the enzymological properties of S.cerevisiae may prove 
illuminating here. In initial studies, LPP-1 was shown to have higher activity on LPA 
than DGPP (Toke et al., 1998). Subsequent experiments, however, proved the 
reverse to be true, and a change in buffer pH was cited as the reason (Furneisen and 
Carman, 2000).
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Most, if not all, of the work on substrate specificity has been carried out in triton 
micelle assays, under biochemical conditions. The discrepancy between the 
published results is of concern since it indicates that assay conditions, and the 
methods of substrate presentation and enzyme purification, are potentially critical to 
efficiency of hydrolysis of individual phospholipids. Although shown to be active on 
these five substrates, there has been no indication as to whether these enzymes are 
capable of recognizing any of these substrates in vivo. This leaves the question of 
what the true physiological substrate(s) of any of the LPP isoforms is, completely 
unanswered.
Considering the potent bioactivity of the apparent lipid substrates and the 
specificity of their receptors, it seems curious that the LPPs should present such 
broad-range activities in biochemical assays. To date, it is unknown whether the fly 
LPP, Wunen, can dephosphorylate any of the mammalian lipid phosphate substrates 
in vitro. The first aim of this work was to examine differences in substrate 
recognition or specificity between Drosophila Wunen and the mammalian isoforms, 
both biochemically on a range of known substrates, and biologically, by 
investigating their abilities to dephosphorylate the PGC-specific guidance molecule 
that functions as a substrate for Wunen.
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2.2) Results
2.21) Sequence analyses and cloning of the LPPs
2.21a) Sequence analyses o f Wunen and the mammalian LPPs
wunen and wunen-2 have a remarkably similar messenger RNA pattern and 
over-expression phenotype, indicating a high degree of conservation between the two 
genes. A phylogenetic tree, as calculated by ClustalW, clearly indicates that both 
Wunen and Wunen-2 are most homologous to the human LPP-3 isoform (Fig. 10).
hLPP-1
hLPP-2
hLPP-3
Wunen
Wunen-2
Fig. 10. Phylogenetic Tree. A phylogenetic tree as calculated by ClustalW  
(http:llwww.ebi.ac.uklclustalwl) indicates that Wunen and Wunen-2 bear greatest 
homology to hLPP-3.
A ClustalW alignment was employed to investigate the relationship between the 
Drosophila LPPs and the three mammalian isoforms. The results indicate a high 
degree of homology, with an almost complete conservation of the three main 
phosphatase domains. In between the transmembrane domains are regions that are 
less well conserved, with the C-termini demonstrating considerable heterogeneity 
(Fig. 11).
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PRG-1
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DESMFQHRDALRSLTDLNQDPNRLLSAKNGSSSDG1AHTEGILNRNHRDASSLTNLKRAN 393
F ig .ll. Sequence alignment o f Wunen and Wunen-2 with the mammalian LPP 
isoforms and PRG-1, calculated using ClustalW. The six transmembrane domains 
are indicated by O R A  N G E boxes, as p red ic ted  by TM Pred
(http://www. ch. embnet. orz/software/TMPRED form. html: (Hofmann, 1993). The 
three conserved catalytic domains are shaded in P A L E  B L l  I , with those residues 
absolutely required for catalytic activity shown in RED. N-glycosylation sites are 
highlighted in GREEN. The N-terminal apical sorting signal in LPP-1, and the 
dityrosine motif targeting LPPS to the basolateral subdomain are shaded in 
PURPLE.  The D:248>T mutation is shown in . Asterisks indicate
amino-acids that are identical between all six sequences, colons indicate conserved
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substitutions, and semi-conserved substitutions are shown by a dot. N.B. The last 
370 C-terminal amino-acids o f PRG-1 have not been included in the diagram for  
spatial reasons. GenBank accession numbers are as follows: Wunen, U73822 (Zhang 
et al., 1997); Wunen-2, AF331162 (Starz-Gaiano et al., 2001); human LPP-1, 
AB000888 (Kai et al., 1997); human LPP-2, AF047760 (Roberts et al., 1998); 
human LPP-3, AB000889 (Kai et al., 1997); PRG-1, AF541281 (Brauer et al., 
2003).
2.21b) Complementary DNAs (cDNAs)
To investigate whether Drosophila Wunen and the mammalian LPP isoforms differ 
in their abilities to dephosphorylate a variety of phospholipid substrates in vitro, 
mouse LPP-1 and human LPP-3 were chosen for comparison, as they had been 
previously cloned and characterized (Kai et al., 1996; Kai et al., 1997) and, alongside 
Wunen, tagged at the C-terminus with green fluorescent protein (GFP). Each of these 
was available already cloned into the transformation vector pUAST (work performed 
by Ken Howard and previous lab members). WunD:248>TGFP was chosen as a 
control. WunD:248>T contains an aspartic acid to threonine conversion at 
amino-acid 248 in the sixth transmembrane domain (Fig. 11). This corresponds to 
D500 in CPO, a highly conserved residue reported to be required for catalysis in this 
protein and hypothesized as contributing to the active site (Neuwald, 1997). 
Disruption of D248 in Wunen, therefore, was proposed to result in a catalytic null 
(Ken Howard personal communication), although this had never been proven.
2.21c) Transfection of S2 cells and analyses o f protein size
Before comparing biochemical activities, it was necessary to confirm that each of the 
GFP-tagged constructs encoded a protein of the correct predicted size, and was 
capable of transcribing the GFP marker. This was done by individually transfecting 
each construct into Drosophila Schneider cells (S2 cells) alongside the ubiquitous 
driver Actin5C-GAL4 (a kind gift from Tom Komberg). After twenty-four to forty- 
eight hours, expression of the GFP protein was clearly visible under the fluorescent 
microscope. These cells were maintained at 25°C for a further two days until 
expression appeared optimal. They were then spun down and washed in PBS 
(phosphate buffered saline) before lysis in a buffer containing protease inhibitors. 
Aliquots were analyzed by standard Western blotting procedures, and visualised with
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a mouse monoclonal antibody to GFP (Roche), followed by a horse-radish 
peroxidase (HRP)-conjugated anti-mouse secondary antibody (Jackson 
ImmunoResearch Laboratories). The results clearly indicated proteins of the correct 
predicted size in each case, demonstrating that each protein was successfully 
synthesized in these cells (Fig. 12).
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Fig.12. Confirmation o f protein size. Blots were probed with a monoclonal antibody 
to GFP.
2.22) Biochemical analyses of LPP substrate preference 
2.22a) Immunocapture o f GFP-tagged proteins
To test biochemical activities, each construct was once again transfected into S2 cells 
alongside Actin5C-GAL4, and the cells were allowed to express the relevant protein 
for three to four days. When protein expression was observed to be at least 30% of 
total cell number, cells were spun down, washed, and lysed in buffer. Individual cell 
extracts were then incubated for two hours at room temperature with Fusion Aid 
GFP resin. This resin utilizes an affinity-purified antibody to GFP coupled through a 
stable hydrophilic spacer arm to cross-linked 4% agarose beads, enabling it to 
specifically recognize and capture the GFP epitope (Vector Laboratories). 
Untransfected S2 cells were used as a control. After incubation, the resin was washed 
extensively for several hours to ensure removal of any extraneous unbound protein. 
An aliquot of the final wash was kept for Western analyses. In order to confirm that
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each protein was expressed, a sample of total cell lysate prior to incubation was run 
on the gel, alongside a sample of the final wash (to confirm that no unbound protein 
was present), and a sample of each resin to confirm that each protein had been 
immunocaptured.
2.22b) Inorganic phosphate release assay
In order to avoid the use of radiolabelled lipid substrates, both time-consuming and 
hazardous, the Molecular Probes PiPer® phosphate release assay (Cambridge 
Bioscience) was adapted for this research (Fig. 13).
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Fig.13. The PiPer ® phosphate release assay.
In the presence o f inorganic phosphate, maltose phosphorylase converts maltose to 
glucose-1-phosphate and glucose. Gluconolactone and hydrogen peroxide (H202) 
are then formed by the action o f glucose oxidase. Using horseradish peroxidase as a 
catalyst, the H202 reacts with the Amplex™ Red reagent to produce the fluorescent 
product resorufin. The increase in detectable fluorescence/absorbance is therefore
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proportional to the amount o f phosphate present. Figure adapted from  
h ttp .7/w ww .probes. com (Molecular Probes).
In keeping with previously published results, the following substrates were chosen 
for the experiment -  PA, LPA, C1P, and SIP. PA was used at a final concentration 
of 70pM, LPA and C1P were used at a final concentration of 500pM. Despite 
numerous attempts, employing various methods, SIP gave no discernable results 
with any of the constructs. Since mLPP-1 has shown previous activity on SIP, the 
conclusion must be that SIP failed to solubilize under these conditions.
For the assay, 50pl of resin containing the relevant immunocaptured protein 
was added to PA, LPA, or C lP  in suspension, and pipetted into three separate wells 
in a 96-well plate. Three wells contained bare resin with no immunocaptured protein 
as a substrate control. Assays were performed at 37°C and fluorescent output read in 
a standard plate-reader at 5 time points during the assay period (Fig. 14). Each 
substrate control gave a small but constant value, which was subtracted from each of 
the samples. To test the linearity of the detection system, a series of phosphate 
standards were simultaneously run in triplicate in each assay. The phosphate 
standards were then converted to nanomoles (nMoles) of phosphate relative to 
flourescent output at an arbitrary time point that appeared to fall within the linear 
range for the enzymes in each assay. This data was used to produce a standard curve. 
A line of best fit was then employed to calculate the amount of phosphate released 
from each protein sample at the same time point (Fig. 15).
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Fig.14. PiPer® Phosphate release assay results. Each left-hand graph shows the 
mean fluorescent readout from the triplicate experiments for each protein over time 
with each o f the three substrates, +/- standard deviation (s.d). The sequential action 
o f the enzymes involved in the detection system following exposure to phosphate in 
solution accounts for the 20-minute lag period seen at the start o f the assay. Running 
phosphate standards alone produces the same lag period (Fig. 15). Plotting
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phosphate standards against the corresponding fluorescent readout at the chosen 
time points indicated on each graph gives a straight line in the presence o f 4 to 6 
nMoles, indicating that the detection system displays first order kinetics at this time 
point. These values are the means o f the three samples for each standard, +/- s.d. 
and are shown by the right-hand graphs. The equation o f the line for each set o f 
phosphate standards was used to calculate nMoles phosphate released at the 
corresponding time point for each protein sample. RFU, relative fluorescence units. 
Fluorescence was measured using a SPECTRAmax™ GEMINI XS Dual Scanning 
Microplate Spectrafluorometer.
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Fig.15. Phosphate standards for the LPA assay. Each o f the phosphate standards 
shows a 20-minute lag period at the beginning o f the assay, due to the sequential 
action o f the enzymes involved. Each value is the mean o f the three readouts for each 
standard at each time point, +/- s.d.
Immediately following an assay, samples were removed from each well, added to an 
equal volume of loading buffer and boiled briefly before loading onto an agarose gel 
for electrophoresis followed by Western analysis. Following development of each
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blot, densitometry analyses were performed using BioRad Quantity One software. 
This enabled the direct comparison of relative protein amounts between samples on 
the same blot. These density readings were then used to calculate the nMoles of 
phosphate released per unit density (Fig. 16 and Tables 2-5).
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Fig.16. Western blots for densitometry. All three wells for each protein were blotted 
for each assay with an anti-GFP antibody, and analysed by BioRad Quantity One 
software. The WunD:248>TGFP samples were blotted separately next to a repeat 
sample o f WunGFP due to insufficient wells in each gel. As WunD:248>TGFP is a 
catalytic null, the blots primarily demonstrate that the protein is present at 
sufficiently high levels in each experiment. A) Results for the LPA assay. B) Results 
for the PA assay. C) Results for the Cl P assay.
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Value 1 Value 2 Value 3 s.d.
WunGFP 40.664 35.392 32.933 3.950
mLPP-lGFP 43.438 41.389 34.038 4.943
hLPP-3GFP 26.305 29.229 28.671 1.552
Table 2. LPA Assay. Each value is a density reading from each o f the three sample 
wells in Fig. 16A, as calculated by BioRad Quantity One software. The means o f the 
three values for each construct were used alongside the nMoles phosphate released 
to calculate the relative activities in Table 5. s.d = standard deviation.
Value 1 Value 2 Value 3 s.d.
WunGFP 11.25 11.29 12.028 0.439
mLPP-lGFP 30.971 27.096 36.12 4.527
hLPP-3GFP 16.197 13.301 12.354 2.002
Table 3. PA Assay. Each value is a density reading from each o f the three sample 
wells in Fig.l6B.
Value 1 Value 2 Value 3 s.d.
WunGFP 26.046 25.039 18.178 4.281
mLPP-lGFP 35.631 61.362 44.345 13.087
hLPP-3GFP 19.691 18.874 16.595 1.605
Table 4. C lP  Assay. Each value is a density reading from each o f the three sample 
wells in Fig.l6C.
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Construct n M o le s  P 0 4
released
(mean +/- s.d.)
n M o le s  P 0 4  
released per unit 
density
(mean +/- s.d.)
Relative activity
LPA
WunGFP 2.819+/- 0.180 0.079 +/- 0.012 1.00
mLPP-lGFP 3.056 +/- 0.496 0.079 +/- 0.024 1.00
hLPP-3GFP 0.359+/- 0.109 0.013 +/-0.004 0.16
WunD:248>TGFP -0.000+/- 0.156 0.000 +/- 0.002 0.00
Untransfected S2 -0.000+/- 0.017 N/A 0.00
PA
WunGFP 0.021 +/-0.016 0.002+/-0.001 1.00
mLPP-lGFP 0.745+/-0.070 0.024+/-0.003 12.00
hLPP-3GFP 0.530+/-0.018 0.038+/-0.005 19.00
WunD:248>TGFP —0.000+/-0.029 0.000+/- 0.002 0.00
Untransfected S2 -0.000+/-0.015 N/A 0.00
C1P
WunGFP 0.098 +/- 0.045 0.0O4+/-0.001 1.00
mLPP-lGFP 3.754 +/- 0.207 0.083+/-0.020 20.75
hLPP-3GFP 0.933 +/- 0.662 0.049+/-0.034 12.25
WunD:248>TGFP -0.000 +/- 0.026 0.000+/-0.003 0.00
Untransfected S2 -0.000 +/- 0.049 N/A 0.00
Table 5. Relative activities of the LPPs. Each immunocaptured enzyme was 
incubated in triplicate with LPA, PA or Cl P in the PiPer® phosphate release assay, 
and the nMoles phosphate released for each individual sample calculated from a 
standard curve. The means o f the three readings for each enzyme is presented, +/- 
s.d.. Less than 11% o f total substrate was broken down in any o f the experiments. 
The density for each individual sample on a Western blot was calculated using Bio­
Rad Quantity One, and used to calculate nMoles P04 released per unit density.
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The putative catalytic null, WunD:248>TGFP, had absolutely no activity in this 
assay on any of the three substrates presented to it, despite the presence of significant 
levels of protein as determined by Western analysis. This shows for the first time that 
this amino-acid is indeed critical for catalysis of phospholipid substrates under these 
conditions. Whilst mLPP-1 and Wunen displayed similar levels of activity on LPA, 
hLPP-3 was considerably less active. hLPP-3 showed approximately 1.6 times more 
activity on PA, however, than mLPP-1, whilst mLPP-1 appeared approximately 1.7 
times more active on C1P than hLPP-3. In comparison, Wunen displayed negligible 
activity on C lP  or PA.
2.23) Biological analyses of LPP substrate preference
2.23a) Phenotypic consequences o f ectopic expression in the mesoderm
The next step was to explore potential differences in substrate choice when faced 
with a physiological substrate in vivo, by examining the ability of each LPP to 
recognise the same germ cell specific guidance and survival factor as Drosophila 
Wunen. In order to do this, transformant flies were generated for each construct 
using standard microinjection techniques (Rubin and Spradling, 1982). Four to ten 
day old males carrying a homozygous viable insert on an autosome were crossed en 
masse to homozygous viable twist-GAL4 virgins (homozygous viable on the X 
chromosome), to drive expression of each protein specifically in the mesoderm. Flies 
were maintained at 25°C and embryos from over-night lays collected on apple-juice 
plates. These were dechorionated and fixed prior to immunostaining with a primary 
antibody to GFP to visualize protein expression in the mesoderm, and a primary 
antibody to Vasa, to visualize the PGCs (Fig. 17).
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Fig.17. Ectopic expression in the mesoderm. Embryos were immunostained with 
anti-Vasa antibody to visualize the PGCs in brown, and anti-GFP to visualize 
protein expression in blue. Embryos in figures A-E are viewed laterally with the 
posterior pole to the right, embryos in F-J are viewed dorso-ventrally. Expression o f 
WunGFP (A) or hLPP-3GFP (B) at stage 10 results in an early loss o f PGCs 
compared to ectopic expression o f WunD:248>TGFP (C) or mLPP-lGFP (D). 
These can be compared to a wild-type embryo (E) with a full complement o f PGCs at 
the same stage. By the end o f embryo gene sis, those expressing WunGFP (F) or 
hLPP-3GFP (G) show a dramatic loss o f PGCs, whilst those that remain 
demonstrate migration defects. Embryos expressing WunD:248>TGFP (H) or 
mLPP-lGFP (I), however, show no apparent perturbation or loss, and have formed 
two clear gonads, as seen in a wild-type embryo at the same stage (J). Wild-type 
embryos do not express GFP and consequently show no blue staining.
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Expression of WunGFP disrupted PGC migration and reduced PGC number, as 
previously reported for untagged Wunen. PGCs are observed in tissues other than the 
gonads, having been repelled from the mesoderm, so failing to contact the somatic 
gonadal precursors (Fig. 17 A, F).
The Wunen catalytic null D:248>T had no biological activity. PGC migration 
occurred normally even in the presence of high levels of the mutant protein in the 
mesoderm (Fig. 17 C, H).
Surprisingly, expression of hLPP-3GFP also resulted in highly perturbed 
PGC migration and a dramatic reduction in PGC number. In some embryos only one 
or two PGCs remain at the end of embryogenesis (Fig. 17 B, G). Human LPP-3 may, 
therefore, recognise and dephosphorylate the same PGC specific substrate in flies as 
Drosophila Wunen.
Conversely, expression of the biochemically active mLPP-1 GFP showed no 
phenotype, with no aberrant migration or apparent PGC loss (Fig. 17 D, I). Mouse 
LPP-1 is therefore incapable of recognizing the same germ cell specific factor as 
Wunen in vivo, demonstrating an absolute difference in functional bioactivity 
between the 1 and 3 isoforms.
2.24) Confirmation of Cell-Surface Localisation 
2.24a) Confocal microscopy
The LPPs have been shown to possess ecto-enzymatic activity, and structural and 
enzymatic analyses indicate that, as transmembrane proteins, they should be 
localised to the plasma membrane. Although it is not know if the germ cell migration 
phenotype is caused by an extracellular activity of Wunen or hLPP-3, it was 
necessary to exclude the possibility that mLPP-1 GFP was simply failing to traffic 
correctly to the cell-surface, thus potentially precluding its access to a substrate. 
Embryos expressing the GFP-fusion proteins in their mesoderms were examined by 
confocal microscopy. All of the proteins were readily detected on the mesodermal 
cell surface (Fig. 18). Proteins were not observed localising to intracellular 
membrane structures when transiently expressed in embryonic mesoderm by this 
method.
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mLPP-1 GFP hLPP-3GFP WunD:248>TGFPWunGFP
Fig.18. Confocal microscopy. Confocal microscopy showing WunGFP, 
mLPPl-GFP, HLPP-3GFP and WunD:248>TGFP at the surface o f mesodermal 
cells in Drosophila embryos. Protein expression is driven by twist-GAL4.
2.24b) Cell-surface biotinylation
The presence of each protein at the cell surface was confirmed by biotinylation of 
stable cell lines expressing either hLPP-3GFP or mLPP-1 GFP. These cells were co­
transfected with a pUAST-hygro construct that confers hygromycin resistance. 
Addition of hygromycin to the media allows for selection of those cells stably 
expressing both hygromycin resistance and up to four other constructs, one of which 
necessarily is Actin5C-GAL4. In these cell lines up to eighty percent of the total 
population express the protein of interest (Makridou et al., 2003). The intact cells 
were incubated with NHS-biotin. N-Hydroxysuccinimide (NHS)-activated biotin 
reacts with primary amino groups (-NH2) by nucleophilic attack. This interaction 
results in the formation of an amide bond and the release of the NHS. NHS-biotin is 
cell impermeable and can only bind to those proteins present on the surface of intact 
cells. After incubation the reaction was quenched by the addition of ammonium 
chloride and the cells were washed extensively to remove any unbound biotinylated 
product prior to lysis. Lysates were spun at 13,000 rpm and the resulting cytosolic 
supematent run over a monomeric biotin binding avidin column. Samples of each 
wash followed by each eluate were analyzed by Western blot (Fig. 19).
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Fig.19. Biotinylation o f cell surface proteins. Biotinylation o f mLPP-1 GFP and 
hLPP-3GFP at the surface o f 52 cells detected with a monoclonal anti-GFP 
antibody. TL = total lysate (cytosolic supernatent) prior to capture on the column; 
W  = washes -  protein that is not biotinylated and has not bound to the column. 
E  = elutions — cell-surface protein that is biotinylated and has bound to the column.
These results confirmed that both the biologically active hLPP-3GFP, and the 
biologically inactive mLPP-1 GFP, were both present at the cell-surface at roughly 
equal proportions.
2.3) Summary
It has previously been shown that point mutations in the conserved catalytic domain 
of Wunen-2 remove biological activity in vivo (Starz-Gaiano et al., 2001). The 
results presented here are the first time that loss of phosphatase activity as confirmed 
in a biochemical assay, however, has been shown to also remove biological function, 
and indicates that converting a single aspartic acid to threonine at residue 248 is 
sufficient to remove catalytic activity both in vitro and in vivo in Wunen. 
Importantly, this tells us that the affect of Wunen (and likely human LPP-3) on PGC 
migration and survival can be directly attributed to its phosphatase activity.
Although these are not detailed kinetic analyses, this work demonstrates that 
the fly LPP Wunen, and mammalian LPP-1 and 3, differ in relative activities on PA, 
LPA and C1P in the PiPer® phosphate release assay. This is the first time that a 
Drosophila LPP has been shown to be active on any of these phospholipid substrates. 
Whilst Wunen can dephosphorylate LPA with similar efficiency to mLPP-1, it
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displays negligible activity towards both PA and Cl P. This indicates that there are 
distinct differences in substrate preference between the fly and mammalian enzymes, 
with Wunen displaying a narrower activity range in this assay than previously 
reported for the mammalian LPPs. Both mLPP-1 and hLPP-3 are active on all three 
substrates. mLPP-1 has a 1.7 fold higher activity on C1P than hLPP-3 in this assay. 
hLPP-3, however, displayed a 1.6 fold higher activity to mLPP-1 on PA. Previous 
data on activity for each isoform on these substrates has tended to vary somewhat 
(Kai et al., 1997; Roberts et al., 1998). The inconsistencies that have been observed 
for the same isoform on the same substrates may be due to the particular assay 
conditions or method of enzyme preparation. This could account for the variation in 
relative activities between Wunen and hLPP-3 in vitro, despite their close homology. 
Alternatively, there may be fundamental differences between the fly and mammalian 
isoforms that will only be uncovered with a more detailed analysis of their structures.
Perhaps more importantly, this work also shows that hLPP-3 is highly active
when ectopically expressed in Drosophila embryos, as assayed by the disruption of
PGC migration and survival, resulting in a phenotype similar to ectopic expression of
Wunen or Wunen-2. That hLPP-3 shows the same phenotype in a bioassay as the 
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Drosophila LPPs,^point towards a signalling pathway regulating germ cell 
migration and survival that has been conserved from flies to man. Conversely, 
though active in the biochemical assay, mLPP-1 is completely inactive in vivo, and 
has no apparent affect on PGC migration or survival. This demonstrates an absolute 
difference in functional bioactivity between the mammalian LPP isoforms. That the 
LPP isoforms present different functional outputs when assayed in vivo, holds a 
number of implications. It may be that the LPP-1 isoform simply cannot recognize or 
catalyze the dephosphorylation of the specific factor seen by Wunen and LPP-3. This 
would then demonstrate specificity in substrate choice between the isoforms, and 
may indicate that the germ cell specific factor is not PA, LPA or C1P, on which 
mLPP-1 is active in vitro, particularly since Wunen displays negligible activity 
towards PA and C1P in the same assay. Alternatively, there may be specific 
components of the pathway that are required for selection and recognition of the 
factor. It is possible that as yet unidentified conformational or structural differences 
in mLPP-1 preclude its association with these factors, thus inhibiting its enzymatic 
function in this system. Thus, LPA could potentially be the factor, and the unnatural 
presentation and high concentration of LPA in the biochemical assay may over-ride
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the specific selection mechanisms used to regulate activity in vivo, allowing mLPP-1 
access to this otherwise inaccessible substrate. Primary sequence analyses have not 
identified any immediate candidates for residues conferring such a difference, 
although it has been speculated that the regions of heterogeneity present between 
these proteins could be responsible for regulation of activity or substrate specificity 
(Neuwald, 1997). Indeed, the contributions of the N- and C-termini to the biological 
and biochemical properties of the LPPs have yet to be reported in any detail.
This work has now been published:
Burnett, C. and Howard, K. (2003). Fly and mammalian lipid phosphate 
phosphatase isoforms differ in activity both in vitro and in vivo. EMBO Rep 4, 793- 
9.
3) CHAPTER TWO
Oligomerisation of the LPPs as a Mechanism of Action
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3.1) Introduction
Oligomerisation of protein sub-units occurs frequently within biological systems and
is particularly common with transmembrane receptors. GPCRs, a large and diverse
family of seven transmembrane receptors, are now known to form both homo-and
hetero-oligomeric receptor complexes. Work to determine this employed a variety of
techniques including the use of chimeric receptor sub-units, point mutations,
cross-linking and co-immunoprecipitation of differentially tagged proteins. More
recently the use of bioluminescence or fluorescence resonance energy transfer
(BRET and FRET) has confirmed the presence of receptor dimers in intact living
cells (for review see (Bouvier, 2001).
is a good example of an oligomeric 
p53 ^  multifunctional cellular protein, perhaps best known for its role in the
suppression of tumourigenesis. p53 is activated in response to cellular stress and can
regulate or arrest the cell-cycle, as well as induce apoptosis, in an affected cell. In
fact mutations in p53 have been characterised in fifty percent of known cancers. The
protein consists of a central DNA-binding domain, an N-terminal transactivation
domain and C-terminal localisation and oligomerisation signals. Rather than a single
unit, the active form of p53 consists of a tetramer made up of two dimers. A
Drosophila  homologue of p53, dmp53, demonstrates the same oligomerisation
activities as those reported for human p53 (Chan et al., 2004; Hofseth et al., 2004;
Sutcliffe and Brehm, 2004).
It is now known that the molecular weight of the LPPs falls at around 35 kDa.
The first attempts to purify LPP activity from membranes, however, indicated a
much larger molecular mass. Indeed, SDS polyacrylamide gel electrophoresis of
extracts from porcine thymus indicated an 83 kDa band that was shown convincingly
to account for the observed enzymatic activity (Kanoh et al., 1992). It wasn’t until a
few years later that this proved inaccurate, as the enzyme was re-purified and the
enzymatic activity shown to be attributable to a much smaller protein of 31-35 kDa
(Kai et al., 1996; Siess and Hofstetter, 1996). The original work using porcine
membrane-extracts, however, had clearly demonstrated that the native enzyme
possessed a molecular weight of 150 kDa. Purification of LPP activity from rat liver
membranes and analysis of its Stokes’ radius and sedimentation coefficient also
indicated a molecular mass of 186 kDa. These results led both groups to postulate
that although enzymatic function can be observed for the smaller species in vitro, the
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native protein may exist as homo-oligomers and may even form hexameric 
complexes.
This is a theory that had endured but had yet to be proven. The second aim of 
this work was to investigate this theory in more detail, to determine by use of 
biochemical techniques whether or not the LPPs oligomerise and if so, how specific 
these interactions are. If it proved to be the case that LPPs can form complexes, the 
next aim was to determine whether these complexes are required for activity either 
biochemically, or biologically.
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3.2) Results
3.21) Transfection of S2 cells and analyses of protein size
In order to examine the ability of the LPPs to oligomerise through the use of a 
variety of biochemical techniques, it was necessary to utilise differentially tagged 
versions of each protein. Full length Wunen, WunD:248>T and mLPP-1 were 
available with a C-terminal trimeric myc tag repeat (M3) (Fig.20).
GSEEQKLISEEDLLGSEEQKLISEEDLLGSEEQKLISEEDLL
Calculated molecular weight = 4 .73  kDa
Fig.20. The sequence o f the trimeric myc tag repeat.
In addition, GFP and M3 tagged versions of WunD2 were available. WunD2 is a 
truncation of the last thirty-five C-terminal amino-acids of Wunen (Fig.21). Each of 
these tagged constructs had been previously cloned into the pUAST vector by other 
lab members, and were available completely sequenced by overlapping comfort 
reads through their coding regions.
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Fig.21. The D2 truncation. Schematic diagram o f full-length Wunen with the last 
thirty-five C-terminal amino-acids that are absent in D2 highlighted in PINK. 
Conserved residues required for catalysis are in RED, whilst the D:248>T mutation 
present only in full-length Wunen is indicated in GREEN.
3.22) Co-transfections
3.22a) Confirmation o f protein expression in S2 cells
To determine if the LPPs can interact and form complexes it was first necessary to 
confirm that S2 cells would transcribe both proteins simultaneously, and that the myc 
tagged pUAST constructs transcribe proteins of the correct predicted size. S2 cells 
were transfected with combinations of the differentially tagged constructs and left to
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express for two days until the GFP marker was clearly visible by fluorescent 
microscopy. Cells were then spun down and lysates analysed by Western blot. Two 
identical gels were run for each sample -  one was then incubated with a monoclonal 
antibody to the M3 tag, whilst the other was incubated with a monoclonal antibody 
to the GFP tag. Each cell lysate clearly showed expression of both tagged proteins in 
each case. Smoothened-GFP (SmoGFP) was co-transfected alongside 
WunD:248>TM3 as a possible control transmembrane protein for use in future 
experiments. It was not transcribed at sufficient amounts to be detectable by these 
techniques, however, so was not used further (Fig.22).
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Fig.22. Co-transfected S2 cell lysates. A) Incubated with monoclonal anti-myc 
antibody. B) Incubated with monoclonal anti-GFP antibody. This is a five second 
exposure following ECL detection. Lane 1 = WunD:248>TM3 + WunGFP; lane 2 = 
WunD248> TM3 + SmoGFP; lane 3 = WunM3 + hLPP-3GFP; lane 4 = WunGFP + 
mLPP-lGFP; lane 5 = WunD2M3 + hLPP-3GFP.
3.22b) Immunoprecipitation assays: formation o f homo-oligomers 
To investigate whether LPPs are able to interact and form homo-oligomeric 
complexes, S2 cells were co-transfected with either WunM3 plus WunGFP plus 
Actin5C-GAL4, or with mLPP-lM3 plus mLPP-3GFP plus Actin5C-GAL4. After 
two days cells were spun down, washed and resuspended in 0.1% triton X-100 lysis 
buffer. Aliquots were then incubated for two hours with 50pl of Anti-c-Myc Agarose 
Affinity Gel (Sigma). After incubation the supernatant was removed (termed the 
‘load’) before extensive washing. Samples of the load, the final wash and the resin 
were then boiled and loaded onto two separate gels for analysis with either a 
monoclonal anti-myc antibody or a monoclonal anti-GFP antibody (Fig. 23).
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Fig.23. Immunoprecipitation assays: formation o f homo-oligomers. A) WunM3 
plus WunGFP. There is only a weak band visible in the WunM3 load, as the majority 
o f the protein has been captured by the resin, as seen by the strong band in the third 
lane. This shows that the anti-myc resin does work to capture the M3 tagged 
proteins. There is also a band present in the capture lane o f the GFP blot, indicating 
that WunGFP has been captured on the resin. As the resin is myc specific, the 
WunGFP must be associating with, and brought down by, the WunM3 protein. B ) 
mLPPl-M3 plus mLPP-lGFP. Again mLPP-lGFP is clearly detected by the anti- 
GFP antibody and thus must be captured and immunoprecipitated alongside mLPP- 
1M3, indicating an interaction. As controls, the last two lanes contained either 
untransfected S2 cells or a sample o f resin that has not been incubated with any 
protein. Both lanes are blank when detected with either anti-myc or anti-GFP 
antibodies, indicating that the bands seen in the load and capture lanes are totally 
specific to the transfected and tagged proteins (lanes not shown).
In all these cases there is no band visible in the ‘wash ’ lane indicating that 
there is no extraneous unbound protein present -  the bands in the ‘capture * lanes 
correspond only to that protein immunocaptured on the resin.
These results indicate that under these conditions full length Wunen and mLPP-1 can 
form homo-oligomeric complexes. Unfortunately, despite attempts to create such a 
construct by lab members, a myc tagged version of hLPP-3 was not available.
3.22c) Immunoprecipitation assays: formation o f hetero-oligomers
Could LPPs form hetero-oligomeric complexes between isomeric forms, or between
species? To investigate this S2 cells were transfected with either WunM3 plus
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hLPP-3GFP plus Actin5C-GAL4, or WunGFP plus mLPP-lM 3 plus 
Actin5C-GAL4. Cells that had not been transfected with any construct were treated 
in the same way. After two days cells were spun down and incubated with 50pl of 
anti-myc resin before Western analysis, as before (Fig.24).
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Fig.24. Immunoprecipitation assays: formation o f hetero-oligomers. In these blots, 
TL refers to Total Lysate -  an aliquot o f cell lysate prior to incubation on the resin. 
In the left-hand blot (anti-myc antibody) both mLPP-3M3 and WunM3 are present in 
the capture lanes, so have been immunoprecipitated on the resin. In the right-hand 
blot (anti-GFP antibody) although WunGFP and mLPP-lGFP are present in the 
total lysate and load, neither has been co-captured on the resin indicating that they 
are not immunoprecipitated alongside their myc tagged counter-part.
These results indicate that whilst LPPs can form homo-oligomers, they do not form 
hetero-oligomeric complexes, pointing towards a specific self-interaction. These 
results also show that the immunocapture of GFP in Fig.22 is due to a true 
interaction between protein monomers and not due to an artefact of the procedure.
3.22d) Immunoprecipitation assays: prevention o f  oligomerisation 
Results reported here indicate that the LPPs can form specific interactions between 
full-length monomers of the same protein. In the case of tetrameric p53, only one 
fully functional, non-mutated sub-unit is required for transcriptional activity of the 
complex, although a single monomer that lacks the C-terminal tetramerisation 
domain is inactive (Chan et al., 2004). Does oligomerisation of the LPPs depend on 
the presence of an intact catalytic site in each monomer, or the C-terminus? In order
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to determine this, S2 cells were transfected with either WunD:248>TM3 plus 
WunGFP plus Actin5C-GAL4, or WunD2M3 plus WunGFP plus Actin5C-GAL4. 
Cell lysates were incubated with anti-myc resin and analysed as before (Fig.25).
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F ig . 25. Immunoprecipitation assays: prevention o f  oligomerisation. A)
WunD:248>TM3 is clearly immunocaptured as seen on the left-hand anti-myc blot. 
WunGFP, however, is not co-precipitated as seen by the total absence o f signal in 
the capture lane o f the right-hand blot. B) The WunD2M3 is captured but does not 
bring down WunGFP as seen by the presence ofWunD2M3 in the capture lane o f the 
left-hand blot and the absence o f WunGFP in the capture lane o f the right-hand blot.
These results demonstrate that mutation of one amino-acid essential for catalytic 
activity in one monomer is enough to prevent oligomerisation between otherwise 
identical protein sub-units. Since truncation of the last thirty-five C-terminal 
amino-acids also prevents this association, these residues must also be critical in the 
formation of homo-oligomers. These results further confirm the specificity of the 
observed interactions, and again indicate that they are genuine associations and not 
artefacts.
3.22e) Immunoprecipitation assays: repeat with NEM
The homo-oligomerisation of Wunen with itself, the catalytic null and the truncation 
was repeated with the addition of 2 mM A-ethylmaleimide (NEM) to the lysis buffer. 
NEM is an effective reducing agent, used here to remove any bonds that may have 
formed through oxidation, leading to artefactual oligomers. S2 cells were transfected 
with WunGFP plus Actin5C-GAL4 plus either WunM3, WunD:248>TM3 or
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WunD2M3. The results confirmed the results obtained without addition of NEM to 
the lysis buffer, that full-length monomers of Wunen can form interactions that are 
abolished by mutation of the catalytic site in one monomer, or truncation of the 
C-terminus.
3.22f) Immunoprecipitation assays: Wunen and Wunen-2
To investigate the specificity of the homo-oligomerisation in more detail, cells were 
transfected with WunM3 plus Wun-2GFP (Fig.26) or Wun-2M3 plus Wun-2GFP. 
These results reveal that Wunen and Wunen-2 do not form associations under these 
conditions, again indicating that the associations that do form are highly specific. In 
this experiment Wun-2M3 failed to immunoprecipitate on the resin. This may be due 
to a structural or conformational incompatibility. The experiment was repeated using 
a Wun-2myc construct donated by the Lehmann lab and tagged at the C-terminus 
with a single myc sequence. This construct failed to be expressed in S2 cells at high 
enough levels to detect on these Western blots.
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Fig.26. Immunoprecipitation assays: Wunen and Wunen-2. WunM3 plus 
Wun-2GFP. The left-hand blot is probed with monoclonal anti-myc antibody, the 
right-hand blot is probed with monoclonal anti-GFP antibody. The last lane is an 
aliquot o f an immunocapture o f co-transfected WunM3 plus WunGFP, run as a 
control.
This confirms that Wunen and Wunen-2 fail to form associations. Despite several 
attempts using different constructs, Wun-2M3 failed to be expressed at adequate 
levels. Thus the question of whether Wunen-2 can homo-oligomerise is left
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unanswered, although evidence from Wunen and mLPP-1 would suggest that it 
probably does.
3.22g) Immunoprecipitation assays: 1% triton X-100
The co-transfections of WunM3 plus WunGFP, and WunD2M3 plus WunGFP, were 
repeated, but the S2 cells expressing the proteins were lysed into buffer containing 
1% triton X-100 (as opposed to 0.1% as previously) before immunocapture on the 
resin and Western analyses as before (Fig.27).
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Fig.27. Immunoprecipitation assays: 1% triton X-100.
The first three lanes o f each blot correspond to WunM3 plus WunGFP, the last three 
correspond to WunD2M3 plus WunGFP. Addition o f 1% triton X-100 to the lysis 
buffer prevents WunM3 immunoprecipitating WunGFP.
This shows that in the presence of increased detergent concentration the association 
between Wunen monomers is disrupted -  WunGFP is no longer immunocaptured 
alongside WunM3. This further confirms that the resin does not recognise the GFP 
epitope, and that previously observed immunocaptured GFP must be due to that 
protein’s association with its myc tagged counterpart.
3.22h) Immunoprecipitation assays: post-transfection
S2 cells were singly transfected with either WunM3, WunGFP or WunD2M3 (plus 
the Actin5C-GAL4 driver) and lysed two days later in 0.1% triton X-100 buffer.
66
Aliquots of WunM3 and WunGFP, or WunD2M3 and WunGFP, were then mixed 
and incubated on ice for thirty minutes before immunocapture and Western analyses 
as before. A very weak band was detected for WunGFP, which may point towards an 
ability of these proteins to form associations post lysis. The experiment was repeated 
for WunM3 and WunGFP, this time with the addition of ImM zinc chloride to half 
of the samples (zinc chloride can stabilize certain protein interactions under these 
conditions). Samples were mixed and incubated either on ice or at 25 °C for one hour 
before immunocapture and blotting.
No interaction between WunM3 and WunGFP was observed under these 
conditions, demonstrating that the associations that form do so within the confines of 
the cell when the proteins are co-transfected, and do not occur randomly in solution 
post-lysis.
3.23) Order of Oligomerisation 
3.23a) Para formaldehyde cross-linking
To investigate the order of oligomerisation and to determine how many sub-units 
each complex was composed of, intact cells expressing each protein individually 
were incubated with 3% or 12% Para formaldehyde (PFA) for thirty or sixty minutes 
before the reaction was quenched by the addition of ammonium chloride. Cells were 
then washed and lysed in 0.1% triton X-100 buffer before samples were analysed. 
The cross-linking was repeated with WunD:248>TGFP, WunD2GFP, mLPP-lM3 
and hLPP-3GFP in 3% PFA (Fig.28).
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Fig.28. Para formaldehyde cross-linking
A) WunM3 samples, probed with anti-myc antibody. The first lane is total lysate that 
has not been incubated with PFA. The second lane corresponds to 3% PFA for thirty 
minutes; lane three corresponds to 3% PFA for sixty minutes; lane four corresponds 
to 12% PFA for thirty minutes and lane five corresponds to 12% PFA for sixty 
minutes. B) WunGFP samples probed with anti-GFP antibody. The lanes correspond 
to the same treatments as fo r  WunM3. C) Incubation o f WunD2GFP, 
WunD:248>TGFP and hLPP-3GFP with and without PFA. D) Incubation o f 
mLPP-lM3 with and without PFA. M -  monomer; D = dimer. Bands that fall below 
the expected molecular weight fo r  a protein most likely correspond to 
immunoreactive break-down products.
68
This confirms oligomerisation for full-length Wunen. A dimeric form is clearly 
visible at around 64 kDa with higher order species also present. It is unclear at this 
point, however, whether these aggregates occur normally.
As demonstrated by immunoprecipitation, incubation with PFA reveals the 
presence of oligomers for mLPP-1 and hLPP-3 but not for the catalytic null or 
truncation. Again, alongside the monomer, a dimeric form is visible as well as higher 
order aggregates.
3.24) Comparison of in vitro and in vivo activities 
3.24a) Biochemical activities of the multimer and monomer
With access to the wild-type multimeric protein (Wunen) and a monomeric form 
(WunD2) it was possible to address which form is active both in vitro and in vivo. In 
order to compare the biochemical activities WunM3, WunD2M3 and 
WunD:248>TM3 were individually transfected into S2 cells and then 
immunocaptured on Anti-c-Myc Agarose Affinity Gel as before. Aliquots were then 
fed into the PiPer® phosphate release assay with LPA as the substrate, and incubated 
alongside a range of phosphate standards. The equation of the line for each set of 
phosphate standards was used to calculate nMole phosphate released at the 
corresponding time point for each protein sample. Immediately following the assay 
all samples were Western blotted and analysed by densitometry to compare relative 
protein amounts and subsequently calculate relative activities, as before (Fig.29, 
Tables 6 and 7).
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Fig.29. PiPer® phosphate release assay results. A) The graph shows the mean 
fluorescent readout from triplicate experiments for each protein with LPA. RFU, 
relative fluorescence units. Fluorescence was measured using a SPECTRAmax™ 
GEMINI XS Dual Scanning Microplate Spectrafluorometer.
B) Western blot o f all three protein samples for each construct.
Value 1 Value 2 Value 3 s.d.
WunM3 16.293 24.603 20.003 4.163
WunD2M3 13.762 13.163 13.522 0.301
W unD:248>TM3 22.817 21.507 22.434 0.673
Table 6. Densitometry. Each value is a density reading from each o f the three 
sample wells in Fig.29B, as calculated by BioRad Quantity One software.
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Construct Mean nMole. PO4 
released +/- s.d.
Mean PO4 
released/unit 
density +/- s.d.
Relative activity
WunM3 1.392+/- 0.340 0.069 +/- 0.012 1.00
WunD2M3 1.059 +/- 0.068 0.078 +/- 0.004 1.13
WunD:248>TM3 -0.000 +/- 0.026 0.000 +/- 0.001 0.00
Untransfected S2 -0.000+/- 0.120 N/A 0.00
Table 7. Relative activities o f the monomer and multimer. Each immunocaptured 
enzyme was incubated in triplicate with LPA in the PiPer® phosphate release assay, 
and the nMoles phosphate released for each individual sample calculated from a 
standard curve. The means o f the three readings fo r  each enzyme is presented, +/- 
s.d.. Less than 3% o f the total LPA was broken down in any o f the experiments. The 
density for each individual sample was used to calculate nMoles P04 released per 
unit density. The data presented is the mean o f these values, +/- s.d.. This was then 
converted into relative activity.
These results show that under these conditions, using immunopurified proteins, the 
monomeric version of Wunen, WunD2M3, is slightly more active than multimeric 
full-length Wunen. This indicates that dimerisation is not required for catalysis in 
this biochemical assay.
3.24b) Biological activities o f the multimer and monomer
To examine the ability of the truncated, monomeric form to act on the PGC-specific 
survival factor in Drosophila  embryos, transgenic flies were generated with 
WunD2GFP and WunD2M3, and crossed to the mesoderm driver twist-GAL4. 
Ectopic expression of WunD2GFP gave a similar phenotype to ectopic expression of 
full-length Wunen, with scattered germ cells, a failure to form functional gonads, and 
a marked reduction in germ cell number (Fig.30). This indicates that neither 
dimerisation nor the C-terminal thirty-five amino-acids are required for activity in 
vivo. Surprisingly, expression of WunD2M3, which has significant activity in the 
LPA assay, had no affect on PGC migration or survival (Fig.30). WunM3 was also 
mis-expressed in vivo and this too showed a total loss-of-function, despite high levels
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of protein in the mesoderm and activity in the in vitro LPA assay (Fig. 30). This 
indicates that in vivo, this trimeric myc tag prevents the function of a previously 
active protein and cannot be relied on as a passive tag. These results also show that 
catalytic activity as assayed biochemically, is not a true reflection of activity as 
assayed in vivo.
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Fig.30. Ectopic expression in the mesoderm. Embryos A-C are viewed laterally with 
the posterior pole to the right, embryos D-I are viewed dorso-ventrally. Expression 
o f WunD2GFP (A) at stage 10 has a similar phenotype to WunGFP (B) with an 
early and dramatic loss o f PGCs compared to wild-type (C). By the end o f 
embryogenesis, neither WunD2GFP (D) nor WunGFP (E) expressing embryos have 
formed gonads, as opposed to a wild-type embryo at the same stage (F). Expression 
o f WunD:248>TGFP (G), WunD2M3 (H) or WunM3 (I) give no discernable 
phenotype with all embryos forming two distinct gonads. Wild-type embryos do not 
express GFP and consequently show no blue staining. Antibodies as before.
3.25) Confirmation of Cell-Surface Localisation
3.25a) Biotinylation o f cell-surface proteins
It was important to confirm that the M3 tag did not interfere with trafficking to the 
cell surface. This would then rule out the possibility that the M3 tag prevented 
WunM3 from reaching the cell surface precluding access to its substrate. Intact cells 
expressing either WunM3 or WunGFP were incubated with NHS-biotin, and lysates
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run over a monomeric biotin-binding avidin column before Western blotting as 
before. As a control for the procedure, WunM3 was co-transfected with the cell- 
surface marker CD2 (Dunin-Borkowski and Brown, 1995) and blotted for the 
presence of CD2 and the internal protein tubulin. As the NHS-biotin biotinylates 
only those proteins on the cell-surface, CD2 should be present in the elutions, 
whereas tubulin should not be biotinylated and instead pass through the column in 
the washes (Fig. 31).
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Fig.31. Biotinylation o f cell-surface proteins. S2 cells were co-transfected with 
WunM3 and CD2, and blotted for the presence o f the M3 tag, CD2 and tubulin. 
TL = an aliquot o f total cell lysate prior to column binding. A) WunM3 is detected 
in the elutions, demonstrating that it is biotinylated at the cell-surface. It is also 
detected in the washes. WunM3 is expressed at high levels in these cells and we
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would expect there to be a quantity o f intracellular protein. Alternatively, the high 
level o f WunM3 expression may have titrated out the biotin, leaving a percentage o f 
WunM3 not biotinylated but still at the cell-surface. This protein would also pass out 
in the washes. B) CD2, a cell-surface protein, is biotinylated, and so passes out in 
the elutions. Again, a proportion also passes out in the washes. This is probably 
intracellular protein that has yet to arrive at the cell-surface. C) Tubulin is an 
intracellular protein not found at the cell-surface. Consequently it is not biotinylated 
and is only detected in the washes.
Densitometry analysis by Bio-Rad Quantity One Software indicated that similar 
percentages of each protein were present at the cell surface (Fig. 32).
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Fig.32. Biotinylation o f WunM3 and WunGFP. Biotinylation o f WunM3 and 
WunGFP at the cell surface. Washes = non-biotinylated proteins; 
Eluates = biotinylated cell-surface proteins.
3.3) Summary
The combination of these results demonstrate that the fly LPP Wunen dimerises, that 
a C-terminal truncation or mutation of a conserved catalytic residue prevents this 
association, and that dimerisation is not required for activity either in vitro or in vivo. 
They also show that whilst hLPP-3 and mLPP-1 can both homo-dimerise, none of 
the LPPs tested, including Wun-2, can form associations with Wunen.
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This is the first time that an LPP has been shown to dimerise, although protein 
oligomerisation per se is not novel. Outer membrane phospholipase A (OMPLA) 
resides in an inactive, monomeric form in the outer membrane of gram-negative 
bacteria. Perturbation of the bacterial membrane activates the enzyme by reversible 
dimerisation (Dekker et al., 1997) forming functional active sites, substrate binding 
pockets and essential calcium binding sites (Snijder et al., 1999). Pre-incubation with 
increasing detergent results in dissociation into monomers and a 15-fold decrease in 
activity (Dekker et al., 1997). Wunen also forms dimers, which are dissociated by 
increasing detergent concentration, but the monomer remains active both in vitro and 
in vivo.
Dimerisation, or oligomerisation, is also believed to be an important feature 
of GPCR activation, with the existence of homo- and hetero-oligomeric complexes 
now widely accepted. The presence of constitutive homo-dimers in the absence of 
activating agonists indicates that receptor dimerisation may be important for other 
aspects of GPCR function. Indeed there is evidence to suggest that for certain 
GPCRs, for example the metabotropic GAB A receptor isoforms A and B, 
dimerisation is necessary for correct protein folding and trafficking to the 
cell-surface. In this particular case co-expression of both GABAa and GABAb and 
the subsequent formation of a hetero-dimer is required for a functional cell-surface 
receptor. If GABAa is expressed alone, it is retained intracellularly and fails to 
transport to the cell surface. GABAb, on the other hand, does reach the cell-surface 
but fails to function correctly (Bouvier, 2001).
Conversely, receptor-like protein tyrosine phosphatases (RPTPs) are also 
found as monomers or homo-dimers, but it is the monomeric version that is active. 
CD45, a transmembrane leukocyte-specific RPTP, was shown by chemical 
cross-linking and sucrose gradient ultracentrifugation to exist as monomers and 
homo-dimers, both of which associate with a 30 kDa phosphorylated protein (Takeda 
et al., 1992). Further work by the same group demonstrated that the associating 
protein, termed CD45-AP, exists in a complex with CD45 mediated through the 
single-span transmembrane domains. In CD45-AP-null cell lines, the proportion of 
CD45 dimers was significantly increased, indicating that CD45-AP inhibits 
dimerisation and results in increased activity of CD45. They further reported that this 
associating protein may play a further role in regulating access of CD45 to its 
substrate (Takeda et al., 2004). The inhibitory nature of the dimeric interaction lies in
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a wedge-shaped element present on each monomer sub-unit that inserts into the 
active site of the corresponding monomer. Thus within the dimer, each active site is 
occupied by the opposing monomer’s wedge. This wedge-mediated suppression of 
activity regulates biological activity of CD45 in cellular systems and is therefore 
believed to play a corresponding physiological role in vivo. It is proposed that ligand 
binding may stabilise the monomeric form (Jiang et al., 2000; Majeti et al., 1998)
Point mutations in the catalytic core of human arginase I, a metalloenzyme 
widely distributed from bacteria to mammals, breaks association between its 
monomers. L-arginine aminohydrolase (arginase) catalyzes the hydrolysis of 
L-arginine to L-ornithine and urea, so regulating their levels. Both of these 
amino-acids play vital roles in a range of metabolic processes. Arginase is found as 
trimers in eukaryotes, but hexamers in prokaryotes. As in Wunen, monomers retain 
wild-type activity in biochemical assays (Sabio et al., 2001). The mutated residue, 
involved in inter-monomer salt links, is believed to stabilise the multimeric structure 
since the monomer is less thermally stable and binds manganese with a reduced 
affinity. Although the absolute structure of the LPPs has yet to be determined, the 
superfamily is defined by three highly conserved domains proposed to form a 
3-dimensional active site (Neuwald, 1997) (Stukey and Carman, 1997). It seems 
possible that the D:248>T mutation may also break oligomerisation due to structural 
changes in the catalytic core. The core may serve two separate functions -  provision 
of an active site, and stabilisation of the quartenary structure. This may be 
substantiated in the future by the use of alternative point mutations in other 
catalytically important residues.
Truncation of the non-conserved C-terminal tail of avian sarcoma virus 
integrase (ASV IN) hampers multimerisation and results in loss of activity (Andrake 
and Skalka, 1995). Intergrase is required for the integration of retroviral DNA into a 
target genome and multimerisation is essential for catalytic function. In both ASV IN 
and arginase I it is proposed that the catalytic core and the C-terminus interact to 
form complexes. This could account for the loss of dimerisation seen in WunD2 and 
WunD:248>T. The loss of catalytic function would then be directly due to mutating 
a residue essential for catalytic activity.
It has recently been reported that the requirement of mLPP-3 in 
vasculogenesis in the mouse is independent of its phosphatase activity (Escalante- 
Alcalde et al., 2003). It has further been reported that hLPP-3 may be involved with
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cell-cell interactions and the regulation of adhesion, possibly another 
phosphatase-independent role. It may be, therefore, that oligomerisation is required 
for an alternative function to PGC migration and survival, and possibly for the 
regulation of a phosphatase-independent role. Thus truncation of Wunen and 
prevention of oligomerisation may not interfere with its affects on PGCs, but may 
well inhibit or modify its activities elsewhere within Drosophila.
Although the Wunen monomer is active, it is not known whether the dimer is 
active or inactive. It may be that Wunen exists as both forms with dimerisation 
regulating activity or enzyme levels. Alternatively dimerisation may be required for 
wild-type function, protein folding or trafficking to the cell-surface, but driving 
expression of the monomeric protein at unnaturally high levels in the mesoderm may 
over-ride this, with a percentage of expressed protein reaching the cell-surface due to 
the unnaturally high levels present in the cell. That the M3 tag does not prevent 
catalysis on LPA, but absolutely prevents activity in vivo indicates caution should be 
applied in interpretation of biochemical data. Since the M3 tag does not prevent 
trafficking to the cell surface, it may instead introduce conformational or structural 
changes that prevent the enzyme from recognizing or associating with either the 
substrate, or an associating factor in the pathway.
This work has now been published:
Burnett, C., Makridou, P., Hewlett, L. and Howard, K. (2004). Lipid phosphate 
phosphatases dimerise, but this interaction is not required for in vivo activity. BMC 
Biochem 5, 2.
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4) CHAPTER THREE 
Identification of a GPCR Involved in Drosophila PGC Migration
78
4.1) Introduction
Previous work has shown that the mammalian LPPs are capable of 
dephosphorylating a range of bioactive phospholipids, including LPA and SIP. The 
work presented here demonstrates for the first time that the fly LPP, Wunen, is also 
capable of dephosphorylating LPA in vitro. Both LPA and SIP function in a highly 
diverse range of pathways influencing such processes as cellular proliferation and 
differentiation, as well as cell survival and apoptosis. Perhaps more relevant to this 
work, however, are results implicating LPA, SIP and their receptors in the regulation 
of cell migration, tumour cell invasiveness and wound healing.
Cell migration and invasiveness are both key components of tumourigenesis. 
In the mid-1990s, researchers reported the isolation and identification of Ovarian 
Cancer Activating Factor (OCAF) from the ascites of ovarian cancer patients. Able 
to induce proliferation of ovarian cancer cells, OCAF was found to be composed of a 
variety of species of LPA (Xu et al., 1995b). In 1998, in a study of 165 women at the 
Cleveland Clinic Foundation, researchers confirmed that levels of LPA were 
significantly increased in the ascites of women suffering from either ovarian cancer 
or a range of other gynaecological malignancies. These results led to the suggestion 
that LPA may serve as a potent biomarker for early diagnosis of these diseases (Xu 
et al., 1998). LPA is known to induce ovarian cancer cell proliferation (Xu et al., 
1995a), whilst it has also been shown to induce the chemotaxis and chemokinesis of 
four separate ovarian cancer cell lines (Bian et al., 2004).
Both LPA and S IP  have been shown to increase the migration and 
proliferation of endothelial cells in the process of wound healing (Lee et al., 2000), 
whilst topical application of LPA increased the migration and subsequent infiltration 
of histiocyte macrophage cells to a full-thickness wound in vivo, resulting in an 
acceleration of wound repair (Balazs et al., 2001).
Olfactory ensheathing cells (OECs) demonstrate migratory behaviour 
throughout vertebrate adult life. OECs are a macroglia cell-type derived from the 
olfactory system that ensheath ingrowing olfactory nerve fibre. Interest in these cells 
stems from experiments demonstrating their ability to restore axonal re-growth and 
function, post-transplantation, in experimental models and the impact this may have 
in spinal cord injury research. Within the olfactory system of the adult rodent, 
neurons have an average life-span of thirty days, after which they degenerate and are
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replaced from a stem cell population. These newly formed neurons extend axons that 
migrate to their destination in the olfactory bulb. Transplantation of cultured OECs 
into rat cortico-spinal tract lesions has resulted in induction of regeneration of the cut 
axons and the restoration of function by encouraging elongation along their original 
pathway, a process that is distinctly lacking in central nervous system injuries 
(Raisman, 2000; Raisman, 2003). Addition of LPA to OECs cultured on Transwell 
membranes increased their proliferation, but more significantly, enhanced their 
migration in a dose-dependent manner. This was associated with changes in cell 
morphology and actin re-organisation (Yan et al., 2003).
Another type of glial cell from the peripheral nervous system, Schwann cells, 
have been shown to respond to both LPA and SIP  stimulation. In both primary rat 
cells and cells from the rat-derived SCL4.1/F7 line, SIP and LPA induced process 
retraction, cell spreading and the formation of lamellipodia. When assayed in a 
Boyden chamber, both LPA and SIP induced a significant increase in cell motility, 
with a gradient of SIP  generating a directional chemotactic response (Barber et al., 
2004).
LPA and SIP  are similar molecules, both structurally and functionally. It 
should be of little surprise, then, that they bind and exert their affects through a 
single family of specific cell-surface receptors. So far five receptors have been 
identified that bind SIP, whilst three bind LPA. Originally termed the endothelial 
differentiation gene receptors (Edg), Edgl, 3, 5, 6 and 8 bind SIP, whilst Edg2, 4 
and 7 bind LPA. They have now been renamed SIPj_5 and LPAj_3 (Takuwa et al., 
2002).
The receptors for both LPA and SIP have also been implicated in influencing 
cell migration and invasiveness. In the study on epithelial wound healing, 
quantitative RT-PCR indicated a significant up-regulation of Edgs 1, 2 and 3 (Lee et 
al., 2000), whilst over-expression of Edgl in HEK293 cells was shown to enhance 
chemotaxis, a result also observed in HUVEC (Human Umbilical Vein Endothelial 
Cells) and BAEC (Bovine Aortic Endothelial Cells) cell lines. Furthermore, cells 
were shown to migrate directionally in response to a gradient of SIP. The authors 
concluded from this study that the binding of SIP to the SIP-specific Edgl receptor 
increases cell motility in vascular endothelial cells (Wang et al., 1999).
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During zebra-fish development, myocardial precursor cells migrate towards the 
midline where they eventually fuse, forming the heart tube. A large-scale genetic 
screen revealed a novel mutation termed miles-apart {mil). In mil embryos the 
second wave of precursor migration is severely disrupted, a phenotype that is 
restricted to the myocardial precursor cells. Researchers discovered through the use 
of cell transplantations and genetic mosaics that, when introduced into a wild-type 
background, mutant cells could migrate normally. When the reverse was applied, 
however, wild-type cells failed to migrate correctly in a mil background. Further 
analysis revealed that mil encodes an Edg5 homologue, and expression of the protein 
in Jurkat T cells resulted in activation of SIP-associated signalling pathways upon 
exposure to SIP. Thus for cell migration to occur normally in this system, the 
SIP-specific Edg5 receptor is required not within the myocardial precursor cells 
themselves, but within the surrounding tissue (Kupperman et al., 2000).
In a similar vein, PGCs in Drosophila  respond to extra-cellular signals 
regulated in some fashion by Wunen and Wunen-2, enzymes that we know can 
dephosphorylate LPA (their activity on SIP remains untested). It stands to reason, 
therefore, that in order to respond to these directional cues, PGCs should possess 
receptors on their surface that can interpret and respond to the appropriate and 
specific cues in their surrounding environment.
The Edg receptors are members of the GPCR superfamily, an extremely large 
family of proteins which is divided into three main sub-families: the rhodopsin and 
P2-adrenergic receptors (family A), the glucagon-like receptors (family B), and the 
metabotropic neurotransmitter-like receptors (family C). A degree of homology 
exists between members in the same family, but, overall, GPCRs make up a diverse 
and complex group, activating a wide variety of signal transduction pathways and 
binding an equally diverse range of ligands, including biogenic amines, lipids, 
peptides, nucleotides, ions and light. GPCRs share a common overall structure 
comprising seven transmembrane a-helical segments, which interact to form a 
three-dimensional barrel, with an extracellular N-terminal segment and an 
intracellular C-terminal tail.
GPCRs comprise a signal transduction unit consisting of the receptor linked 
to a trimeric G-protein (guanine nucleotide-binding regulatory protein) complex. 
Upon ligand binding to the GPCR, the G-protein is activated: the a  sub-unit releases
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GDP in exchange for GTP, and dissociates from the py Part °f the complex. Both the 
a  and py units are then free to activate or inhibit an effector protein. Effectors 
include adenylyl cyclase and phospholipases C and D. Hydrolysis of GTP to GDP by 
an intrinsic GTPase activity of the a  sub-unit terminates this process and returns the 
a  sub-unit to the complex (Bouvier, 2001; Gether, 2000).
The third aim of this work was to search for sequences within the Drosophila 
genome that may encode putative PGC-specific receptors, and, having identified any, 
to test whether or not they do indeed function in the regulation of PGC migration.
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4.2) Results
4.21) Computational Analyses 
4.21a) Identification o f Gene 11
Previous work in the Howard lab by Dan Marsden to identify sequences in the 
Drosophila genome with homology to the mammalian Edg receptors revealed Gene 
11 (synonyms CG4322, EG:22E5.11) at 2C7-8 on the X chromosome. Gene 11 was 
identified in FlyBase as an orphan member of the rhodopsin-like superfamily, and 
sitting just 5’ are two EP elements, EP(X)1529 and EP(X)1631. The full-length 
cDNA, RE26846, was ordered, cloned into the pUAST vector and sequenced, before 
injection into flies and recovery of transformants. Phenotypic analyses of this gene 
using ectopic expression and analysis of the insertions, revealed no significant 
perturbation in PGC migration and this work was not pursued any further.
4.21b) Identification ofTre-1
In 2002, Clark Coffman et al reported the results of an EMS mutagenesis screen of 
the X chromosome that identified a mutation affecting PGC migration and PGC 
programmed cell death, which they termed scattershot (sett). In sett embryos, PGCs 
enter the posterior mid-gut and traverse the epithelium normally, but then fail to 
reach the gonads and are left scattered throughout the posterior half of the embryo. 
Furthermore, these ectopic PGCs continue to express germ cell markers and are not 
eliminated as is usually seen for ‘lost’ (ectopic) PGCs during wild-type 
embryogenesis. sett is a maternal-effect mutation and its product is required both 
maternally and zygotically. Paternal rescue results in wild-type numbers of PGCs 
locating and associating with the gonads, but does not restore the cell death 
phenotype -  ectopic PGCs are not eliminated resulting in a significantly increased 
final overall number of PGCs (Coffman et al., 2002).
sett maps to between 4C11 and 6D8 on the X chromosome. Computational 
analyses of this area revealed a number of genes, both annotated and putative. One 
gene, Trehalose-1 (tre-1, CG3171), was identified as an orphan member of the 
rhodopsin-like superfamily, which maps to 5A11-5A12 (FlyBase, 2003).
The Genome Annotation Database of Drosophila (GadFly) identified 
RE07751 as a full-length cDNA for tre-1. A BLAST search using the tre-1 sequence
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revealed homology to CG4322, or Gene 11. As this had initially been identified 
through a search for Edg-like receptors, a ClustalW analysis was performed using 
sequences for tre-1, Gene 11 and Edgsl-8, and the results were used to construct a 
phylogenetic tree (Fig.33).
hEDG-1
— hEDG-3
—  h EDG-5
h EDG-2
h EOG-4 
 hEDG-7
------------------------ h EDG-6
hEDG-8
 Tre-1
Gene 11
Fig.33. Phylogenetic tree. The phylogenetic tree was constructed using ClustalW, 
and sequences with the following accession numbers: human Edgl to Edg8 = 
N M 001400, N M 057159, N M 005226, N M 004 720, NM004230, NM003775, 
NM012152, NM030760. Tre-1 = NM080053, Gene 11 = NM130614.
The phylogenetic tree indicated that Tre-1 is closer to the LPA receptors (Edgs2, 4 
and 7) than the SIP receptors. Consequently tre-1 appeared to be a candidate locus 
for sett, and thus a candidate receptor involved in the regulation of both PGC 
migration and PGC death.
4.22) Phenotypic analyses
4.22a) tre-1, GrSa and Tre-1*BF3
tre-1 was originally identified as encoding a taste receptor to the sugar trehalose 
(Ishimoto et al., 2000). Further analyses of the region, however, identified the 
neighbouring gene GrSa, and not tre-1, to be responsible for trehalose sensitivity, 
leaving Tre-1 with an unknown function (Dahanukar et al., 2001; Ueno et al., 2001). 
The Gr5a phenotype was uncovered through imprecise excisions of the EP element 
EP(x)496, located approximately one hundred base pairs upstream of the tre-1 
transcription start site and seven hundred base pairs upstream of Gr5a. Mobilisation
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of EP(X)496 resulted in various deletions of the Tre locus, including fre -/AEP3 
(AEP3) and the slightly larger fre-/AEP5 (AEP5). AEP3 deletes 2.1kpb, uncovering 
1.4kbp toward tre-1, and removing the promoter, exon 1 and part of the first intron. 
AEP3 also removes 0.7kbp towards Gr5a, deleting the promoter (Fig.34).
Gr5a EP(X)496 Tre-1
A A A A A  3'
—
►
AEP3 deletion
■  ■ ■  ■ ■ ■  7
<
---------1 AEP5 deletion
I " . . .
|----------------------------------------------------------
—  Introns H i  mRNA ■ ■  Coding sequence ► RT-PCR primers
Fig.34. The tre-1 genomic region. The diagram illustrates the tre-1 coding sequence 
in PURPLE, the introns in GREEN as well as the EP insertion EP(X)496 used to 
create the deletions AEP3 and AEP5. Part o f the neighbouring gene, Gr5a, is also 
represented to the left o f the figure.
4.22b) In situ hybridisation
The RE07751 cDNA was obtained from Invitrogen in the pFLCl vector. This was
liftused to produce labelled probes for use in ISH. ISH in wild-type W embryos 
revealed transcripts in a variety of embryonic tissues, including the proventriculus 
and ventral nerve cord (Fig.35).
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Fig.35. In situ hybridisation. ISH o f Tre-1 probe (RE07751) to W118 embryos.
Embryos are oriented with the posterior to the right at around stage 16. A) Viewed
various tissues
dorso-ventrally. Tre-1 expression is observed in \  (WHITE arrow-headty. B)
Viewed laterally. Tre-1 expression is observed in the proventriculus (ORANG E  
arrow-head) and the ventral nerve cord ( arrow-heads).
This was confirmed by data available on the Berkeley Drosophila Genome Project 
(BDGP) gene expression page (http://www.fruitfly.org/cgi-bin/ex/insitu.pl) which 
reports that tre-1 has a dynamic expression profile beginning in the maternal pole 
plasm and found in various tissues throughout embryogenesis. Most significantly for 
this work, however, tre-1 is also expressed in the PGCs at stages 7-8 and 13-16 
(Tomancak et al., 2002).
4.22c) AEP3 and PGC migration
The AEP3 deletion was obtained as a kind gift from Kunio Isono, as a homozygous 
viable purified stock extracted over an X chromosome FM7 balancer (personal 
communication). The germ cell phenotype in AEP3 flies was examined and 
compared to wild-type, by staining embryos with the anti-Vasa antibody and 
counting the number of PGCs left ectopic to the gonads by stage 13. Results clearly 
indicated that 47% of the PGC population showed a severe disruption in migration, 
without a single germ cell managing to coalesce with the gonad by stage 13. 
Although this phenotype displayed variable penetrance, 87% of the total population 
examined demonstrated perturbed migration (Fig. 36 and Fig.37).
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Fig.36. Phenotypic analysis o f AEP3. All embryos are viewed dorso-ventrally with 
the posterior pole oriented to the right. PGCs are stained with anti-Vasa antibody 
and are visualised in brown. A) Wild-type. B-D) AEP3 embryos demonstrating the 
variable phenotype. In B, no PGCs have associated with the gonads, whereas in C a 
few  have made it (indicated by the white arrow-heads), and in D there are two 
definite gonads (indicated by the white arrow-heads), whilst a number o f PGCs still 
remain in the main body o f the embryo.
4.22d) Genomic rescue o f the PGC migration defect
The question remained whether the observed phenotype was due to a deletion in 
tre-1 or the neighbouring gene Gr5a. To determine this, Kunio Isono kindly sent 
Tre-lAEP3:mlOf, a stock containing a third chromosomal insertion of a 6 Kb CG3171 
genomic fragment in pCaSpeR-4 vector. Phenotypic analysis of these flies 
demonstrated that this addition of tre-1 was sufficient to rescue the PGC migration 
defect in the AEP3 flies, indicating that it is the deletion in tre-1 and not GrSa that is 
responsible (Fig. 37).
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Fig.37. Tre-1 rescue. Embryos were fixed and stained at stages 12 onwards. All 
PGCs ectopic to the gonads were counted. Where no PGCs at all managed to locate 
the gonads, numbers were scored as 20+.
4.22e) PGC cell death phenotype
The variable spread of numbers of PGCs left ectopic to the gonads in the AEP3 
mutation indicated a heterogeneous population. However, closer analyses of these 
embryos revealed a second distinct phenotype. During wild-type embryogenesis, 
embryos start off with a complement of around 36 PGCs. By the time that they have 
divided into two bilateral groups and associated with the somatic gonadal precursors 
at around stage 12, however, there is on average only 10 to 11 PGCs per gonad, with
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2 to 3 left outside -  a final total of approximately 22 to 25 PGCs, and a reduction in 
total number by a third. Embryos were scored at stage 11, when the PGCs exit the 
midgut and spread out on its basal surface just prior to dividing into two bilateral 
groups (Fig.38). Careful scoring of PGC numbers at this stage indicated an average 
of 35.26 PGCs per embryo in wild-type. PGC number was scored again at stage 12 
as the PGCs line up in two groups, just prior to coalescence with the gonadal tissue -  
again at this stage individual PGCs can be easily visualised. In contrast to an average 
of 10.4 PGCs per gonad in wild-type embryos at this stage, AEP3 embryos had an 
average of 15.63 PGCs per gonad with 5.47 ectopic, giving a total of 36.44 PGCs per 
embryo. This phenotype was scored only for those embryos in which a proportion of 
the PGCs escaped the gut and made it to the gonads (Fig.38).
Fig.38. Cell death phenotype. All embryos are stained with anti-Vasa. A and B are 
viewed dorso-ventrally, C and D are viewed laterally. A) Wild-type at stage 11 
showing PGCs post-exit from the mid-gut, spreading out over the basal surface. B) 
AEP3 stage 11. There is no difference in PGC numbers as counted at this stage for  
wild-type and AEP3. C) Stage 12 embryo showing a wild-type gonad. D) AEP3 
embryo at the same stage, showing a gonad with an increased number o f associated 
PGCs.
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These results indicate that in those embryos that have a less severe PGC migration 
defect, where the vast majority of the PGCs exit the gut and correctly locate the 
gonads, the normal reduction in PGC number observed during wild-type 
embryogenesis does not occur, resulting in gonads that are over-populated by up to 
fifty percent. Those that do not reach the gonad continue to express Vasa, and fail to 
be eliminated. Furthermore, this phenotype is strikingly similar to that observed for 
sett. In sett flies, paternal rescue results in correct migration to the gonads but again 
the embryos retain the full complement of PGCs with no reduction in number. The 
difference here, however, is that in sett the numbers of PGCs scored in each gonad 
under these conditions are wild-type, with the rest remaining ectopic but failing to be 
eliminated.
4.23) Is sett a mutation in tre-1?
4.23a) Complementation
Both sett and tre-1 produce similar phenotypes, with PGCs failing to migrate 
correctly and remaining ectopic to the gonads by the end of embryogenesis whilst 
failing to be eliminated (the usual fate of ‘lost’ PGCs). If sett were a mutation in 
tre-1 we would not expect the AEP3 deletion to complement the sett mutation, sett 
virgins were crossed to AEP3 males, and the resultant embryos stained with 
anti-Vasa to visualise the PGCs (Fig. 39).
Fig.39. Complementation. A) sett embryo. B) sett x AEP3 embryo. Both demonstrate 
highly perturbed PGC migration, with very few  PGCs successfully locating the 
gonads.
90
These embryos still showed perturbed PGC migration, indicating that sett and tre-1 
do not complement each other.
4.23b) RT-PCR and real-time PCR
If se tt were a mutation in tre-1 , we would expect Tre-1 expression to be 
down-regulated in sett mutant embryos. To test this, Clark Coffman collected 
embryos from sett homozygous flies and the original parental stock Faf-LacZ, at 
specific developmental intervals: 0-3 hours, 3-6 hours, 6-9 hours and 9-12 hours. 
These were sent to us on dry ice. Upon arrival, RNA was extracted from each sample 
and subsequently converted to cDNA by reverse transcription. An aliquot of each 
cDNA was put through a standard polymerase chain reaction (PCR) amplification 
before running on an agarose gel to confirm the reaction had worked. Primers were 
designed to amplify the sequence between the first (Tre289Exonl) and third 
(Tre548Exon3) exons of tre-1. Control primers were also designed to amplify the 
house-keeping gene Actin (Actin42 and Actin361).
Quantitative real-time PCR allows more accurate quantification of RNA. To 
perform this, aliquots of each cDNA were added to DyNAmo SYBR® Green reagent 
(MJ Research) plus the relevant volume of primer mix, mixed gently and aliquoted 
into three wells of a 96-well plate. Samples were run with either Tre289Exonl plus 
Tre548Exon3, or Actin42 plus Actin361, under parameters that had been previously 
optimized, in an MJ Research DNA Opticon ® 2 real-time thermal cycler. The entire 
run was repeated three times, using the exact same cDNA samples, before analysis 
by the 2'AACT method (Livak and Schmittgen, 2001) (Table 8). This method relies on
the calculation of relative, as opposed to absolute, amounts of RNA. Rather than 
determining exact copy number, relative quantification looks at the fold change in 
gene expression in relation to a treatment (in this case developmental staging), and 
normalizes it to a standard house-keeping gene, in this case Actin.
The results indicated that Tre-1 expression is somewhat down-regulated in 
sett embryos (Table 8). Taken alongside the complementation data, it would appear 
that tre-1 might be a hypomorphic allele of sett. This is currently under further 
investigation by the Coffman lab.
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G enotype Tre-1 CT Actin C j ACt AACj 2-AACy
RUN 1 Faf 0-3 26.08 21.82 4.26
Sett 0-3 27.18 25.80 1.37 -2.90
RUN 2 Faf 0-3 25.53 21.68 3.85
Sett 0-3 27.42 23.65 3.76 -0.09
RUN 3 Faf 0-3 25.83 21.92 3.91
Sett 0-3 28.22 23.61 4.62 0.71
RUN 1 Faf 3-6 25.57 22.40 3.18
Sett 3-6 28.64 24.13 4.51 1.33 0.40
RUN 2 Faf 3-6 25.23 22.69 2.54
Sett 3-6 26.65 23.45 4.19 1.66 0.32
RUN 3 Faf 3-6 24.91 22.42 2.49
Sett 3-6 28.38 23.36 5.02 2.54 0.17
RUN 1 Faf 6-9 26.62 23.14 3.47
Sett 6-9 27.20 22.94 4.26 0.78 0.58
RUN 2 Faf 6-9 25.66 23.07 2.60
Sett 6-9 25.48 22.57 2.90 0.31 0.81
RUN 3 Faf 6-9 26.20 22.45 3.73
Sett 6-9 26.50 21.91 4.59 0.87 0.55
RUN 1 Faf 9-12 25.70 23.98 1.73
Sett 9-12 27.89 23.31 4.58 2.85 0.14
RUN 2 Faf 9-12 25.32 22.57 2.71
Sett 9-12 26.53 21.30 5.23 2.51 0.18
RUN 3 Faf 9-12 26.06 22.31 3.74
Sett 9-12 26.91 21.87 5.04 1.29 0.41
Table 8. Quantitative real-time PCR analyses o f Tre-1 expression in sett embryos.
The results are values from three replica runs. Values were read in an MJ Research 
DNA Opticon® 2 real-time thermal cycler, using SYBR Green® reagent (MJ 
Research) and are represented by the CT value. CTis the ‘threshold cycle’, the PCR 
cycle number at which the measured fluorescence for each sample exceeds the
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background. The first value o f 7.41 in RUN 1 appears to be a PCR anomaly and 
should be discounted.
4.24) Tre-1 and Wunen
It appears from the phenotypic analyses that Tre-1 may regulate PGC survival. Over­
expression of Wunen in the mesoderm results in PGC death, presumably by 
depletion of an extracellular factor required for PGC survival. Could Tre-1 be the 
receptor for the signal that Wunen mediates? If it were, one would expect over­
expression of Wunen in a AEP3 background to have no affect on PGC number. In 
order to investigate this, it was first necessary to cross the twist-GAL4 mesodermal 
driver, and those flies carrying WunGFP, into the AEP3 background. The original 
mis-expression study utilised a twist-GAL4 inserted on the X chromosome. Since 
AEP3 is also on the X chromosome, this driver was unsuitable, and 24B-GALA  
(Brand and Perrimon, 1993) was employed instead. This stock carries a mesodermal 
driver on the III chromosome. Males of AEP3;24B-GAL4 (1:3) were crossed to 
virgins of AEP3, WunGFP (2) and AEP3;WunGFP (1:3). Embryos were stained with 
both anti-Vasa and anti-GFP antibodies, and the numbers of PGCs left by stage 13 
were counted in those embryos where PGCs had clearly exited the mid-gut at stage 
10.
Initial results appeared encouraging, with populated gonads clearly visible in 
the AEP3;WunGFP sample, and no significant reduction in PGC number. However, 
analyses of the WunGFP sample revealed that unlike the original twist-GAL4 driver, 
PGC loss was not nearly as significant, and the GFP staining appeared weaker. 
Again, gonads were visible in some of the embryos (Fig.40). This raised doubts as to 
the efficacy of this driver for these purposes, and the experiment was repeated with 
two alternatives, twist-GAL4 on the II chromosome (a kind gift from Marcel van den 
Heuvel) and a twist-GAL4 linked to a GIT5 balancer on the III chromosome (Halfon 
et al., 2002).
Ectopic expression in the mesoderm using either of these two drivers resulted 
in large numbers of ‘dead’ or severely degenerated embryos, making analysis of the 
phenotype difficult. This was not due to the fixing process, since alternative 
genotypes fixed and stained at the same time were normal. Observation of the
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surviving embryos indicated that both drivers effectively reduced PGC number in the 
WunGFP embryos to virtually zero. In the AEP3;WunGFP embryos, many PGCs 
remained. Closer examination, however, indicated that it was only those PGCs that 
failed to exit the gut at stage 10, and so remained inside throughout embryogenesis, 
that survived (Fig.40). Expressing WunGFP in the mesoderm in a huckebein (hkb) 
mutant background also failed to result in PGC death (Fig. 40). In hkb embryos, 
PGCs enter the gut, but due to a failure in gut development, remain trapped inside 
(Jaglarz and Howard, 1994; Weigel et al., 1990). This would indicate that the PGCs 
that remain in the AEP3;WunGFP embryos survive because they are protected from 
the Wunen signal by remaining inside the gut.
These results may indicate that Tre-1 is not the receptor for the 
Wunen-mediated signal, however, due to the nature of the drivers used, the 
subsequent quality of the embryos, and the variability of the AEP3 phenotype, this 
possibility cannot be conclusively ruled out.
Fig.40. Ectopic expression o f WunGFP in the AEP3 background. All embryos are 
viewed dorso-ventrally with their posterior poles to the right. PGCs are stained with 
anti-Vasa and are visualised in brown. GFP expression is visualised in blue. A) 
AEP3;WunGFP x AEP3 ;24B-GAL4. Many embryos formed gonads, as indicated by 
the white arrow-head. B) WunGFP x either o f the alternative twist-GALA drivers 
(the same result is observed for both). Only a couple o f PGCs remain (white
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arrow-heads). Overall, most embryos within a sample were severely degenerated. C) 
AEP3;WunGFP x either alternative twist-GAlA driver. PGCs survive, but remain 
trapped inside the gut, as circled. Few if  any PGCs are observed outside, or having 
reached the somatic gonadal precursors. D) WunGFP in an hkb background. PGCs 
are unaffected by overexpression o f WunGFP, but also remain trapped inside the 
gut.
4.3) Summary
The work presented here identifies a novel GPCR member of the rhodopsin 
superfamily localised to the pole plasm and expressed in PGCs at stages 7 to 8, and 
13 to 16. Deletions in this gene result in perturbed PGC migration, with the AEP3 
deletion presenting a variable phenotype. In a proportion of embryos, no PGCs 
contact the gonadal precursors and no gonads form, whereas in others, many reach 
and associate with the gonadal precursors, with a variable number remaining ectopic. 
In those embryos that form gonads, the gonads are over-populated with up to fifty 
percent more PGCs per side, with the remainder spread through the interior of the 
embryo. This would suggest, then, that Tre-1 function is required for correct PGC 
migration and that Tre-1 plays a role in eliminating excess PGCs during wild-type 
embryogenesis.
In sett embryos, PGCs traverse the posterior mid-gut as in wild-type, but then 
disperse through the posterior half of the embryo, failing to form gonads. PGCs 
continue to express PGC markers, indicating that they fail to undergo the 
programmed cell death normally associated with ‘lost’ or mis-located PGCs. This 
cell-death is essential to prevent ectopic PGCs potentially forming teratomas or 
metastases. Full characterisation of this process has yet to be completed, however, 
therefore it cannot be stated categorically that ectopic PGCs are eliminated through 
programmed cell death, or ‘apoptosis’. Interestingly, zygotic rescue of sett results in 
normal numbers of PGCs migrating to the gonads, but again, failure of ectopic PGCs 
to be eliminated. This indicates that the zygotic and maternal components of sett can 
be uncoupled -  the recessive maternal component is required for correct PGC 
migration, whereas the zygotic component is required for cell death.
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In contrast to sett, the phenotype observed for AEP3 embryos as described above, is 
highly variable. AEP3 is not a simple deletion of tre-1 since it removes the promoter 
region but leaves the coding sequence intact. Preliminary quantitative real-time PCR 
analysis of the AEP3 embryos from over-night lays indicates that Tre-1 expression is 
severely reduced but not completely absent in these embryos (data not shown). This 
may indicate that AEP3 is a regulatory allele, and this may account for the variability 
in phenotypes observed. Further work is required to fully characterise the genetic and 
molecular properties of this deletion.
Considering their relative map positions and the similarities in phenotype, the 
question remains, is tre-1 sc ttl Analyses presented here, although somewhat 
inconclusive, appear to indicate that tre-1 may be a hypomorphic allele of sett. More 
recent research may yet substantiate this, as it is now believed that sett may be a 
splice variant and may undergo alternative splicing. This is currently under further 
investigation (Clark Coffman, personal communication).
Originally called tre-1 because of its supposed role as a trehalose receptor, 
tre-1 has recently been renamed ‘trapped in endoderm-1\  due to findings with the 
AEP5 deletion by the Lehmann lab. They extracted this deletion over an X 
chromosome FM7 balancer and observed a fully penetrant phenotype, in which 
PGCs were unable to cross the posterior mid-gut epithelium at stage 10, and instead 
remained trapped inside the gut, as seen in the most severe cases reported for AEP3 
(Fig.36B) (Kunwar et al., 2003). They reported that Tre-1 is inherited maternally, 
and that AEP5 removes both the maternal and early zygotic components. They 
observed that embryos lacking just the zygotic component were effectively 
wild-type, concluding that it is only maternal Tre-1 that is required for correct PGC 
migration. They further reported that paternal rescue resulted in an increased number 
of PGCs traversing the gut and successfully making it to the gonads. This is similar 
to observations for sett, in which paternal rescue resulted in a wild-type number of 
PGCs locating the gonad, although those left outside failed to be eliminated, 
demonstrating a failure in programmed cell death. Isogenisation of Kunio Isono’s 
AEP3 stock by extraction of individual chromosomes over an FM7 balancer, gave 
similar results to the Lehmann lab’s isogenised AEP5, with almost all embryos 
demonstrating a ‘trapped in gut’ phenotype, as opposed to the variability observed 
with the original stock. Unfortunately, the nature of this phenotype makes it very
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difficult to accurately count numbers of PGCs, since many are tightly clustered or 
stacked ‘on top’ of each other. However, it was reported that PGC numbers appear 
wild-type in the AEP5 deletion, something that is contrary to observations on the 
original AEP3 (Kunwar et al., 2003). This may indicate that as with sett, tre-1 
regulates both PGC migration and survival, by means of a complex genetic 
interaction that is lost upon isolation and purification of the deletion.
The Lehmann lab also investigated the relationship of tre-1 to sett. Having 
sequenced the area and found no significant changes, they too concluded that tre-1 is 
a hypomorphic allele of sett.
The question remains as to whether or not tre-1 encodes a receptor for the 
Wunen-mediated guidance and survival signal. It appears that PGCs inside the gut 
are protected from Wunen activity, regardless of genetic background, but data as to 
what befalls those PGCs that successfully cross the midgut in AEP3 embryos, during 
ectopic expression of WunGFP in the mesoderm, is inconclusive. It must also be 
remembered that ectopic expression of WunGFP results in unnaturally high levels of 
this protein in tissues where it is not normally found. This may over-ride wild-type 
mechanisms, resulting in loss of PGCs through alternative pathways that would not 
normally be employed. Whether a genetic interaction exists between wunen and tre-1 
is an interesting and important question, and will continue to be investigated in 
greater detail.
Tre-1 demonstrates a variable and dynamic expression pattern. Among other 
tissues, it is found in the ventral nerve cord, ventral midline and central nervous 
system of Drosophila embryos, and was pulled out in a gain-of-function screen for 
genes involved in neural development (Norga et al., 2003). Further provisional 
analyses of the AEP3 mutants indicate that there are deficiencies in hemocyte 
formation (Nathalie Franc, personal communication), and it is interesting to note that 
Tre-1 expression is also reported in the embryonic and larval circulatory system 
(Tomancak et al., 2002). Although implicated in the regulation of PGC migration 
and survival, it seems likely, that in the future, Tre-1 will prove to function in a 
num ber of alternative and significant roles during developm ent.
DISCUSSION
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5.1) Summary
Primordial germ cells (PGCs) are the embryonic stem cell precursors of the adult 
gametes, and as such, carry the genetic information from generation to generation. 
They are capable of generating not only an entirely new individual, but also the 
future germline of that individual. In many organisms, including Drosophila, the 
PGCs are set aside as a distinct sub-set of cells early on in embryogenesis, in a 
location both temporally and spatially removed from their target tissue, the somatic 
gonad. During their migration to the developing somatic gonad, the PGCs display 
motile, proliferative and invasive behaviours, and come under the influence of a 
variety of guidance, survival and cell death signals. In studying PGC migration and 
survival in Drosophila, therefore, we hope to gain insights into the processes that 
regulate and control both cell migration and stem cell survival in general.
The work presented here reports novel findings for the lipid phosphate 
phosphatases (LPPs) Wunen and Wunen-2, both of which are involved in the 
regulation of PGC migration and survival in Drosophila. This work demonstrates 
that D rosophila  Wunen displays a far narrower substrate range in vitro than 
previously reported for the mammalian LPPs, and that in vivo, human LPP-3 can 
recognise and regulate the same endogenous PGC-specific factor as Wunen, whilst 
mouse LPP-1 cannot. Importantly, these findings establish that the effect of Wunen 
on PGC migration and survival is due to the phosphatase activity of the protein, and 
not to an alternative function as yet determined. Furthermore, this work proves that, 
as previously believed but not shown, the LPPs are capable of forming oligomeric 
complexes, that these interactions are dependent on the C-terminus and an intact 
catalytic site, but that oligomerisation is not required for activity either in vitro, or in 
vivo within the assays presented here. Finally, this work identifies a novel GPCR 
expressed on the surface of PGCs that also regulates both PGC migration and 
survival. One of the key questions within this field, is what is the PGC survival 
factor that the LPPs regulate? It is hoped that this research will help to identify this 
elusive substrate.
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5.2) Models for Wunen/Wunen-2 function
Two main models have been suggested for Wunen and Wunen-2 function in 
Drosophila. The first is that Wunen and Wunen-2 act redundantly in the posterior 
mid-gut to degrade an attractive guidance signal that acts as a PGC survival factor. 
The second is that their activities result in the production of a repellent factor, that at 
high levels of exposure kills PGCs. Recent data, simultaneously published by two 
independent groups, adds significantly to our current understanding of these two 
proteins. Combined with the discovery of Tre-1 as a potential receptor within this 
system, these data lead us to consider alternative and more complex models for LPP 
function within Drosophila.
The recently published results demonstrated that Wunen-2 is in fact inherited 
maternally, is expressed ubiquitously in early cleavage embryos, and is consequently 
localised to the PGCs themselves. The first zygotic expression of Wunen-2 was 
observed in a posterior stripe beginning at stage 5 (Hanyu-Nakamura et al., 2004; 
Renault et al., 2004). Loss of maternal Wunen-2 resulted in a dramatic reduction in 
PGC number, a phenotype similar to that observed for ectopic expression of Wunen, 
Wunen-2 or hLPP-3 in the mesoderm. This PGC loss could be rescued by driving 
expression of any one of these proteins using a PGC-specific driver. Whilst PGCs 
formed normally, entered the posterior mid-gut and traversed to the other side in 
mutant embryos, by stage 11, when they began to associate with the mesoderm, they 
demonstrated a dramatic reduction in number, and 80% of the resultant germline 
Wunen-2 null females were agametic. If zygotic Wunen and Wunen-2 expression 
was removed alongside germline Wunen-2 expression, this PGC loss was rescued. 
Conversely, simultaneous over-expression of both Wunen and Wunen-2 in the 
mesoderm and Wunen-2 in the PGCs partially rescued this loss, although PGCs still 
mis-migrated to the gonads (Hanyu-Nakamura et al., 2004; Renault et al., 2004). It 
was clearly demonstrated that the distributions of various pole plasm components 
such as nanos, germ cell-less and Nanos were wild-type, that transcriptional 
repression was not altered, and that the control of zygotic gene expression was 
normal within the Wunen-2 null PGCs (Hanyu-Nakamura et al., 2004). Furthermore, 
both groups demonstrated that this requirement for Wunen-2 in the PGCs was 
dependent on the phosphatase activity of the protein. Significantly, it was shown 
through the use of a photoactivatable lineage tracer (caged flourescein), combined
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with an anti-Vasa antibody that PGC loss in these embryos occurred in a 
caspase 3-independent manner. This is contrary to observations for ‘lost’ PGCs in 
wild-type embryos, that were seen to die in a caspase-3-dependent manner (Hanyu- 
Nakamura et al., 2004). This suggests that although conventional apoptotic pathways 
are employed in the normal elimination of ‘lost’ or ectopic PGCs, the loss of PGCs 
that lack maternal Wunen-2 expression occurs by an alternative, as yet undiscovered, 
mechanism.
Both groups propose the same model: germline Wunen-2 competes with 
Wunen and Wunen-2 activities in the soma, for uptake (via dephosphorylation and 
subsequent internalisation) of a common lipid phosphate substrate required for PGC 
survival. Local depletion of this substrate by somatic Wunen and Wunen-2 results in 
a gradient that guides the PGCs towards the gonads. If maternal Wunen-2 is absent, 
PGCs are incapable of competing for this substrate, cannot make the survival signal, 
and die, through an as yet undetermined mechanism. If somatic Wunen and Wunen-2 
are absent, PGCs survive, but are unable to locate the gonad due to a failure to form 
a gradient of lipid phosphate. If Wunen or Wunen-2 are over-expressed in the soma, 
the resultant widespread depletion of the substrate makes it unavailable to the PGCs, 
again resulting in their death. If Wunen-2 is simultaneously over-expressed in the 
PGCs, however, they can now compete for the substrate, and thereby survive. This 
model is supported by biochemical data which indicate that membrane fractions from 
Hi5 cells expressing Wunen-2 are capable of dephosphorylating both PA and LPA, 
and that Wunen-2 promotes the rapid internalisation, and cytoplasmic localisation, of 
flourescein labelled PA analogs into intact cells (Renault et al., 2004). One potential 
caveat to this model is that PGCs survive in the absence of both maternal and zygotic 
Wunen and Wunen-2. This could be explained by three possibilities -  firstly, other, 
as yet uncharacterised Drosophila LPPs may act redundantly in the absence of 
germline Wunen-2 (there are 8 known Drosophila LPPs in the database). Secondly, 
trace amounts of maternally inherited Wunen-2 remain which may be sufficient for 
dephosphorylation and internalisation of the substrate. Thirdly, alternative 
mechanisms may exist that work in parallel to promote PGC survival (Hanyu- 
Nakamura et al., 2004; Renault et al., 2004).
How would Tre-1 fit into this model? Results presented here indicate that a 
decrease in Tre-1 expression results in a loss of the reduction in PGC number 
observed post stage 10-11 in wild-type embryos. This would indicate that Tre-1
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plays a role in the elimination of excess PGCs, reducing their number from around 
36 to a final average of around 23. We know that Wunen and Wunen-2 are expressed 
in the posterior mid-gut at the time of PGC exit, and that loss of both proteins in the 
double mutant 10201/k (Starz-Gaiano et al., 2001; Zhang et al., 1997) results in 
PGCs exiting the midgut normally, but then failing to orient toward the mesoderm or 
undergo guided migration. Closer phenotypic analyses of these embryos, however, 
reveals that in those embryos where both somatic Wunen and Wunen-2 are absent, 
PGCs also fail to undergo any sort of elimination, and are found in similar final 
numbers as in AEP3, with an average of 37 PGCs by the end of embryogenesis (data 
not shown). These data were not reported in the original or subsequent papers on 
these mutants. Furthermore, analysis of PGC numbers in hkb embryos also reveals 
no reduction in PGC number, with an average of 40 PGCs trapped inside the gut 
(data not shown). This may indicate that in wild-type embryos, somatic Wunen and 
Wunen-2 function to eliminate a ‘swathe’ of central PGCs after they exit the mid-gut 
at around stages 10-11. This could occur by local dephosphorylation of the 
PGC-specific lipid phosphate substrate, and would serve two functions -  elimination 
of central PGCs and the division of the remainder into two distinct bilateral groups, 
and formation of a gradient of the substrate, which would provide directional cues 
for correct migration of PGCs to the mesoderm. A reduction in Tre-1 expression 
gives similar results to loss of somatic Wunen and Wunen-2, with no reduction in 
PGC number. In this model, Wunen/Wunen-2 and Tre-1 must interact genetically, 
otherwise in the AEP3 mutants, PGCs would still be exposed to the reduction in 
signal by Wunen upon exiting the midgut, and would still undergo elimination by a 
Tre-1-independent Wunen/Wunen-2-mediated mechanism. This model suggests 
separate roles for Wunen-2 and Tre-1 in PGCs -  whilst Wunen-2 acts to 
dephosphorylate the lipid phosphate, internalise the lipid moiety and protect PGCs 
from cell death, Tre-1 acts to detect the localised reduction in this same signal and so 
eliminate the central ‘superfluous’ PGCs.
In this model, loss of zygotic Wunen/Wunen-2, as in the 10201/k stock 
(maternal supply of Wunen-2 in the PGCs is provided by the balancer chromosome) 
would result in an abundance of lipid phosphate substrate and a failure to form a 
gradient. Tre-1 would not be activated, whilst Wunen-2 would continue to 
dephosphorylate the substrate leading to its internalisation and subsequent PGC
102
survival. Thus we would expect loss of directional migration, and the preservation of 
the full complement of PGCs - both conditions are observed in these embryos. Loss 
of Wunen-2 in the PGCs would result in an inability to dephosphorylate and 
internalise the lipid phosphate substrate, resulting in PGC death, as seen. Over­
expression of the somatic Wunens would result in global depletion of the substrate. 
Tre-1 would be activated in a greater proportion of PGCs, initiating cell death. At the 
same time, less substrate would be available to Wunen-2, and failure to internalise 
the dephosphorylated lipid would again result in PGC death, through a 
Tre-1-independent mechanism. Concurrent over-expression of germline Wunen-2 
would enable PGCs to compete for, and internalise, more of the substrate before its 
depletion, increasing PGC survival, whereas loss of Tre-1 would simply mean that 
PGCs would not detect the localised depletion in signal and would survive, leading 
to increased final numbers of PGCs, as observed inAEP3 embryos.The incorporation 
of Tre-1 into this model may explain the discrepancies observed between PGC death 
in germline Wunen-2 null embryos, and elimination of ectopic PGCs in wild-type 
embryos (Hanyu-Nakamura et al., 2004). Authors observed that caspase 3-mediated 
cell death occurred in ectopic PGCs in wild-type embryos, but that this did not 
account for the dramatic loss of PGCs in Wunen-2 null embryos. In the model 
proposed here, PGC elimination in wild-type embryos would occur through a 
Tre-1-mediated mechanism, potentially leading to activation of classic apoptotic 
pathways. Germline Wunen-2 would act to promote PGC survival through uptake 
and internalisation of the lipid phosphate substrate. Loss of germline Wunen-2 would 
mean that PGCs could no longer internalise this substrate, and so would die through 
a Tre-1-independent pathway not seen in wild-type embryos.
In this model one would expect that those PGCs trapped in the gut in hkb 
embryos, which are not exposed to this survival factor, to also die. This does not 
appear to be the case. It may simply be that the survival signal is present within the 
interior of the gut lumen and is only depleted on the exterior, or it may be that PGCs 
only require this signal post-exit, when they enter a different environment, become 
more motile and require directional cues. It is interesting to note that PGC numbers 
in hkb embryos are slightly greater than in AEP3 embryos -  AEP3, however, is not a 
total depletion in Tre-1 and there may be a very low level of expression sufficient to 
result in loss of a few PGCs. It should also be noted that isogenisation of the AEP3
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stock results in a failure of PGCs to exit the mid-gut, suggesting a further role of 
Tre-1 in transepithelial migration.
It is also possible that germline Wunen-2 acts at the cell-surface as a novel 
type of transmembrane receptor. Rather than dephosphorylating and internalising a 
substrate that is then used to promote PGC survival, dephosphorylation of the lipid 
phosphate substrate would result in a conformational change in Wunen-2. This 
change would then signal to the PGCs directly, or would result in the recruitment of 
an associating protein to promote PGC survival. This model is consistent with a local 
pool of substrate that somatic Wunen/Wunen-2 and germline Wunen-2 compete for.
Are there further models that fit with the current data and incorporate the 
information on Tre-1, but which have not yet been fully proposed or explored within 
the literature?
It is possible that somatic Wunen/Wunen-2 activity produces a species that 
kills PGCs upon exposure, rather than depleting a factor required for their survival. 
This species would be produced locally in the specific region of somatic 
Wunen/Wunen-2 expression resulting in a repellent gradient, and PGCs would be 
exposed to it immediately post-exit from the gut. Central PGCs, exiting within the 
region of highest Wunen/Wunen-2 expression, would receive critical levels of this 
signal via Tre-1, and be eliminated, whilst those remaining on either side, now in two 
groups and in regions of lower or negligible expression, would survive and move 
away from this area towards the mesoderm. It may be that once in the mesoderm 
PGCs are protected, and alternative guidance mechanisms take over. Prior to entry 
into the mesoderm, however, PGCs may be protected from further exposure to this 
cell ‘death’ signal, by the action of germline Wunen-2. It would follow in this model 
that the role of germline Wunen-2 would be to recognise this ‘death’ signal, and 
further dephosphorylate it to an inactive form. Rather than dephosphorylating and 
internalising a signal used to promote cell survival then, Wunen-2 would instead 
protect PGCs from ceil death, by modifying and attenuating the presence of a 
repellent, lethal, receptor-active signal. The loss of somatic Wunen/Wunen-2 would 
result in a loss in the production of this death signal, resulting in a full complement 
of PGCs at the end of embryogenesis, as seen in 10201/k. Loss of Tre-1 would result 
in a failure of the central PGCs to receive this signal in the area of highest somatic 
Wunen/Wunen-2 expression, resulting in excessive numbers. PGCs trapped in the 
gut would also fail to receive this signal, and would not be eliminated. Loss of
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germline Wunen-2 would mean that the signal would no longer be 
modified/inactivated in the peripheral PGCs, and PGC death would increase. Loss of 
somatic Wunen and Wunen-2, together with the loss of germline Wunen-2, however, 
would mean that the signal would no longer be produced, negating the need for a 
protective role of germline Wunen-2, and PGCs would survive. Over-expression of 
Wunen/Wunen-2 in the soma would produce more of the death signal, over­
whelming the PGC-specific Wunen-2, whilst concomitant over-expression of 
Wunen-2 in the PGCs would somewhat compensate for this, and increase the 
conversion to the inactive/secondary form, leading to a partial rescue (Tre-1 would 
still eliminate central PGCs, further decreasing the observed rescue affect).
This model suggests that Tre-1 and Wunen-2 act simultaneously within the 
PGCs, but at different thresholds of signal -  in the regions of highest somatic 
W unen/W unen-2 expression, Tre-1 activation would eclipse Wunen-2 
dephosphorylation of the lipid phosphate, resulting in PGC elimination. At the outer 
limits of the gradient, where Wunen/Wunen-2 activities would be weaker or even 
absent, Wunen-2 would over-ride Tre-1 activation, or Tre-1 expression would be 
down-regulated (Fig.41).
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Fig.41. Proposed model fo r  WunenlWunen-2/Tre-l function.
A) Proposed action o f the somatic Wunens, germline Wunen-2 and Tre-1 in a 
wild-type embryo. Embryos are represented dorso-ventrally at stage 11 as the PGCs 
exit the posterior midgut and spread out on its surface, and can be compared to a 
wild-type embryo stained for anti-Vasa at stage 11 in B. The central dark pink 
region shows the highest level o f somatic Wunen/Wunen-2 expression, and PGCs 
within this region are eliminated, as demonstrated by the black cross. Central PGCs 
receive the ‘death* signal via the Tre-1 receptor expressed on their surface. 
Peripheral PGCs in regions o f lower expression, as indicated by the pale pink area, 
attenuate the signal through action o f germline-specific Wunen-2 at the cell surface.
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C) Over-expression of somatic Wunen/Wunen-2 in the mesoderm results in high 
levels of the signal, over-whelming the capabilities of germline Wunen-2 and 
resulting in widespread PGC elimination. D) A loss of germline Wunen-2 activity 
means peripheral PGCs in regions of low somatic Wunen/Wunen-2 expression can 
no longer attenuate the signal, resulting in increased PGC elimination. E) A loss of 
somatic Wunen/Wunen-2 means no signal is produced, but neither is there a 
repellent signal driving PGCs towards the mesoderm. Consequently whilst Tre-1 is 
not activated and PGCs survive, they lack directional cues, and scatter widely upon 
exiting the midgut. F) Over-expression of both somatic Wunen/Wunen-2 and 
germline Wunen-2 means an increase in PGC cell-surface Wunen-2 available to 
attenuate the increased signal from the soma, resulting in increased cell survival. 
Tre-1 is still activated, however, and PGC numbers are only partially rescued. G) 
Loss or down-regulation of Tre-1 means that PGCs in the highest region of somatic 
Wunen/Wunen-2 expression do not receive the signal, resulting in survival of all 
PGCs.
The first model suggests a single lipid moiety internalised by germline Wunen-2, 
which promotes PGC survival. Tre-1 perceives the localised reduction in the lipid 
phosphate precursor in regions of somatic Wunen/Wunen-2 expression, and initiates 
PGC death. In contrast, the second model proposes a lipid species that at critical 
levels promotes cell death through activation of PGC-specific Tre-1. In this scenario, 
germline Wunen-2 acts in competition at the cell-surface, to attenuate the 
receptor-active signal, reducing its availability to Tre-1. The dephosphorylation or 
attenuation of receptor-active substrates is an already recognised function of the 
plasma membrane-bound mammalian LPPs (Le Stunff et al., 2002; Brindley, 2004). 
This model, however, suggests that PGC death occurs through a single pathway, 
activation of Tre-1, and this does not explain the observation that PGCs in the 
Wunen-2 null embryos died in a manner independent of that seen for ectopic PGCs 
in wild-type embryos (Hanyu-Nakamura et al., 2004).
It remains a possibility that Tre-1 and the Wunens are not epistatic. It may 
also be that due to the nature of both Tre-1 activation and the AEP3 deletion, 
epistasis between Tre-1 and Wunen/Wunen-2 will be impossible to prove 
conclusively. Ectopic expression of Wunen and Wunen-2 in the mesoderm results in
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extremely high levels of protein, which might activate alternative pathways 
independent of Tre-1 receptor activation. Moreover, it appears that AEP3 is not a 
total deletion in Tre-1. It may be that residual low level Tre-1 expression is 
insufficient to initiate PGC loss when Wunen/Wunen-2 expression is wild-type in the 
AEP3 background. Over-expression of Wunen/Wunen-2, however, results in far 
more signal, which may be sufficient for Tre-1 activation. That AEP3 is not a Tre-1 
null is a significant point, since the phenotypic consequences of Tre-1 loss-of- 
function are currently unknown. Isogenisation of either deletion (AEP3 or AEP5) 
results in late stage embryonic lethality, but these too are not true loss-of-function. 
Determination of this phenotype is an important step that may give more insight into 
the role of Tre-1 during Drosophila embryogenesis.
5.3) LPA and SIP as potential substrates for the Drosophila LPPs 
It has previously been shown that mammalian LPPs are capable of 
dephosphorylating a number of phospholipid substrates, specifically LPA, PA, SIP, 
C1P, and DGPP, in an apparently non-specific manner (Dillon et al., 1997; Jasinska 
et al., 1999; Kai et al., 1997; Roberts et al., 1998; Waggoner et al., 1996). The work 
presented here demonstrates that Drosophila Wunen can dephosphorylate LPA in 
vitro, but has little activity on PA or Cl P. Its activity on SIP remains unconfirmed. 
Exogenous application of SIP  has been shown to promote mammalian oocyte 
survival in culture, whereas in vivo application of SIP prevented oocyte loss due to 
irradiation (Morita et al., 2000). Furthermore, over-expression of LPP-1 results in 
severely disrupted spermatogenesis and atrophic testes in mice, although females 
appear grossly unaffected (Yue et al., 2004). Both LPA and SIP exert their affects 
through a number of cell-surface GPCRs (EdgSj_8), which can associate with 
different G proteins, dependent on the cell type involved. The receptors have been 
shown to influence a wide range of down-stream effectors including Ras, Rac, 
RhoA, phospholipase C and adenylate cyclase. The resultant range of 
receptor/effector/G protein combinations means that SIP and LPA can influence a 
huge variety of cellular responses including migration, proliferation, cell survival or 
apoptosis (for a comprehensive review, see (Saba, 2004)). It would seem possible 
that either SIP  or LPA could be the cell survival/migration/apoptotic factor that 
Wunen and Wunen-2 recognise. How would this theory fit with the current models?
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LPPs act to dephosphorylate LPA to biologically inactive monoacyl glycerol (MAG). 
According to the first model, LPA would exist as a local pool of attractant, 
promoting cell survival through dephosphorylation and subsequent internalisation by 
germline Wunen-2. Somatic Wunen/Wunen-2 activity would deplete this reservoir. 
Both somatic and germline Wunen/Wunen-2 activity, however, would result in the 
production and internalisation of biologically inactive MAG, perhaps ruling LPA 
out. LPA would not fit comfortably as a substrate in the second model, which 
proposes that Wunen/Wunen-2 activity results in a repellent factor that induces cell 
death at high concentrations. Although LPA could be this factor, Wunen/Wunen-2 
activity would most likely convert it to an inactive form.
The action of LPPs on SIP results in its dephosphorylation to sphingosine. 
Although both SIP and sphingosine are able to induce a range of cell responses, in 
general SIP  promotes cell survival, whereas sphingosine promotes apoptosis (for 
comprehensive reviews see (Pyne, 2002; Pyne and Pyne, 2000)). Sphingosine can be 
rapidly internalised by a range of cell-types and metabolised intracellularly to 
produce a variety of sphingolipids, including SIP (Pushkareva et al.,). In the first 
model, S IP  would act as an attractive survival factor. Dephosphorylation by either 
somatic or germline Wunen/Wunen-2 would result in sphingosine, which would be 
internalised and used to promote PGC survival, perhaps by intracellular 
phosphorylation back to SIP. Tre-1 would act to detect the extracellular depletion in 
S IP , and initiate PGC death. In the second model, however, although 
dephosphorylation of SIP would result in apoptotic levels of sphingosine in regions 
of somatic Wunen/Wunen-2 expression, germline Wunen-2 would be unable to 
attenuate sphingosine by further dephosphorylation. As an alternative Wunen-2 
could promote the dephosphorylation and uptake of sphingosine, and intracellular 
conversion to a cell-survival factor. This model suggests two distinct pathways 
regulating PGC survival through one substrate. In regions of somatic 
Wunen/Wunen-2 expression, critical levels of sphingosine would activate Tre-1 and 
initiate PGC death. PGCs would move up the gradient of SIP towards the mesoderm. 
W unen-2 would then dephosphorylate S IP  to sphingosine within a 
microenvironment at the cell-surface, maintaining Tre-1 in an inactive state. 
Sphingosine internalised through Wunen-2 would then be used to promote cell 
survival.
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Until the lipid phosphate in question is identified, the mechanism of LPP action 
within Drosophila will remain uncertain.
5.4) Vertebrate systems
Are any of these models paralleled in vertebrate systems, or can knowledge of PGC 
migration in vertebrates give us insights into possible substrates for the LPPs? The 
route of PGC migration in mice mimics that of Drosophila, and a number of proteins 
have been identified that regulate individual steps along the way. PGC determination 
in mice differs from that in flies in that mice do not possess germ plasm, and instead 
PGCs arise during gastrulation through cell-cell signalling events. As in many other 
organisms including Drosophila, mouse PGCs first appear in a location remote from 
their target tissue the developing gonad, and actively migrate through the embryonic 
tissues. The PGCs arise in the embryonic ectoderm (epiblast) and move through the 
posterior primitive streak during gastrulation. From here they move into the 
definitive endoderm and are incorporated into the developing hind-gut. As with entry 
of PGCs into the posterior midgut in Drosophila, it is unclear whether this is an 
active or passive incorporation. As the hindgut extends to form a tube, the PGCs 
remain inside, before beginning an active migration around the cells of the hindgut 
epithelium, to emerge from the dorsal side, where they divide into two streams and 
begin their migration towards the two genital ridges. PGCs that are retarded fragment 
and die (McLaren, 2003; Molyneaux and Wylie, 2004; Molyneaux et al., 2001; 
Wylie, 1999).
Whilst a variety of growth factors have been shown to influence mouse PGC 
survival and migration in vitro, in vivo two main signalling systems that guide the 
PGCs to the genital ridge have been characterised. The first involves the receptor 
tyrosine kinase c-kit, encoded by W, and its ligand Steel Factor, encoded by Steel. 
Steel Factor is expressed as a membrane-bound growth factor that can undergo 
proteolysis to a soluble form, and is found along the migratory route of the PGCs as 
well as in the urogenital ridges. The receptor, c-kit, is expressed on the surface of 
migrating PGCs. Mutations in either the receptor or its ligand result in a severe 
decrease in PGC number, and a failure to migrate through the hind-gut wall; whilst 
the majority of PGCs remain as clumps inside the hind-gut, those that do exit migrate 
into ectopic locations and die. In these mutants, PGCs are determined normally and 
begin to increase in number, before proliferation ceases (McLaren, 2003; Molyneaux
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and Wylie, 2004). This regulation of migration and proliferation bears similarities to 
the co-activation of the STAT92E/Ras signalling pathway activated by the receptor 
tyrosine kinase Torso in Drosophila, whereby inactivation of this signalling system 
results in a failure in PGC proliferation and guided migration (Li et al., 2003).
The second system in mice involves the chemokine SDF-1 (stromal-derived 
factor 1) and its receptor CXCR4. SDF-1, the only known ligand for CXCR4, is 
known to act as a guidance cue for a range of cell types, including PGCs. SDF-1 is 
expressed throughout the dorsal body wall, and is especially enriched in the genital 
ridges. Addition of soluble SDF-1 to cultured embryo slices disrupts PGC migration 
by decreasing their motility, whereas the addition of SDF-1 coated beads is sufficient 
to attract PGCs over short distances (Molyneaux et al., 2003). In SDF-1 null mice, 
PGCs are retarded and reduced numbers reach the genital ridges. Once associated 
with the genital ridges, however, proliferation occurs normally (Ara et al., 2003). 
CXCR4 is expressed on the surface of migrating PGCs. In embryos deficient in 
CXCR4, the number of PGCs that successfully colonize the genital ridge is greatly 
reduced. Once in the gonad, however, PGCs continue to proliferate normally. Thus 
the SDF-1/CXCR4 interaction is required in mice for PGC survival and migration 
(Molyneaux et al., 2003).
Zebrafish PGC migration differs somewhat from mice, but also employs 
SDF-1 and CXCR4. PGCs arise as 4 distinct clusters, distributed in any one of 3 
separate orientations towards the dorso-ventral axes. As gastrulation proceeds, these 
clusters move dorsally and align with the head and trunk mesoderm. Two of the 
clusters on each side move and join up with each other, and the resulting two clusters 
migrate posteriorly towards the somatic gonadal tissue (Molyneaux and Wylie, 2004; 
Santos and Lehmann, 2004a; Weidinger et al., 1999). Whilst CXCR4b is expressed 
in the PGCs, SDF-1 a is expressed along their migratory route. The use of 
morpholino antisense oligonucleotides to knock-out either, results in PGCs scattering 
randomly and demonstrating irregular and non-directional movements. Conversely, 
over-expression of SDF-1 a in the PGCs has the same effect, whereas ectopic 
expression of SDF-la is sufficient to attract PGCs to those areas (Doitsidou et al., 
2002; Knaut et al., 2003).
Recent data indicates that zebrafish PGC migration is dependent on the 
prenylation of proteins by geranylgeranyl transferase (GGT1), and that HMGCoAR 
is required to supply the necessary lipid precursors. Investigators found that
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inhibition of HMGCoAR with statins results in severe PGC migration defects, 
rescued by the addition of mevalonate, the downstream product of HMGCoAR 
activity. Squalene, a downstream product in the cholesterol branch of the pathway 
fails to rescue, whereas injection of compounds from the isoprenoid branch of the 
pathway does result in rescue. Addition of GGT1 inhibitors, but not farnesyl 
transferase inhibitors, perturbs PGC migration, leading authors to conclude that 
protein prenylation by GGT1 is required for correct PGC migration in zebrafish, and 
that this pathway is independent of the SDF-1 a/CXCR4 pathway (Thorpe et al., 
2004). These results parallel findings in Drosophila, which also demonstrate the 
importance of isoprenoid synthesis in the regulation of PGC migration (Santos and 
Lehmann, 2004b).
Despite extensive computational analyses, no homologue for SDF-1 has been 
found within the Drosophila genome, and over-expression of zebrafish SDF-1 a (a 
kind gift from Holgaer Knaut) did not result in any obvious defects. Thus, 
preliminary results indicate that the SDF-1/CXCR4 system is unlikely to regulate 
PGC m igration or survival in D ro so p h i la .  Both the c-kit/Steel and 
HMGCoAR/isoprenoid pathways, however, do appear to be conserved in flies. 
Neither of these pathways, however, point towards, or appear to involve, substrates 
for Wunen/Wunen-2 or the LPPs in general, and so far the LPPs have not been 
shown to influence PGC migration or survival in vertebrates. Data on the 
physiological functions of the vertebrate LPPs in vivo, however, has been decidedly 
sparse until recently. As work in this area continues to gain pace, new roles for the 
LPPs will undoubtedly be exposed.
Indeed, recent findings on PRG-1 suggest a role for LPA as a physiological 
substrate. In this study, LPA was found to act as a repellent, inducing axonal collapse 
(Brauer et al., 2003). LPA is still a candidate for an Wunen/Wunen-2 substrate, but it 
is more likely to act as an attractive survival factor in this scenario, rather than a 
repellent.
5.5) Substrate specificity of the LPP isoforms
Most of the work to date on LPPs has concentrated on the 5 main phospholipid 
substrates already mentioned. Considering the potent bioactivity of these molecules, 
it is surprising that the LPPs should act non-specifically when presented to them in 
vitro. It may well be that substrate specificity varies dependent on which LPP
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isoform is expressed in which tissue, for whichever function. Thus in tissue A, SIP 
may be the substrate for LPP-3, whilst in tissue B, it may act on Cl P. This would 
certainly account for the non-specificity seen in biochemical assays, where 
endogenous controls are absent. It may also account for the discrepancy in results 
reported by different groups using slightly different assay conditions or cell types. As 
we have seen with the M3 tag, however, biochemical activity in vitro is not always a 
true reflection of biological activity in vivo. Whilst these 5 substrates are certainly 
very good candidates for the physiological substrates of the LPPs, investigators 
should perhaps be wary of restricting their studies to these 5 alone. As more and 
more physiological functions of the LPPs are revealed, it may be worth considering 
alternative substrates related to these alternative functions, as possible candidates. It 
is particularly noteworthy that VCIP (hLPP-3) can interact with a variety of integrins 
(Humtsoe et al., 2003), and that recent findings demonstrate a function of LPP-3 in 
mouse development that is independent of its phosphatase activity (Escalante- 
Alcalde et al., 2003). Conversely, it is clearly demonstrated here that the influence of 
LPP-3 on PGC migration and survival in Drosophila is dependent on its phosphatase 
activity.
5.6) Conclusion
In conclusion, the work presented here demonstrates novel results for the Drosophila 
LPPs Wunen and Wunen-2, and identifies a GPCR expressed on the surface of PGCs 
that is involved in PGC migration and survival. Whatever the substrate for the LPPs 
(and it seems increasingly likely that there will be more than one), it is hoped that 
this work will contribute to further understanding of this important and interesting 
family of enzymes.
Further Work
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6.1) Alternative functions of oligomerisation
It is intriguing that the LPPs oligomerise in a highly specific manner, yet there is 
currently no discernable function either biochemically, or biologically, for the 
interactions observed. It may be that oligomerisation regulates functions in 
Drosophila  that are unrelated to PGC migration and survival. VCIP (hLPP-3) 
appears to function in capillary morphology and cell-cell interactions via its 
integrin-binding RGD domain. Like Wunen and Wunen-2, mLPP-3 lacks an RGD 
domain but it also has a critical role in vasculogenesis and capillary formation. It 
would be interesting to see whether Drosophila Wunen can influence cell-cell 
interactions/aggregation in vitro, and whether this function is abolished in the 
monomeric WunD2 truncation. This could be approached relatively simply, by 
over-expressing each GFP-tagged construct in Drosophila S2 cells alongside a GFP 
control, seeding the cells sparsely into tissue culture dishes, and observing cell 
behaviour with time-lapse fluorescence imaging. If S2 cells proved inappropriate, 
full-length Wunen and WunD2 could be cloned into a suitable vector and expressed 
in HEK293 cells, as used in the original study.
6.2) Characterisation of AEP3
6.21) Molecular characterisation of the deletion
The original AEP3 stock displays significant phenotypic variability, whereas 
isogenisation over FM7 is far more penetrant. This may indicate a complicated 
genetic interaction that is lost upon isogenisation of the chromosome, or it may 
indicate another ‘floating’ copy of tre-1 that is responsible for variability in protein 
expression. This is an important question that must be addressed. Previous work 
involving these stocks centred on the deletion of the neighbouring gene Gr5a as a 
potential trehalose receptor, and consequently neither the AEP3, nor the AEP5, 
deletions have been properly sequenced. This is a priority, and will be performed 
after Southern analyses have been completed for both the isogenised and 
non-isogenised stocks.
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6.22) Genetics
It is reported for the AEP5 deletion that paternal rescue results in an increased 
number of PGCs crossing the midgut wall. What is not reported, however, is that 
embryos from AEP5 homozygous mothers crossed to AEP5 males (and the same for 
the isogenised AEP3) die during the late stages of embryogenesis, and that the stock 
is in fact sterile. It will be important to determine whether this late stage embryonic 
death is due to the deletion in tre-1 or to a deletion/mutation elsewhere. If embryonic 
death is due to a deficiency in Tre-1, this should be followed up and reported, as it 
would indicate a vital role for Tre-1 during embryogenesis, one that is not so simply 
restricted to PGC migration and survival. Preliminary experiments using a hemocyte 
driver to overexpress Tre-1, showed extreme degeneration of the embryos, similar to 
that observed with the twist-GAL4 drivers and Wun-GFP. It would appear that Tre-1 
is expressed in the hemocytes (BDGP gene expression data) and preliminary 
analyses of hemocytes in the AEP3 stock indicate perturbation in their development. 
These data are extremely provisional, but interesting, and will require detailed 
further study.
6.23) Mis-expression studies
The Lehmann lab reported that expression of Tre-1 in the PGCs themselves, using 
the insertion EP(X)496, results in rescue of the AEP5 migration defect. Since Tre-1 
appears to regulate PGC migration, it would be interesting to see whether mis- 
expression in alternative tissues could redirect migrating PGCs. One way of doing 
this would be to clone Tre-1 into the pUAST vector and cross these flies to a number 
of different tissue-specific drivers. This work is underway, but initial results using 
nervous system and mesoderm-specific drivers have been disappointing. This 
construct, however, failed to reproduce the rescue reported for AEP5 when expressed 
in the PGCs of AEP3 embryos. This pUAST-Trel construct has been completely 
sequenced through its coding sequence, but it may be that the particular insertion site 
in question blocks effective expression. This work should be repeated using 
alternative insertions alongside EP(X)496 as a rescue control. Although ISH could be 
used to look for up-regulation of the protein in the appropriate tissues, it would be 
more beneficial to GIT* tag the receptor, and follow its expression that way. The
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caveat here, however, is that there is no way of knowing whether the GFP-tag (either 
N- or C-terminal) will compromise biological activity.
6.24) Epistasis between Tre-1, Wunen and Wunen-2
Initial studies into the possible interaction between Tre-1 and the Wunen-mediated 
signal were somewhat inconclusive. It is important that this relationship is fully 
characterised, as one goal of this research is to determine what the PGC guidance 
and survival signal is. If Tre-1 is the receptor for this signal, it is an important piece 
in the puzzle, and may provide novel methods for searching for the signal in the 
future. Furthermore, analyses of the AEP3 phenotype in the non-isogenised stock 
indicate a role for the receptor in the regulation of PGC survival. It is extremely 
important that this phenotype be carefully and accurately characterised, so that the 
function of Tre-1 in this process can be established. The first approach would be to 
repeat the mis-expression studies, using further alternative mesoderm-specific 
drivers. It has been reported that expression of Wunen in tissues other than the 
mesoderm, for example the nervous-system, also result in PGC loss (Starz-Gaiano et 
al., 2001). The mis-expression of WunGFP in the AEP3 background could be 
repeated using drivers specific to a range of tissues other than the mesoderm.
It is important to determine the effect of the combined loss of Wunen, 
Wunen-2 and Tre-1. This would involve crossing flies carrying a double deletion of 
Wunen and Wunen-2 into the AEP3 background, and then staining embryos to 
observe the PGC migration phenotype. This work is currently underway. Perhaps 
more pertinent will be to study the effect of loss of germline Wunen-2 and Tre-1. If 
the model proposed here that suggests that Tre-1 detects local depletion in a substrate 
required for PGC survival is accurate, one might expect to see PGCs exit the gut with 
those in the centre of the group at stage 11 surviving, whilst those on the outer flanks 
are eliminated. The Wunen-2 maternal deletions are now available, and work is 
underway to cross them into the AEP3 background.
6.3) Microarray analyses
Microarray analyses of both AEP3 stocks and the AEP5 stock would reveal what 
genes are up- or down-regulated along with the down-regulation of Tre-1. This may 
begin to elucidate what signalling pathways Tre-1 activates or suppresses.
117
6.4) Tre-1 receptor activation
It is possible that Tre-1 and Wunen/Wunen-2 are epistatic, but that Tre-1 and 
germline Wunen-2 respond to separate extracellular factors. Either way, Tre-1 plays 
an important part in PGC migration and survival, and as such, determining its 
ligand(s) is a primary goal for the future, which might eventually reveal the true 
substrate for the Drosophila LPPs. Desensitisation of the majority of GPCRs occurs 
through a common mechanism involving p-arrestins. P-arrestins bind to 
agonist-activated receptors, terminating signal transduction. This interaction has been 
employed to help identify the ligands for a number of orphan GPCRs, including 
several neuropeptide receptors in Drosophila (Barak et al., 1997; Johnson et al., 
2003). This technique involves the use of GFP-tagged p-arrestin2. Initially 
distributed throughout the cytosol and excluded from the nucleus, P-arrestin2-GFP 
translocates to the plasma membrane upon receptor activation. One benefit of this 
technique is that the receptor remains untagged. To investigate possible agonists for 
Tre-1, cells would be co-transfected with both P-arrestin2-GFP and Tre-1 before the 
addition of a range of potential agonists. Translocation of the GFP signal would be 
followed by real-time GFP imaging. The P-arrestin2-GFP construct is already 
available and work will begin with sphingosine and S2 cells. If S2 cells prove to be 
too small for this purpose, then HEK293 or Cos-7 cells will be employed instead.
MATERIALS AND METHODS
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7.1) Chapter One
2.21a) Sequence analysis o f Wunen and the mammalian LPPs
To investigate conservation between the genes and draw up a phylogenetic tree, 
ClustalW was employed: http://www.ebi.ac.uk/clustalw/.
To determ ine the transmembrane domains, TMPRED was employed:
http://www.ch.em bnet.org/software/TM PRED form.htm l.
G enbank  access io n  num bers w ere o b ta in ed  from  PubM ed:
http://www.ncbi.nlm .nih.gov/entrez/querv.fcgi.
2.21c) Transfection ofS2 cells
Drosophila  S2 cells (Invitrogen) were maintained in HyQCCM3 media (Perbio 
Science) plus penicillin and streptomycin at 25°C. All DNA was prepared by Cesium 
Chloride density gradient centrifugation and resuspended in Millipledge double 
distilled water, before concentrations were ascertained in a spectrophotometer. Cells 
were transfected using Effectene Transfection Reagent (Qiagen) according to the 
manufacturer’s protocol. 48 hrs post transfection, cells were washed in phosphate 
buffered saline (PBS), spun at 3000rpm and lysed on ice in cell lysis buffer (50mM 
HEPES,0.1M sodium chlorideJOmMsodium fluoride, 5mMl EDTA, 0.5mMsodium 
orthovanadate, 0.1% triton X-100, Complete protease inhibitors (Roche)).
Western blots were performed using standard techniques, utilizing the NuPAGE® 
Novex Bis-Tris and XCell SureLock™ Mini-Cell system (Invitrogen). Blots were 
incubated with a mouse monoclonal anti-body to GFP (Roche) at 1:500 in PBS plus 
0.1% tween (PT) plus 3% BSA, for 1 hour at room temperature, washed extensively 
in PT and incubated with HRP-conjugated anti-mouse (Jackson ImmunoResearch 
Laboratories) at 1:40,000 in PT plus 5% powdered milk, for 1 hour at room 
temperature. After extensive washes in PBS, blots were visualized with ECL Plus™ 
Western Blotting Detection Reagent (Amersham Biosciences).
2.22a) Immunocapture o f GFP-tagged proteins
S2 cells were transfected and lysed in cell lysis buffer as before, and an equal volume 
of lysate added to an aliquot of Fusion Aid GFP resin (Vector laboratories). The
120
resin was washed several times prior to addition of the lysate in cell lysis buffer. 
After incubation for two hours at 4°C, the resin was washed extensively to remove 
extraneous unbound protein and resuspended in 5 x volume cell lysis buffer prior to 
Western analyses as above.
2.22b) Inorganic phosphate release assay
The Molecular Probes PiPer® phosphate release assay (Cambridge Bioscience) was 
specifically adapted for this assay. In the presence of inorganic phosphate, maltose 
phosphorylase converts maltose to glucose-1-phosphate and glucose. Gluconolactone 
and hydrogen peroxide (H202) are then formed by the action of glucose oxidase. 
Using horseradish peroxidase as a catalyst, the H202 reacts with the Amplex™ Red 
reagent to produce the fluorescent product resorufin. The increase in detectable 
fluorescence/absorbance is therefore proportional to the amount of phosphate 
present.
Each reaction was performed in triplicate, using 50 pi of the anti-GFP resin 
containing the immunocaptured proteins. Assays were performed at 37°C and the 
resulting fluorescence read in a SPECTRAmax™ GEMINI XS Dual Scanning 
Microplate Spectrafluorometer in a final volume of lOOpl at up to 7 time points 
during the assay period. Each substrate control gave a small but constant value, 
which was subtracted from each of the samples. LPA (Sigma) in 50% ethanol and 
C1P (Affiniti) in 100% ethanol were used at a final concentration of 500pM. PA 
(Sigma) in 100% ethanol was used at a final concentration of 70pM in the supplied 
buffer plus 0.01% phosphate free triton X-100 (Sigma) plus lmg/ ml fatty acid free 
BSA (Sigma). In order to test the linearity of the detection system, a range of 
phosphate standards were simultaneously run in triplicate. Activity was examined at 
an arbitrary time point that appeared to fall within the linear range for the enzymes 
for each assay. The phosphate standards were converted to nMoles phosphate at this 
time, and used to produce a standard curve. This was linear in each case, indicating 
that the detection system displays first order kinetics in the presence of up to 4 
nMole phosphate. A line of best fit was used to calculate the amount of phosphate 
released from each protein sample. Each sample was Western blotted and 
densitometry performed using Bio-Rad Quantity One software to compare relative 
protein amounts in each, on the same blot.
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Lipid substrates were prepared as follows:
LPA -  A stock solution of 5mg/ml in 50% ethanol was prepared and stored at -20°C. 
When required, this was warmed to room temperature before bath sonicating at 65°C 
for 20 minutes. lOOpl was then added to 900pl of the supplied reaction buffer plus 
0.01% phosphate free triton X-100 (Sigma) plus lmg/ ml fatty acid free BSA 
(Sigma) and this solution bath sonicated for a further 10 minutes at 65°C. The resin 
was resuspended in this solution before assaying.
PA -  A stock solution of 1 mg/ml was prepared in 100% ethanol and stored at -20°C. 
When required this stock was warmed to room temperature before bath sonicating at 
37°C for 10 minutes. lOOpl of this was then added to 900pl of the supplied reaction 
buffer plus BSA plus triton as above.
C1P -  A stock solution of 5mg/ml was prepared in 100% ethanol and stored at 
-20°C. When required, this was warmed to room temperature before bath sonicating 
at 65°C for 20 minutes. lOOpl was then added to 900pl of the supplied reaction 
buffer plus BSA plus triton as above.
Densitometry was performed by scanning Western blots into a Bio-Rad GS-710 
Calibrated Imaging Densitometer, and employing BioRad Quantity One software.
2.23a) Ectopic expression in the mesoderm
Fly husbandry -  all flies were maintained on standard agar/yeast/molasses/malt 
extract and fed with live baker’s yeast. Flies were raised, and all experiments 
performed, at 25°C.
Microinjection - All constructs were prepared by Cesium Chloride density gradient 
centrifugation and resuspended in Millipledge double distilled water, before 
microinjection into White118 embryos alongside the helper plasmid pUAST-Turbo (a 
kind gift from Michael Levine) in a 3:1 ratio. Transformants were recovered and 
mapped using standard techniques (Rubin and Spradling, 1982).
Unless otherwise stated, all other stocks were obtained from the Bloomington 
Drosophila Stock Center at Indiana University.
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Expression in the mesoderm -  four to ten day old adult males carrying a 
homozygous viable GFP-tagged insert on an autosome were crossed en masse to 
twist-Gal4 virgins carrying the mesoderm-specific twist driver on the X 
chromosome. The twist-GAL4 stock was obtained as a kind gift from Gerry Rubin.
Embryo collection -  fly crosses were set up and allowed to mate for 24 hours at 
25°C before being transferred to a laying ‘cage’. Flies were allowed to lay on fresh 
agar plates containing 25 % apple juice, 2.25% agar and 2.5% brown sugar and 
seeded with live baker’s yeast paste.
Embryo fixation - when ready, embryos were washed off the plates onto nylon 
mesh in a 12-place Millipore Filtration manifold, with distilled water plus 0.01% 
triton X-100. After washing 3-4 times in distilled water, embryos were dechorionated 
by incubation for 2 minutes in 50% bleach solution, before extensive washing with 
distilled water. Embryos were transferred into the interface of 2.25mls PBS plus 
0.75mls 16% w/v formaldehyde (TAAB), and 3mls heptane, where they were 
agitated for 20 minutes at room temperature before the bottom phase was removed 
and 3mls of methanol added. The test-tube was shaken and de-vitellinised embryos 
allowed to fall to the bottom before removal into a fresh test-tube. Embryos were 
then dehydrated through several changes of 100% methanol until storage at -20°C.
Embryo staining -  embryos were rehydrated through several changes of PT, before 
incubation with the primary antibody in PT plus 4% BSA over-night at 4°C. 
Embryos were then washed several times before incubation with the secondary 
antibody in PT for two hours at room temperature. For biotinylated secondary 
antibodies, embryos were further incubated for 30 minutes with VECTASTAIN® 
ABC reagents (Vector Laboratories) before further washing and visualization with a 
standard DAB reaction, and quenching in PT plus 0.01% sodium azide. Where 
alkaline-phosphatase conjugated secondary antibodies were used, the signal was 
visualized by incubation in NBT/BCIP solution (NBT/BCIP Ready-to-Use Tablets, 
Roche) before washing in PT.
A mouse monoclonal primary antibody to GFP (Roche) at 1:500, followed by 
alkaline phosphatase conjugated anti-mouse secondary antibody (Jackson
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ImmunoResearch Laboratories) at 1:500 was used to visualize the GFP-tagged 
proteins in the mesoderm.
A chicken anti-Vasa primary antibody (Ken Howard) at 1:10,000, followed by 
biotin-conjugated anti-chicken antibody (Jackson ImmunoResearch Laboratories) at 
1:500 was used to visualize the PGCs.
Mounting -  Embryos were dehydrated through 100% ethanol, cleared in methyl 
salicylate and mounted in Canadian balsam (Polysciences Inc.). Slides were then 
heated at 60°C for 2 days.
Microscopy -  Embryos were observed with a Zeiss Axiophot combined with an 
Optronics © MicroFire digital camera (Indigo Scientific). Images were recorded with 
Pictureframe 0.9 software (Indigo Scientific).
2.24a) Confocal microscopy
Hies carrying an autosomal viable GFP-tagged insert were crossed to twist-GAL4 
virgins. Embryos were fixed in 4% formaldehyde and observed under glycerol with a 
BioRad MRC1024 upright Confocal microscope.
2.24b) Cell-surface biotinylation
S2 cells expressing the protein of interest were washed twice in PBS and counted. 
25 x 106 cells in 1ml PBS were incubated with Pierce No-Weigh™ Premeasured 
NHS-PE04 Biotin (Perbio Science) according to the manufacturer’s protocol for 45 
minutes at room temperature. The reaction was quenched with 100 mM ammonium 
chloride for 10 minutes. Cells were washed twice in PBS to remove extraneous 
unbound biotin, lysed on ice in 1.5 ml cell lysis buffer (1% triton X-100) and spun 
for 5 minutes at 13000rpm, 4°C. The supernatant was applied to a Pierce 
Immunopure Monomeric Avidin column (Perbio Science) according to the 
manufacturer’s instructions. Fractions were analyzed by Western blot using 
antibodies to the specific tag as before.
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7.2) Chapter Two
3.22a) Confirmation o f protein expression in S2 cells
S2 cells were transfected with both GFP and M3-tagged constructs alongside the 
Actin-5C-GAL4 driver, lysed and analysed by Western blot according to the protocol 
above (2.21c). Two gels were run for each sample. The M3 tag was detected with a 
mouse monoclonal 9el0 anti-myc primary antibody (Laboratory for Molecular Cell 
Biology stock) at 1:500, plus HRP conjugated anti-mouse (Jackson ImmunoResearch 
Laboratories) at 1:500. The GFP tag was detected with a mouse monoclonal 
anti-body to GFP (Roche) at 1:500, followed by HRP conjugated anti-mouse 
(Jackson ImmunoResearch Laboratories) also at 1:500.
3.22b) Immunoprecipitation assays: formation o f homo-oligomers
S2 cells were transiently co-transfected with GFP and M3 tagged constructs 
alongside the Actin-5C-GAL4 driver, and allowed to express for 2-3 days. Cells 
were spun down, washed and lysed in cell lysis buffer as before, and an equal 
volume of lysate added to an aliquot of Anti-c-Myc Agarose Affinity Gel (Sigma). 
The resin was washed several times prior to addition of the lysate in cell lysis buffer 
plus protease inhibitors. After incubation for two hours at 4°C, the resin was washed 
extensively to remove extraneous unbound protein and resuspended in 10 x volume 
cell lysis buffer prior to Western analyses with antibodies as before.
3.22c) Immunoprecipitation assays: formation o f hetero-oligomers
The same protocol was followed as for 3.22b.
3.22d) Immunoprecipitation assays: prevention o f oligomerisation 
The same protocol was followed as for 3.22b.
3.22e) Immunoprecipitation assays: repeat with NEM
The same protocol was followed as for 3.22b, but 2mM NEM was included in the 
cell lysis buffer.
3.22f) Immunoprecipitation assays: Wunen and Wunen-2
The same protocol was followed as for 3.22b.
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3.22g) Immunoprecipitation assays: 1% triton X-100
The same protocol was followed as for 3.22b, but 1% triton X-100 was added to the 
cell lysis buffer rather than 0.1%. The resin was washed several times in this buffer 
prior to addition of the cell lysate.
3.22h) Immunoprecipitation assays: post-transfection
S2 cells were singly transfected with each construct, allowed to express protein for 2- 
3 days, spun down, washed and lysed in 0.1% triton X-100 cell lysis buffer as before. 
25pi of each was then combined in an eppendorf and left on ice for 30 minutes. 
These lysates were then immunocaptured on Anti-c-Myc Agarose Affinity Gel 
(Sigma) for 2 hours. This was repeated with either incubation on ice for 60 minutes, 
or at 25 °C. ImM zinc chloride was added to the lysis buffer in half of the samples. 
Captures were then Western blotted as before.
3.23a) Para formaldehyde cross-linking
Cells expressing each tagged protein were incubated at room temperature with 3% or 
12% para formaldehyde (PFA) for 30 or 60 minutes in PBS, quenched with 100 mM 
ammonium chloride for 10 minutes at room temperature, washed in PBS plus 
ammonium chloride followed by just PBS, lysed on ice in 0.1% triton X-100 cell 
lysis buffer and snap frozen in liquid nitrogen, before running on a gel and analysing 
by Western blot.
3.24a) Biochemical activities o f the multimer and monomer
This followed the same protocol as 2.22b. Each reaction was performed in triplicate, 
using 50 pi of the anti-c-Myc resin containing the immunocaptured proteins. The 
LPA control gave a small but constant value, which was subtracted from each of the 
samples. LPA (Sigma) in 50% ethanol was used at a final concentration of 500pM 
in the supplied buffer plus 0.01% phosphate free triton X-100 (Sigma) plus lmg/ ml 
fatty acid free BSA (Sigma). Each sample was Western blotted and densitometry 
performed using Bio-Rad Quantity One software to compare relative protein 
amounts in each, on the same blot.
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3.24b) Biological activities of the multimer and monomer
This followed the same protocol as 2.23a using the same antibodies for protein and 
PGC visualization.
3.25a) Biotinylation of cell-sutface proteins
This followed the same protocol as 2.24b. S2 cells expressing WunM3 plus the cell 
surface marker CD2 were biotinylated and analysed by Western blot. Blots were 
probed with monoclonal anti-myc (Laboratory for Molecular Cell Biology stock), 
anti-CD2 (Serotec) or anti-tubulin (Sigma), before addition of HRP-conjugated 
anti-mouse at 1:40,000.
7.3) Chapter Three
4.21b) Identification of tre-1
Identification of tre-1 utilised the Genome Annotation Database of Drosophila 
(GadFly) and the Berkeley Fly BLAST services, which have subsequently been 
retired. Equivalent services can be found at: http://flvbase.net/annot/.
4.22b) In situ hybridisation probe synthesis
A standard restriction digest was set up on 500ng of RE07751 in pFLCl, with either 
EcoRl or Eco01091, incubated for 4 hours and heat-killed. Four reactions were set 
up to synthesise a probe, a control anti-probe and two negative controls, using a 
standard transcription reaction and T3 or T7 polymerase. Products were precipitated 
by the addition of 10M lithium chloride and ethanol at -20°C for 2 hours. The probe 
and anti-probe were then spun for 20 minutes at 13,000rpm, and the pellets 
resuspended in 50pl double distilled water. An incorporation assay with alkaline 
phosphatase conjugated anti-DIG (Roche) antibody and NBT/BCIP confirmed that 
the reaction was successful.
In situ hybridisation protocol -  Embryos were rehydrated through 70% then 30% 
ethanol before rinsing 3 times for 2 minutes each in DEPC (Diethyl pyrocarboante, 
Sigma) treated PBS plus 0.1% tween (PTD). Embryos were incubated for 3 minutes 
in PTD plus a 1:400 dilution of proteinase k (Boehringer Manneheim) before rinsing 
2 x 30 seconds in 2mg/ml glycine (Sigma) in PTD to stop the digestion. Embryos
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were then washed twice in PTD and fixed for 5 minutes in 4% formaldehyde in PTD. 
Embryos were washed a further 5 times in PTD and then once in 1:1 
PTD:hybridisation buffer (hybridisation buffer - deionised formamide (Sigma) 
(5.0ml), 20 x SSC (Sigma) (2.5ml), tRNA (Sigma)(10mg/ml) (lOOpl), heparin 
(lOOmg/ml) (5pl), tween 20 (lOpl), DEPC treated dH20 to 10ml. The samples were 
pre-hybridised in hybridisation buffer at 55 °C for several hours before addition of 
the probe at a dilution of 1:2000 in hybridisation buffer. These were left to hybridise 
overnight. In the meantime, the anti-DIG antibody (Boehringer Manneheim) was 
allowed to pre-absorb for as long as possible with spare embryos at a dilution of 
1:400 in PTD plus a 1:1000 dilution of ribonucleoside vanadyl complex (RVC, New 
England Biolabs).
Post-hybridisation, the probe was washed off the embryos with hybridisation buffer 
for 20 minutes at 55°C before a further wash in 1:1 hybridisation buffer:PTD (plus 
1:1000 RVC (PTDvc)). Embryos were then washed extensively in PTDvc before 
hybridisation with a-D IG  1:400 in PTDvc for one hour at room temperature. 
Embryos were again washed extensively in PTDvc before the signal was visualised 
by incubation in BCIP/NBT solution (Boehringer Mannheim). Washing the embryos 
in PTD plus lOmM EDTA without RVC stopped the reaction.
4.22c) AEP3 and PGC migration
Flies were maintained, and embryos fixed and stained, as in 2.23a, using only 
chicken anti-Vasa primary antibody (Ken Howard) at 1:10,000, followed by 
biotin-conjugated anti-chicken antibody (Jackson ImmunoResearch Laboratories) at 
1:500. Flies were allowed to lay for 2 hours, the plates were removed, and the 
embryos aged for a further 9 hours, to ensure embryos were between stages 12 and 
14.
4.22d) Genomic rescue of the PGC migration defect 
Embryos were collected and stained as in 4.22c.
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4.22e) PGC cell death phenotype
AEP3 flies were allowed to lay on apple juice plates at 25°c for 2 hours before plates 
were removed, and aged for either 5 hours to stages 10-11, or 7 hours to stages 
11-12. Embryos were collected and fixed as before, and stained with chicken anti- 
Vasa primary antibody (Ken Howard), followed by biotin-conjugated anti-chicken 
antibody (Jackson ImmunoResearch Laboratories).
4.23a) Complementation
Embryos were collected and stained as in 4.22c.
4.23b) RT-PCR and real-time PCR
Embryos from Clark Coffman were received on dry ice. Total RNA was extracted 
using the RNeasy Mini Kit (Qiagen) and quantified in a spectrophotometer.
500ng of each RNA sample was then converted to cDNA using the Superscript™ 
First-Strand Synthesis System for RT-PCR (Invitrogen). lpl of each sample was put 
through a standard PCR reaction on ‘3-step’, in a MJ Research Inc. PTC-100™ 
Programmable Thermal Controller, with either Tre289Exonl plus Tre548Exon3, or 
Actin 42 plus Actin 361 (see primer and PCR details below), before running on a 1% 
agarose gel to confirm the presence of DNA.
3pi of each cDNA was added to 42pl of double distilled H20 and mixed gently. 
18.75pl of DyNAmo SYBR® Green reagent (MJ Research) and primers (Actin 42 
plus Actin 361 or Tre289Exonl plus Tre548Exon3 -  see primer details below) were 
added and the mixture dispensed into three wells of a standard 96-well plate, before 
transferral to the DNA Opticon-2.
PRIMER SEQUENCE 5’ - 3 ’
Tre289Exonl GAAAACAGTGAAACGGGTTCGAG
Tre548Exon3 CGAAATGACGAAGGCGGTTG
Actin 42 T CAGCC AGC AGTCGT CT A AT CC
Actin 361 ACCGTGCTCA ATGGGGT ACTTC
Table 9. Primer sequences for RT-PCR and quantitative real-time PCR.
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PCR Runs:
3-Step:
1. 94° C
2. 92°C
3. 60°C
4. 75°C
60 seconds 
40 seconds 
40seconds 
90 seconds
5. GOTO step 2 29 times
6. 75°C 5 minutes
7 .4°C hold
10 minutes 
10 seconds 
20 seconds 
20 seconds 
20 seconds
Opticon-2:
1. 95 °C
2. 94°C
3. 60°C
4. 72°C
5. 81°C
6. Plate read
7. GOTO step 2 35 times
8. 72°C 5 minutes
9. Melting curve 75-95°C every 0.5 
seconds, hold 1 second
10. End.
4.24) Tre-1 and Wunen
To place each mesoderm driver into the AEP3 background, the following crosses 
were performed:
A)
w ; 24B-GAL4 ; + X AEP3 ; + ; +
y 24B-GAL4 + AEP3 + +
C)
D)
IB)
AEP3 : 24B-GAL4 : + X AEP3 ; + ; +
y + + AEP3 + +
1
AEP3 ; 24B-GAL4 ; + and AEP3 ; 24B-GAL4 ; +
y + + AEP3 + +
1
AEP3 ; 24B-GAL4 ; + and AEP3 ; 24B-GAL4 ; +
y 24B-GAL4 + AEP3 24B-GAL4 +
Fig.42. Fly crosses to place the mesoderm driver in the AEP3 background.
The 24B-GAL4 carries a w+ marker giving red-eyed flies. AEP3 flies have 
white-eyes.
A) Males carrying the 24B-GALA driver on the second chromosome were crossed to 
AEP3 virgins.
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B) Resulting FI males were selected and crossed again to AEP3 virgins.
C) Red-eyed males were selected in the next generation alongside red-eyed virgins 
and these were inter-crossed.
D) Males and virgins were selected from the resulting progeny that had the darkest 
red eyes, and so were presumed to be homozygous for the driver. These were selfed 
and maintained for 3 generations to ensure that this was the case.
This scheme was repeated for both the alternative mesoderm drivers, and for 
WunGFP on the second chromosome, to make it homozygous in the AEP3 
background.
In order to express WunGFP in an hkb background driven by twist-GAL4, the 
following crosses were performed:
A)
+ : + : hkb X w : WunGFP : +
y + TM3,sb
1
w WunGFP +
w : WunGFP : hkb
+ + +
B)
twist-GAL4 : + : + X w : + : hkb
twist-GAL4 + + y + TM3,sb
1
▼
twist-GAL4 : + : hkb
y + +
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C)
w : WunGFP : hkb X twist-GAL4 : + : hkb
+ + + y + +
1
twist-GAL4 : WunGFP : hkb
w/+ + hkb
Fig.43. Fly crosses to place WunGFP in an hkb background with twist-GAL4.
A) Males heterozygous for  hkb on the third chromosome were crossed to virgins 
carrying WunGFP as a homozygous insert on the second chromosome. Virgins were 
selected in the next generation that lack the TM3,sb balancer.
B) Simultaneously, virgins homozygous for twist-GAL4 on the X chromosome were 
crossed to males heterozygous for  hkb on the third. Males were selected in the next 
generation that lack the TM3,sb balancer.
C) The selected virgins were crossed to the selected males. The result is a proportion 
o f embryos that express WunGFP in the mesoderm in an hkb homozygous 
background.
Bloomington Stocks:
• w[*]; P{w[+mW.hs]=GawB}how[24B] = 24B-GAL4 (1;3)
• w[l 118]; Dr[Mio]/TM3, P{w[+mC]=GAL4-twi.G}2.3, P{UAS- 
2xEGFP}AH2.3, Sb[l ] Ser[l ] = twist-GAL4 (1;3)
• hkb[21p[p]/TM3,p[+]Sb[l] 
twist-GAL4 (2) - a gift from Marcel van den Heuvel
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